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AcOH: acetic acid 
APT: attached proton test  
Ar: aryl 
B2A: but-2-enyl 
B3A: but-3-enoic 
BDE: bond dissociation energy 
BINAP: 2,2’-bis(diphenylphosphyno)-1,1’-binaphtalene 
Bn: benzyl 
BQ: benzoquinone 
CDCl3: chloroform deuterated  
DCE: dichloroethane  
DCM: dichloromethane 
DIPEA: N,N-diisopropylamine  
DMA: N,N-dimethylacetamide 
DMAP: 4-dimethylaminopyridine  
DMF: N,N-dimethylformamide 
DMSO: dimethylsulfoxide  
dppe: 1,2-bis(diphenylphosphino)ethane 
DPPF: 1,1′-ferrocenediyl-bis(diphenylphosphine) 
ee: enantiomeric excess 
Et3N: triethylamine 
HBQ: hydroquinone 
HCl: hydrochloric acid 
IR: infrared  
MeCN: acetonitrile 
MeOH: methanol 
MnO2: manganese dioxide 
Mp: melting point 
NBS: N-bromosuccinimide  
NCS: N-chlorosuccinimide 
NIS: N-iodosuccinimide 
NMP: N-methyl-2-pyrrolidone 
NMR: nuclear magnetic resonance 
NQ: naphthoquinone 
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Ns: nosyl 
Nu: nucleophile 
NXS: N-halosuccinimide  
OMe: methoxy 
Phth: phthalimide 
Piv: pivalate 
ppm: parts per million 
PTSA: p-toluenesulfonic acid  
py: pyridine 
r.t.: room temperature 
TBME: methyl tert-butyl ether  
THF: tetrahydrofuran 
Tol: toluene 
TOx: terminal oxidant  
Ts: tosyl  
Xantphos: 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene 
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In the past few decades, transition metal-catalyzed reactions have gained a fundamental role in 
organic chemistry. This is undisputed and underlined by the list of Nobel prizes assigned to chemistry 
in the last century: Sabatier in 1912, Ziegler and Natta in 1963, Wilkinson and Fischer in 1973, 
Sharpless, Noyori and Knowles in 2001, Grubbs, Schrock and Chauvin in 2005 and, most recently, in 
2010 Heck, Suzuki and Negishi for “palladium-catalyzed cross couplings in organic synthesis”. 
These three pioneering studies of palladium chemistry have developed independently a way to 
link organic molecules, which had previously been impossible, especially under mild reaction 
conditions and with the high degrees of selectivity and stereochemical control. These coupling 
reactions are now carried out routinely across the world, in research laboratories and industrial 
processes to assemble the building blocks of complex molecules.  
 
Since these discoveries, many other couplings catalyzed by various transition metals have been 
reported the last years. In this thesis, we focused more particularly on reactions catalyzed by late 
transition metals in high oxidation states. These metals allow the formation of new bonds in mild 
conditions starting from easily accessible substrates, often not pre-functionalized, working selectively 
even in presence of high complex functional groups.  
Among the most suitable starting material to perform these types of reactions with transition 
metals in high oxidation states, there are unactivated alkenes and alkynes that are extremely abundant 
chemical feedstocks, produced in large quantities from petrochemical sources. Consequently, they 
have been widely used for the synthesis of a vast range of organic chemical building blocks. A huge 
variety of synthetic transformations of multiple bonds is now achievable either at intermolecular or 
intramolecular level.  
The oxidation of alkenes (or alkynes) to introduce carbon–oxygen and other carbon–heteroatom 
bonds is a highly important process, which enables higher polarity molecules to be prepared from 
these abundant hydrocarbons. Metal-catalyzed oxidation reactions are particularly notable in this 
respect and a palladium-catalyzed alkene oxidation, the Wacker oxidation, was one of the first 
transition metal-catalyzed industrial processes, permitting the efficient generation of acetaldehyde 
from ethylene.  
 
These metal-catalyzed oxidation reactions involve the use of functional groups with similar 
electron properties, typically electron-rich groups, like C-C multiple bonds and alcohols or amines. The 
complexation of the metal to the multiple bonds generates an umpolung of reactivity, leading to a π-
complexed species, which is susceptible to undergo a nucleophilic attack. This approach, which avoids 
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the need of leaving groups, offers many advantages in terms of atom economy of the process and 
environmental impact.  
We can mechanistically differenciate these metal-catalyzed oxidations of C-C multiple bonds 
into different catalytic cycles based on the structure of isolated products. Two classes can imply 
catalytic cycles presented in Figure 1, allowing hydroamination or hydroalkoxylation reactions as well 
the alternative processes of amination or alkoxylation. In these catalytic cycles, the C-C multiple bond 
is activated by a complexation with an electron poor transition metal, allowing the nucleophilic attack.1 
The resulting-alkyl (or -vinyl complex) I, could undergo a demetallation process involving a hydrogen 
atom on the carbon in position (β-H elimination – Wacker-type process – Figure 1 left) or by the 
participation of an electrophile species (protonation – Figure 1 right). The result is an aminated and 
alkoxylated product deriving by a process involving amination or hydroamination, and alkoxylation or 
hydroalkoxylation, respectively. In any case, by the elimination step the catalytic species is 
regenerated. The preferency towards to one of the two paths depends by the type of metal employed 
and by the structural characteristics of the intermediate I, in turn related to the starting material.  
 
 
 
Figure 1: Possible Mechanism of Transition Metal-Catalyzed Reactions on Multiple Bonds. 
 
The other class of mechanism occurs, more precisely, during palladium-catalyzed reactions. 
Since the pioneering Wacker process was developed, a wide range of palladium-catalyzed oxidation 
reactions are commonly used in synthetic laboratories (Scheme 1, bottom – nucleopalladation 
                                                 
1 Collmann, J. P.; Hegedus, L. S.; Norton, J. R.; Finke, R.G. Principles and Applications of Organotransition Metal 
Chemistry, University Science Books, Mill Valley, CA, 1987. 
25 
 
mechanism). However, during these protocols and depending of the conditions used, an alternative 
mechanism to the Wacker-type catalytic cycle can take place if the substrate bears an allylic hydrogen 
atom in the α-position of the double bond. This latter can be removed and generate a η3-allyl palladium 
complex, which can be in situ trapped by a nucleophilic species to deliver the final compound (Scheme 
1, top – Allylic C-H activation process). 
 
 
 
Scheme 1: Pathways for Palladium-Catalyzed Alkene Oxidation. 
 
In this wide panorama of transition metals usable in catalysis, our attention has been directed 
towards the formation of carbon-nitrogen or carbon-oxygen bonds by palladium and copper 
complexes. In the first chapter, we will evoke the studies under intramolecular copper(II)- or 
palladium(II)-catalyzed alkoxylation of terminal triple and double bonds, and in the second chapter, 
new protocols of intermolecular palladium(II)-catalyzed allylic amination of β,γ-unsaturated 
compounds will be presented. 
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Introduction  
 
Since over the past few decades, one of the main challenges for an organic chemist is to find a way 
to produce synthetic or natural compounds in a more efficient and economical manner. Thus several 
highly regio- and stereo-selective procedures have been developed. Moreover, considering that one 
of the major problems in chemical production is the handling of waste, this drawback inescapably 
drives the chemists toward the search for environmental tolerable procedures since today there is not 
only the problem of what we can synthesize but also how we do it. In this panorama, the usefulness 
of reactions involving more than one bond formation in a single sequence without the isolation of the 
intermediates or without changing conditions is obvious.  
 
Bearing in mind this target, we will focus on transition metal-catalyzed reactions involving more 
precisely an alkoxylation reaction as well a second functionalization step in a single procedure, 
performed at intramolecular level and allowing the construction of oxygenated heterocycles, which 
are important motifs in many biologically active compounds. This ubiquity continues to justify the 
development of new methods for their preparation.  
 
In this chapter, we will present two methods for the construction of oxygen-containing 
heterocycles, such as a copper(II)-catalyzed intramolecular alkoxylation / halogenation of alkynyl ureas 
and secondary amides, and then a palladium(II)-catalyzed oxidative alkoxylation / arylation of alkenols.  
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1.1 Copper(II)-Catalyzed Intramolecular 
Alkoxyhalogenation Reactions of Alkynes 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
A highly effective synthesis of haloalkylidene-substituted heterocycles by copper(II)-catalyzed 
cyclization of alkynyl ureas and secondary amides has been developed. The reaction, which involves 
catalytic CuCl2 and stoichiometric amount of N-halosuccinimide, occurs selectively through an 
alkoxyhalogenation process. Alternatively, alkoxychlorination and alkoxybromination reactions can be 
performed working solely with stoichiometric CuCl2 or CuBr2 respectively. 
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1.1.1. Aim of This Work  
 
Processes leading to the generation of C−O bonds from multiple bonds have been reported in 
the literature, but these approaches are substantially devoted to the functionalization of alkenes and 
allenes. Related alkoxylation reactions involving alkynes are somewhat limited.2 
That is why, pursuing our ongoing project on intramolecular transition metal-catalyzed 
amination and alkoxylation reactions,3 we have investigated a copper-catalyzed alkoxylation / 
halogenation sequence of alkynyl derivatives. In particular, we focused on the use of alkynyl ureas and 
secondary amides to lead to a range of haloalkylidene-substutited heterocycles (Scheme 2).4 It should 
be note that among the reported alkoxylation, reactions based on the use of secondary amides or 
ureas as nucleophiles represent a useful tool to perform directly functionalized oxygenated 
heterocycles. Indeed, in principle, starting from alkynyl ureas and secondary amides the formation of 
an intramolecular bond could involve both the nitrogen and / or the oxygen atoms.5 However, in our 
procedure, as we see, the cyclization will take place only via the addition of the oxygen atom to the 
triple bond, leading to oxygenated heterocycles. 
 
                                                 
2 Hintermann, L. Topics in Organometallic Chemistry 2010, 31, 123. For Pd-catalyzed reactions, see: a) Asao, N.; 
Nogami, T.; Takahashi, K.; Yamamoto, Y. J. Am. Chem. Soc. 2002, 124, 764. b) Cavicchioli, M.; Decortiat, S.; Bouyssi, 
D.; Goré, J.; Balme, G. Tetrahedron 1996, 52, 11463. c) Rossi, R.; Bellina, F.; Biagetti, M.; Mannina, L. Tetrahedron Lett. 
1998, 39, 7599. d) Wang, Z.; Lu, X. J. Org. Chem. 1996, 61, 2254. For Cu-catalyzed reactions, see: e) Bates, C. G.; 
Saejueng, P.; Murphy, J. M.; Venkataraman, D. Org. Lett. 2002, 4, 4727. For Au-catalyzed reactions, see: f) Belting, V.; 
Krause, N. Org. Biomol. Chem. 2009, 7, 1221. g) Antoniotti, S.; Genin, E.; Michelet, V.; Genêt, J.-P. J. Am. Chem. Soc. 
2005, 127, 9976. For Ru-catalyzed reactions, see: h) Li, M.; Hua, R. J. Org. Chem. 2008, 73, 8658. For Ir-catalyzed 
reactions, see: i) Genin, E.; Antoniotti, S.; Michelet, V.; Genêt, J.-P. Angew. Chem. Int. Ed. 2005, 44, 4949. For Pt-
catalyzed reactions, see: j) Hartman, J. W.; Sperry, L. Tetrahedron Lett. 2004, 45, 3787. For Rh-catalyzed reactions, 
see: k) Isono, N.; Lautens, M. Org. Lett. 2009, 11, 1329. 
3 a) Broggini, G.; Poli, G.; Beccalli, E. M.; Brusa, F.; Gazzola, S.; Oble, J. Adv. Synth. Catal. 2015, 357, 677. b) Broggini, 
G.; Borsini, E.; Fasana, A.; Poli, G.; Liron, F. Eur. J. Org. Chem. 2012, 3617. c) Broggini, G.; Barbera, V.; Beccalli, E. M.; 
Borsini, E.; Galli, S.; Lanza, G.; Zecchi, G. Adv. Synth. Catal. 2012, 354, 159. d) Borsini, E.; Broggini, G.; Fasana, A.; Galli, 
S.; Khansaa, M.; Piarulli, U.; Rigamonti, M. Adv. Synth. Catal. 2011, 353, 985. e) Basolo, L.; Bernasconi, A.; Borsini, E.; 
Broggini, G.; Beccalli, E. M. ChemSusChem 2011, 4, 1637. f) Basolo, L.; Beccalli, E. M.; Borsini, E.; Broggini, G.; Khansaa, 
M.; Rigamonti, M. Eur. J. Org. Chem. 2010, 1694. g) Beccalli, E. M.; Broggini, G.; Clerici, F.; Galli, S.; Kammerer, C.; 
Rigamonti, M.; Sottocornola, S. Org. Lett. 2009, 11, 1563. 
4 Gazzola, S.; Beccalli, E. M.; Borelli, T.; Castellano, C.; Chiacchio, M. A.; Diamante, D.; Broggini, G. J. Org. Chem. 2015, 
80, 7226.  
5 a) Babij, N. R.; Wolfe, J. P.; Angew. Chem. Int. Ed. 2013, 52, 9247. b) Hopkins, B. A.; Wolfe, J. P.; Angew. Chem. Int. 
Ed. 2012, 51, 9886. c) Frits, J. A.; Nakhla, J. S.; Wolfe, J. P. Org. Lett. 2006, 8, 2531. d) Verniest, G.; Padwa, A. Org. Lett. 
2008, 10, 4379. e) Fritz, J. A.; Wolfe, J. P. Tetrahedron 2008, 64, 6838. f) Moon, N. G.; Harned, A. M. Tetrahedron Lett. 
2013, 54, 2960. g) Yu, J.; Yang, H.; Fu, H. Adv. Synth. Catal. 2014, 356, 3669. 
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Scheme 2: General Cu-Promoted Procedure for Haloalkylidene-Substituted Heterocycles. 
 
The appeal of copper as catalyst arises from its low cost and its tolerance towards many reactive 
functional groups. Moreover, the copper-catalyzed reactions do not require anaerobic or anhydrous 
conditions. These properties highly increased the development of processes for carbon-oxygen and 
carbon-nitrogen bond forming reactions. 
Nevertheless, at the best of our knowledge only a few examples of copper-promoted exo-
selective intramolecular alkyne alkoxylation have been reported in literature.6 Among these 
procedures, in 2009, Patil reported the use of Cu(OTf)2 as a catalyst for tandem hydroalkoxylation–
hydroarylation reaction of alkynes bearing hydroxyl group in presence of indoles (Scheme 3).6c 
 
 
 
Scheme 3: Cu(OTf)2 Catalyzed Hydroalkoxylation-Hydroarylation of Alkynols with Indoles. 
 
Later, in 2010 by Praveen et al., was reported an efficient regioselective Cu(OTf)2-catalyzed 5-
exo-dig hydroalkoxylation of 2-(ethynyl)benzyl alcohol, which provides a concise access to 
functionalized phthalans in high yields (Scheme 4).6b 
                                                 
6 a) Pouy, M. J.; Delp, S. A.; Uddin, J.; Ramdeen, V. M.; Cochrane, N. A.; Fortman, G. C.; Cundari Gunnoe, T. B.; Sabat, 
M.; Myers, W. H. ACS Catal. 2012, 2, 2182. b) Praven, C.; Iyyappan, C.; Perumal, P. T. Tetrahedron Lett. 2010, 51, 4767. 
c) Patil, N. T.; Raut, V. S.; Kavthe, R. D.; Reddy, V. V. N.; Raju, P. V. K. Tetrahedron Lett. 2009, 50, 6576. d) Wang, Y.; 
Jiang, M.; Liu, J.-T. Org. Chem. Front. 2015, 2, 542. 
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Scheme 4: Copper(II)-Catalyzed Synthesis of Phthalans via Hydroalkoxylation of 2-(Ethynyl)benzyl 
Alcohols. 
 
Successively, intramolecular hydroalkoxylation or hydroamination reactions of alkynes 
catalyzed by Cu(I) complexes bearing a N‑heterocyclic carbene ligand are reported by the group of 
Myers (Scheme 5).6a  
 
 
 
Scheme 5: Intramolecular Hydroalkoxylations and Hydroaminations of Alkynes. 
 
In 2015, a copper-catalyzed stereoselective oxytrifluoromethylation of propargyl amides for the 
construction of oxazolines was reported by Liu.6d This reaction took place in the presence of Togni’s 
reagent under mild conditions, giving the corresponding trifluoromethylated oxazoline derivatives in 
moderate to good yields (Scheme 6). Using CuBr as catalyst, the E-isomer was obtained as major 
product. However, the formation of Z-isomer with excellent stereoselectivity was also achieved when 
Cu(CH3CN)4PF6 as catalyst was used. 
 
36 
 
 
Scheme 6: CuBr Catalyzed Oxytrifluoromethylation of a Propargyl Amide.  
 
A stereoselective alkoxy / chlorocyclization of N-alkoxy-2-alkynylbenzamides promoted by CuCl2 
and NCS, both in large amounts, has been developed as a synthetic protocol for the preparation of 
isobenzofuran-1-one derivatives (Scheme 7).7  
 
 
 
Scheme 7: A Cyclization / Chloration of N-Alkoxy-2-alkynylbenzamides. 
 
Recently, the group of Xu has developed a cylization / iodation of terminal propargyl amides in 
the presence of stoichiometric amount of CuI and Selectfluor as terminal oxidant (Scheme 8).8  
 
 
 
Scheme 8: Iodocyclization of Terminal Propargyl Amides with CuI and Selectfluor. 
 
In view of these some examples, which involve all an important amount of copper salt, we have 
desired to extend the scope of alkoxylation-halogenation of alkynes using, on the one hand, special 
                                                 
7 Jithunsa, M.; Ueda, M.; Miyata, O. Org. Lett. 2011, 13, 518. 
8 Zhang, S.; Chen, Y.; Wang, J.; Pan, Y.; Xu, Z.; Tung, C.-H. Org. Chem. Front. 2015, 2, 578. 
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starting materials such as alkynyl ureas or secondary amides, and on the other hand by focusing in the 
use of a catalytic amount of copper as catalyst.  
 
1.1.2. Alkoxychlorination Sequence 
 
Firstly, to screen the effectiveness of various copper(II)-salts for the alkoxyhalogenation 
sequence, we explored the reactivity of 4-nitrophenyl propargyl urea 1a, assumed as a model 
substrate, treated in presence of a copper salt and an additive in different solvents. The results of this 
optimization are presented in Table 1.  
 
 
 
Entry** Copper salt Additive (equiv) Solvent* Time (h) Yield (%) 
1 CuCl2 (1 equiv) - MeCN 2 87 
2 CuCl (1 equiv) - MeCN 6 - 
3 CuCl2 (0.5 equiv) - MeCN 2 61 
4 CuCl2 (1 equiv) K2CO3 (1) MeCN 2 84 
5 CuCl2 (5 mol %) NCS (1) MeCN 5 51 
6 CuCl2 (10 mol %) NCS (1) MeCN 5 54 
7 - NCS (1) MeCN 8 - 
8 CuCl2 (10 mol %) LiCl (2) MeCN 8 3 
9 CuCl2 (5 mol %) NCS (1) Toluene 3 32 
10 CuCl2 (5 mol %) NCS (1) THF 3 51 
11 CuCl2 (5 mol %) NCS (1) DMF 3 - 
12 CuCl2 (5 mol %) NCS (1) DCE 6 18 
* Usually, the reactions were carried out at reflux, except the reaction in toluene or DMF, which were conducted at 90 °C or 
110 °C, respectively. 
** All the cyclization reactions were carried out under air atmosphere. 
 
Table 1: Optimization of Copper-Promoted Alkoxychlorination Conditions on 4-Nitrophenyl Propargyl 
Urea 1a. 
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The first trial was conducted in the presence of 1 equivalent of CuCl2 in acetonitrile at room 
temperature (entry 1) under air atmosphere. The expected oxazole product 2a, generated by a 5-exo-
dig cyclization, was isolated in 87% yield with the insertion of a chlorine atom coming from copper-
chloride salt. The E configuration given to the double carbon-carbon bond was assigned by comparison 
of the NMR spectrum with those of similar compounds reported in the literature.9 An experiment 
realized with one equivalent of copper(I) salt (CuCl) was inefficient, and gave only the recovered 
starting material (entry 2). Then, reducing by half the amount of copper(II) salt to 0.5 equivalent, the 
same expected oxazole was isolated, although in lower yield (61%) (entry 3). The treatment with a 
stoichiometric amount of CuCl2 and a base such as K2CO3 did not improve the reaction (entry 4). 
Afterwards, we tried to find other fruitful additives, which can allow the insertion of the chlorine atom 
in presence of a catalytic amount of copper-salt. N-chlorosuccinimide was proven to be a successful 
additive permitting to isolate the product 2a in 51% or 54% yield with a catalyst loading of 5 mol % or 
10 mol % respectively (entries 5 and 6). Working only in presence of NCS (entry 7), the reaction failed 
demonstrating that CuCl2 was essential for the alkoxychlorination sequence. Subsequently, another 
source of chlorine was investigated as LiCl, unfortunately the result was unsatisfactory (entry 8). 
Finally, keeping fixed 5 mol % of CuCl2 and a stoichiometric amount of N-chlorosuccinimide, a series of 
conditions in different solvents were screened. However, none of these variations provided the 
formation of 2a in better yields (entries 9-12).  
 
Once established the best conditions to perform the sequence (entry 5, 5 mol % of CuCl2 and 
one equivalent of NCS), various substituted alkynyl ureas were tested to extend the scope of this 
method.  
First, the use of aryl propargyl ureas 1b-i allowed the formation of (E)-5-(chloromethylidene) 
oxazole compounds 2b-i (Table 2, entries 1-8). All the cyclization products were obtained in good to 
excellent yields except for the 4-chlorophenyl-substituted oxazole derivative 2d. This behavior was 
completely unexpected and could not be attributed to the chlorine atom since the analogous urea 1i 
(bearing a chorine atom in the same position) underwent the reaction in 85% yield. This unsatisfactory 
outcome provided a complex mixture of degradation products even using a stoichiometric amount of 
CuCl2. Successively, aryl butynyl ureas were tested in the same reaction conditions permitting in these 
cases a 6-exo-dig-process. The cyclization of the ureas 1j-l furnished the expected 1,3-oxazine products 
in moderate yields (entries 9-11). Lastly, 1,2-disubstituted alkynes 1n-o treated in the cyclization / 
                                                 
9 a) Kimura, M.; Kure, S.; Yoshida, Z.; Tanaka, S.; Fugami, K.; Tamaru, Y. Tetrahedron Lett. 1990, 31, 4887. b) Ohe, K.; 
Ishihara, T.; Chatani, N.; Kawasaki, Y.; Murai, S.J. Org. Chem. 1991, 56, 2267. c) Tam, T.F.; Thomas, E.; Krants, A. 
Tetrahedron Lett. 1987, 28, 1127.  
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chlorination conditions permitted to synthesis of the desired 5-(arylidene)oxazole derivatives (entries 
12-13). 
 
 
 
Entry** Urea n R R’ R’’ Yield (%) 
1 1b 1 Me C6H5 H 2b (64) 
2 1c 1 Me 4-MeO-C6H4 H 2c (82) 
3 1d 1 Me 4-Cl-C6H4 H 2d (12) 
4 1e 1 Me 1-naphthyl H 2e (98) 
5 1f 1 Me 3,5-CF3-C6H3 H 2f (75) 
6 1g 1 Bn C6H5 H 2g (98) 
7 1h 1 Bn 4-NO2-C6H4 H 2h (71) 
8 1i 1 Bn 4-Cl-C6H4 H 2i (85) 
9 1j 2 Bn C6H5 H 2j (28) 
10 1k 2 Bn 4-NO2-C6H4 H 2k (56) 
11 1l 2 Bn 1-naphthyl H 2l (77) 
12 1n 1 Me C6H5 C6H5 2n (41) 
13 1o 1 Me 4-NO2-C6H4 4-MeO-C6H4 2o (37) 
** All the cyclization reactions were carried out under air atmosphere. 
 
Table 2: Scope of Cu(II)-Catalyzed Alkoxychlorination of Alkynyl Ureas. 
 
1.1.3. Alkoxybromination and Alkoxyiodination Sequences 
 
Since the applicability of the direct alkoxychlorination of alkynyl ureas is so wide and permits 
the isolation of the desired product in successful outcomes, we extended the procedure to the 
synthesis of bromo- and iodoalkylidene heterocycles.  
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Once adapted the reaction conditions, such as changing the halogen source, various alkoxy / 
bromo- and iodination sequence could be carried out effectively on various propargyl and butynyl 
ureas (Table 3). 
 
 
 
 
a Reaction conditions: alkynyl urea (1 mmol), CuBr2 (1 mmol). 
b Reaction conditions: alkynyl urea (1 mmol), CuCl2 (5 mol %), NXS (1 mmol). 
** All the cyclization reactions were carried out under air atmosphere. 
 
Table 3: Scope of Alkoxybromination and Alkoxyiodination Reactions of Alkynyl Ureas. 
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The reactions on the alkynyl ureas were performed with two different protocols: using 1 
equivalent of CuBr2 (conditions a) or 5 mol % of CuCl2 and a stoichiometric amount of N-
halosuccinimide (conditions b). More in details, bromo-derivatives 3 were obtained either with 
stoichiometric CuBr2 or with a catalytic amount of CuCl2 in the presence of 1 equivalent of N-
bromosuccinimide (NBS). For what concerns compounds 3a, d and m, the catalytic conditions b were 
also tried, and unfortunately the desired products were isolated only in low yields due to a complex 
tarry mixtures. Whereas for the iodo derivatives 4, both the oxazole and the 1,3-oxazine products, 
were synthesized by treatment of alkynyl ureas with catalytic amount of CuCl2 and one equivalent of 
NIS. In summary, whether for the alkoxybromination and for the alkoxyiodination sequence the 
isolated yields were good to excellent. 
 
Single X-ray diffraction10 performed on compound 4i revealed the presence of two 
independent molecules in the asymmetric unit, giving unambiguously the structure and the E 
configuration of the alkoxyhalogenation product (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: ORTEP view of the X-ray Structure of 5-Iodomethylidene-Substituted Oxazole Derivative 4i. 
 
 
                                                 
10 We acknowledge for the X-ray analysis Dr. Carlo Castellano, Chemistry Department, Università degli Studi di Milano. 
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1.1.4. Exploring Other Substrates 
 
Considering the importance of vinyl halides as structural motifs, we extended our investigation 
to the alkoxyhalogenation of others substrates. Keeping the same optimized conditions in hand, the 
sequence was performed from propargyl (hetero)aryl amides 5. However, while alkoxybrominations 
were unsatisfactory since the desired products were quite difficult to isolate from the complex reaction 
mixtures, the outcome of the process was satisfactory for both the synthesis of chloro and iodooxazole 
derivatives from aryl amides bearing either electron-withdrawing or electron-donating groups (5a, b, 
f) (Table 4). 
 
 
 
 
** All the cyclization reactions were carried out under air atmosphere. 
 
Table 4: Alkoxyhalogenation Reaction of Secondary (Hetero)aryl Alkynyl Amides. 
 
The 2-furyl- and 2-(1-methyl)pyrrolyl carboxyamides (5c-e) gave the alkoxyiodination products 6c-
e in low yields from a complex mixture enriched with degradation products. In addition, also the ,-
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disubstituted propargyl benzamides (5g) gave the expected chlorinated or iodinated products 6g and 
7g in moderate yields.  
 
1.1.5. Searching for Mechanistic Evidences 
 
Some general investigations were carried out in order to gain further insights into the 
elementary steps of the copper-promoted alkoxyhalogenation reactions.  
First, we investigated the reaction in standard conditions on our model substrate 1a in the 
presence of catalytic amount of CuCl2 and one equivalent of NCS in acetonitrile at reflux under nitrogen 
atmosphere (Scheme 9, path A). The recovered of starting material allowed us to conclude on the 
essential presence of molecular oxygen which acts as an oxidant able to regenerate the Cu(II) active 
catalytic species.  
To consolidate this hypothesis, bearing in mind the inertness of copper(I) chloride in the 
reaction, the experiment of entry 2 of Table 1 was repeated in the presence of molecular oxygen 
atmosphere (path B). In this case, this oxygen atmosphere promoted intramolecular C-O bond 
formation, however followed by proto-demetallation and isomerization process generating only the 
compound 8 in low yield. Moreover, the addition of NCS to the reaction involving a catalytic amount 
of CuCl under oxygen atmosphere led to the chloromethylidene product 2a in 49% yield (path C). This 
result allows determining the fundamental role of NCS as source of chlorine, which is confirmed by the 
reaction with LiCl as additive furnishing only the hydroalkoxylation / isomerization product 8 (path D). 
The difference in yields shown in paths B and D could derive from the more effective outcome of the 
cyclization step using a catalytic amount of CuCl (Scheme 9).  
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Scheme 9: General Mechanistic Investigations for Copper-Promoted Alkoxyhalogenation Reactions. 
 
Based on these experimental evidences collected, we postulated a plausible mechanism to 
explain the alkoxyhalogenation reactions with CuCl2 and N-halosuccinimide considering only the 
alkoxychlorination reaction of a general propargyl urea as a model example (Scheme 10).  
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Scheme 10: Proposed Mechanism of the Cu(II)-Catalyzed Alkoxychlorination Reactions. 
 
The catalytic cycle begins by the formation of a vinyl-copper intermediate A generated by an 
5-exo-dig cyclization during the nucleophilic attack of the oxygen atom on the activated carbon-carbon 
triple bond. Then, a deprotonation of A leads to the intermediate B. This latter can evolve in either a 
chloro-demetallation in presence of NCS or a reductive elimination giving the final product 2. Then, an 
oxidative treatment in the presence of HCl and molecular oxygen regenerates the copper(II) catalyst.  
 
1.1.6. Conclusions  
 
To sum up, we were able to develop a simple and efficient method of alkoxyhalogenation of 
alkynyl ureas and secondary amides with copper(II)-salts either in stoichiometric amount or as a 
catalyst in the presence of N-halosuccinimides. Moreover, the exocyclic haloalkylidene moieties could 
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become versatile building blocks in organic synthesis by further functionalizations for example with 
transition metal-catalyzed reactions as cross coupling processes. 
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Experimental Part 
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General methods  
 
Melting points are uncorrected. IR spectra were recorded on a FT-IR spectrophotometer. Column 
chromatography was performed on a silica gel 60 (mesh size 63-200 µm). Nuclear magnetic resonance 
spectra were recorded on 200, 300 or 400 MHz spectrometer for 1H NMR and 100 MHz spectrometer 
for 13C NMR. Chemical shifts () for proton nuclear magnetic resonance (1H NMR) spectra are reported 
in parts per million downfield relative to the center-line of the CDCl3 triplet at 7.26 ppm. Chemical 
shifts for carbon nuclear magnetic resonance (13C NMR) spectra are reported in parts per million 
downfield relative to the center-line of the CDCl3 triplet at 77.23 ppm. The abbreviations s, d, t and m 
stand for the resonance multiplicities singlet, doublet, triplet and multiplet, respectively. 13C spectra 
are 1H decoupled and multiplicities were determined by the APT pulse sequence.  
 
General procedure (GP1) for the preparation of ureas 1a-i. 
 
To a solution of alkynyl amine (1 mmol) in THF (5 mL), the suitable isocyanate (1 mmol) was added 
dropwise. The resulting mixture was stirred at room temperature for 16 h, then the solvent was 
removed under reduced pressure and the crude product resulted enough pure to be used in the 
subsequent step without further purification. 
 
N’-Methyl-N-(4-nitrophenyl)-N’-propargylurea (1a) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1a was afforded in 99% yield 
(230 mg, 1.0 mmol). Pale yellow solid, mp: 113 °C. 1H NMR (400 MHz, CDCl3)  2.35 (t, J = 2.5 Hz, 1H), 
3.13 (s, 3H), 4.20 (d, J = 2.5 Hz, 2H), 7.05 (br s, 1H, missing after deuteration), 7.57 (ddd, J = 10.0, 5.0, 
3.0 Hz, 2H), 8.14 (ddd, J = 10.0, 5.0, 3.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  34.5 (q), 38.2 (t), 73.2 (d), 
78.3 (s), 118.7 (d), 125.0 (d), 142.7 (s), 145.1 (s), 154.2 (s). IR (cm-1) : 1655 (C=O). MS (%) ESI 234 
[M+H]+. Anal. calcd for C11H11N3O3: C, 56.65; H, 4.75; N, 18.02. Found: C, 56.82; H, 4.98; N, 17.79. 
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N’-Methyl-N-phenyl-N’-propargylurea (1b) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1b was afforded in 93% yield 
(175 mg, 0.9 mmol). White solid, m.p.: 88 °C. 1H NMR (400 MHz, CDCl3)  2.31 (t, J = 2.5 Hz, 1H), 3.07 
(s, 3H), 4.17 (d, J = 2.5 Hz, 2H), 6.59 (br s, 1H, missing after deuteration), 7.04 (td, J = 8.0, 0.5 Hz, 1H), 
7.28 (td, J = 8.0, 0.5 Hz, 2H), 7.37-7-39 (m, 2H). 13C NMR (100 MHz, CDCl3)  34.2 (q), 37.9 (t), 72.6 (d), 
78.9 (s), 120.1 (d), 123.3 (d), 128.8 (d), 138.8 (s), 155.3 (s). IR (cm-1) max: 1680 (C=O). MS (%) ESI 189 
[M+H]+. Anal. calcd for C11H12N2O: C, 70.19; H, 6.43; N, 14.88. Found: C, 70.38; H, 6.21; N, 14.65. 
 
N-(4-Methoxyphenyl)-N’-methyl-N’-propargylurea (1c) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1c was afforded in 97% yield 
(211 mg, 1.0 mmol). Light brown solid, m.p.: 77 °C. 1H NMR (400 MHz, CDCl3)  2.30 (t, J = 2.5 Hz, 1H), 
3.06 (s, 3H), 3.78 (s, 3H), 4.18 (d, J = 2.5 Hz, 2H), 6.41 (br s, 1H, missing after deuteration), 6.83 (d, J = 
7.0 Hz, 2H), 7.27 (d, J = 7.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) 33.9 (q), 37.8 (t), 55.4 (q), 72.2 (d), 
79.3 (s), 113.9 (d), 122.9 (d), 132.1 (s), 155.8 (s), 156.1 (s).IR (cm-1) max: 1664 (C=O). MS (%) ESI 219 
[M+H]+. Anal. calcd for C12H14N2O2: C, 66.04; H, 6.47; N, 12.84. Found: C, 66.19; H, 6.23; N, 13.10. 
 
N-(4-Chlorophenyl)-N’-methyl-N’-propargylurea (1d) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1d was afforded in 98% yield 
(217 mg, 1.0 mmol). White solid, m.p.: 105-106 °C. 1H NMR (400 MHz, CDCl3)  2.33 (t, J = 2.5 Hz, 1H), 
3.08 (s, 3H), 4.18 (d, J = 2.5 Hz, 2H), 6.55 (br s, 1H, missing after deuteration), 7.23-7.26 (m, 2H), 7.32-
7.34 (m, 2H). 13C NMR (100 MHz, CDCl3)  34.3 (q), 38.0 (t), 72.7 (d), 78.7 (s), 121.2 (d), 128.3 (s), 128.8 
(d), 137.4 (s), 154.9 (s). IR (cm-1) max 1651 (C=O). MS (%) ESI 223 [M+H]+. Anal. calcd for C11H11ClN2O: 
C, 59.33; H, 4.98; N, 12.58. Found: C, 59.05; H, 5.17; N, 12.77. 
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N’-Methyl-N-(1-naphthyl)-N’-propargylurea (1e) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1e was afforded in 98% yield 
(233 mg, 1.0 mmol). White solid, m.p.: 111-112 °C. 1H NMR (400 MHz, CDCl3)  2.38 (t, J = 2.5 Hz, 1H), 
3.14 (s, 3H), 4.22 (d, J = 2.5 Hz, 2H), 6.89 (br s, 1H, missing after deuteration), 7.43-7.53 (m, 3H), 7.66 
(d, J = 8.0 Hz, 1H), 7.73 (d, J = 7.5 Hz, 1H), 7.85-7.89 (m, 2H). 13C NMR (100 MHz, CDCl3)  34.4 (q), 38.2 
(t), 72.8 (d), 78.9 (s), 120.9 (d), 121.0 (d), 125.1 (d), 125.7 (d), 125.8 (d), 126.1 (d), 127.9 (s), 128.7 (d), 
133.6 (s), 134.1 (s), 156.0 (s). IR (cm-1) max: 1648 (C=O). MS (%) ESI 239 [M+H]+. Anal. calcd for 
C15H14N2O: C, 75.61; H, 5.92; N, 11.76. Found: C, 75.46; H, 6.15; N, 11.56. 
 
N-[3,5-Bis(trifluoromethyl)phenyl]-N’-methyl-N’-propargylurea (1f) 
 
Following GP1 with N-methylpropargylamine (1.0 mmol). The product 1f was afforded in 94% yield 
(304 mg, 0.9 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.37 (t, J = 2.5 Hz, 1 H), 3.14 (s, 3H), 4.21 
(d, J = 2.5 Hz, 2H), 6.82 (br s, 1H, missing after deuteration), 7.53 (s, 1H), 7.90 (s, 2H). 13C NMR (100 
MHz, CDCl3)  34.3 (q), 38.1 (t), 73.2 (d), 78.2 (s), 116.4 (d), 116.6 (d), 119.4 (d), 121.8 (s), 124.5 (s), 
131.9 (s), 132.3 (s), 140.3 (s), 154.4 (s). IR (cm-1) max: 1662 (C=O). MS (%) ESI 325 [M+H]+. Anal. calcd 
for C13H10F6N2O: C, 48.16; H, 3.11; N, 8.64. Found: C, 48.29; H, 2.88; N, 8.85. 
 
N’-Benzyl-N-phenyl-N’-propargylurea (1g) 
 
Following GP1 with N-benzylpropargylamine (1.0 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 7:3) to afford 1g in 35% yield (92 mg, 
0.35 mmol). White solid, m.p.: 68 °C. 1H NMR (400 MHz, CDCl3)  2.36 (t, J = 2.0 Hz, 1H), 4.20 (d, J = 2.0 
Hz, 2H), 4.67 (s, 2H), 6.61 (br s, 1H, missing after deuteration), 6.98-7.07 (m, 1H), 7.21-7.46 (m, 9 H). 
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13C NMR (100 MHz, CDCl3)  36.7 (t), 50.7 (t), 73.1 (d), 79.0 (s), 119.9 (d), 123.3 (d), 127.4 (d), 127.9 (d), 
128.9 (d), 129.1 (d), 136.8 (s), 138.8 (s), 155.4 (s). IR (cm-1) max: 1639 (C=O). MS (%) ESI 265 [M+H]+. 
Anal. calcd for C17H16N2O: C, 77.25; H, 6.10; N, 10.60. Found: C, 77.22; H, 6.24; N, 10.41. 
 
N’-Benzyl-N-(4-nitrophenyl)-N’-propargylurea (1h) 
 
Following GP1 with N-benzylpropargylamine (1.0 mmol). The product 1h was afforded in 95% yield 
(294 mg, 0.95 mmol). White solid, m.p.: 72 °C. 1H NMR (400 MHz, CDCl3)  2.41 (t, J = 2.5 Hz, 1H), 4.21 
(d, J = 2.5 Hz, 2H), 4.68 (s, 2H), 7.08 (br s, 1H, missing after deuteration), 7.35-7.47 (m, 7H), 8.11 (d, J = 
8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  36.9 (t), 50.9 (t), 73.7 (d), 78.5 (s), 118.7 (d), 124.9 (d), 127.3 
(d), 128.3 (d), 129.2 (d), 136.1 (s), 142.6 (s), 145.1 (s), 154.4 (s). IR (cm-1) max: 1647 (C=O). MS (%) ESI 
310 [M+H]+. Anal. calcd for C17H15N3O3: C, 66.01; H, 4.89; N, 13.58. Found: C, 65.84; H, 5.19; N, 13.46. 
 
N’-Benzyl-N-(4-chlorophenyl)-N’-propargylurea (1i) 
 
Following GP1 with N-benzylpropargylamine (1.0 mmol). The product 1i was afforded in 98% yield (292 
mg, 1.0 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.36 (t, J = 2.5 Hz, 1H), 4.14 (d, J = 2.5 Hz, 2H), 
4.63 (s, 2H), 6.88 (br s, 1H, missing after deuteration), 7.20-7.41 (m, 9H). 13C NMR (100 MHz, CDCl3) 
36.6 (t), 50.5 (t), 73.2 (d), 78.9 (s), 121.5 (d), 127.4 (d), 128.0 (d), 128.6 (s), 128.7 (d), 129.1 (d), 136.6 
(s), 137.5 (s), 155.3 (s). IR (cm-1) max: 1663 (C=O). MS (%) ESI 299 [M+H]+. Anal. calcd for C17H15ClN2O: 
C, 68.34; H, 5.06; N, 9.38. Found: C, 68.46; H, 4.81; N, 9.11. 
 
General procedure (GP2) for the preparation of ureas 1j-m. 
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To a solution of N-benzylbutynylamine18 (1.0 mmol) in THF (5 mL), the suitable isocyanate (1.0 mmol) 
was added dropwise. The resulting mixture was stirred at room temperature for 16 h, then the solvent 
was removed under reduced pressure and the crude product was purified by silica gel column 
chromatography (eluent: AcOEt / petroleum ether 4:6). 
 
N’-Benzyl-N’-(butyn-4-yl)-N-phenylurea (1j) 
 
Following GP2 with N-benzylbutynylamine (1.0 mmol). The product 1j was afforded in 70% yield (195 
mg, 0.7 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.10 (t, J = 2.5 Hz, 1H), 2.53 (dt, J = 6.5, 2.5 
Hz, 2H), 3.61 (t, J = 6.5 Hz, 2H), 4.67 (s, 2H), 6.69 (br s, 1H, missing after deuteration), 6.99-7.03 (m, 
1H), 7.23-7.42 (m, 9H). 13C NMR (100 MHz, CDCl3)  18.6 (t), 47.1 (t), 51.4 (t), 70.6 (d), 82.2 (s), 119.9 
(d), 123.0 (d), 127.0 (d), 127.9 (d), 128.9 (d), 129.1 (d), 137.2 (s), 139.1 (s), 155.7 (s). IR (cm-1) max: 1666 
(C=O). MS (%) ESI 279 [M+H]+. Anal. calcd for C18H18N2O: C, 77.67; H, 6.52; N, 10.06. Found: C, 77.83; 
H, 6.71; N, 9.86. 
 
N’-Benzyl-N’-(butyn-4-yl)-N-(4-nitrophenyl)urea (1k) 
 
Following GP2 with N-benzylbutynylamine (1.0 mmol). The product 1k was afforded in 78% yield (252 
mg, 0.8 mmol). Pale yellow oil. 1H NMR (400 MHz, CDCl3)  2.14 (t, J = 2.5 Hz, 1H), 2.54 (dt, J = 6.5, 2.5 
Hz, 2H), 3.62 (t, J = 6.5 Hz, 2H), 4.67 (s, 2H), 7.23 (br s, 1H, missing after deuteration), 7.31-7.44 (m, 
7H), 8.10 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  18.5 (t), 47.0 (t), 51.4 (t), 71.1 (d), 82.0 (s), 
118.4 (d), 124.9 (d), 127.0 (d), 128.1 (d), 129.2 (d), 136.6 (s), 142.4 (s), 145.4 (s), 154.8 (s). IR (cm-1) 
max: 1658 (C=O). MS (%) ESI 324 [M+H]+. Anal. calcd for C18H17N3O3: C, 66.86; H, 5.30; N, 12.90. Found: 
C, 67.07; H, 5.15; N, 13.14. 
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N’-Benzyl-N’-(butyn-4-yl)-N-naphthylurea (1l) 
 
Following GP2 with N-benzylbutynylamine (1.0 mmol). The product 1l was afforded in 63% yield (207 
mg, 0.6 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.09 (t, J = 2.5 Hz, 1H), 2.65 (dt, J = 2.5, 6.5 
Hz, 2H), 3.76-3.80 (m, 2H), 4.79 (s, 2H), 6.80 (br s, 1H, missing after deuteration), 7.11 (d, J = 8.0 Hz, 
1H), 7.28 (d, J = 8.0 Hz, 1H), 7.39-7.49 (m, 7H), 7.60 (d, J = 8.0 Hz, 1H), 7.78-7.81 (m, 2H). 13C NMR (100 
MHz, CDCl3)  18.8 (t), 48.0 (t), 52.2 (t), 70.4 (d), 82.2 (s), 119.9 (d), 120.5 (d), 124.5 (d), 125.6 (d), 125.8 
(d), 126.9 (d), 127.3 (s), 128.1 (d), 128.6 (d), 129.3 (d), 133.7 (s), 134.1 (s), 137.2 (s) 156.1 (s). IR (cm-1) 
max: 1667 (C=O). MS (%) ESI 329 [M+H]+. Anal. calcd for C22H20N2O: C, 80.46; H, 6.14; N, 8.53. Found: 
C, 80.29; H, 6.21; N, 8.75. 
 
N’-Benzyl-N’-(butyn-4-yl)-N-(2-methoxyphenyl)urea (1m) 
 
Following GP2 with N-benzylbutynylamine (1.0 mmol). The product 1m was afforded in 67% yield (206 
mg, 0.7 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.05 (t, J = 2.5 Hz, 1H), 2.57 (dt, J = 2.5, 6.5 
Hz, 2H), 3.66 (s, 3H), 3.67 (t, J = 6.5 Hz, 2H), 4.67 (s, 2H), 6.77-6.80 (m, 1H), 6.90-6.95 (m, 2H), 7.17 (br 
s, 1H, missing after deuteration), 7.26-7.41 (m, 5H), 8.15-8.18 (m, 1H). 13C NMR (100 MHz, CDCl3)  
18.6 (t), 47.5 (t), 51.9 (t), 55.6 (q), 70.2 (d), 81.8 (s), 109.8 (d), 109.9 (s), 119.0 (d), 119.7 (d), 121.1 (d), 
122.0 (d), 122.8 (d), 126.9 (d), 127.7 (d), 128.9 (d), 137.1 (s), 147.7 (s), 155.2 (s). IR (cm-1) max: 1667 
(C=O). MS (%) ESI 309 [M+H]+. Anal. calcd for C19H20N2O2: C, 74.00; H, 6.54; N, 9.08. Found: C, 74.17; 
H, 6.68; N, 8.87. 
 
General procedure (GP3) for the preparation of ureas 1n-o. 
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To a solution of N-methylpropargylurea (1.0 mmol) in Et3N (12 mL) and under N2 atmosphere were 
added Pd(PPh3)4 (0.05 mmol), CuI (0.1 mmol) and Ar'I (1.2 mmol). The resulting mixture was stirred at 
room temperature for 2 h and then heated at 60 °C for 3 h. The solvent was removed under reduced 
pressure, then the crude was filtered through a short pad of silica with AcOEt and the solvent was 
removed under reduced pressure. The crude product was purified by silica gel column 
chromatography. 
 
N-Methyl-3-phenylprop-2-yn-1-amine 
 
Colorless oil (156 mg, 78%). 1H NMR (400 MHz, CDCl3)  3.15 (s, 3H), 4.45 (s, 2H), 6.77 (br s, 1H, 
missing after deuteration), 7.31-7.41 (m, 5H). These data are in good agreement with those 
reported in the literature.11 
 
3-(4-Methoxyphenyl)-N-methylprop-2-yn-1-amine 
 
Yellow oil (150 mg, 59%). 1H NMR (400 MHz, CDCl3) δ 3.15 (s, 3H), 3.84 (s, 3H), 4.38 (s, 2H), 6.85 (d, J = 
9.0 Hz, 2H), 7.18 (br s, 1H, missing after deuteration), 7.37 (d, J = 9.0 Hz, 2H). These data are in good 
agreement with those reported in the literature.12 
 
 
 
 
 
 
                                                 
11 Hong, L.; Shao, Y.; Zhang, L.; Zhou, X.; Chem. Eur. J. 2014, 20, 8551-8555. 
12 Lemhadri, M.; Doucet, H.; Santelli, M. Synthesis 2005, 8, 1359-1367. 
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N’-Methyl-N’-(1-phenylpropyn-3-yl)-N-phenylurea (1n) 
 
Following GP3 with N-methylpropargylurea (1.0 mmol) The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 1n in 41% yield (108 mg, 
0.4 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.13 (s, 3H), 4.41 (s, 2H), 6.70 (br s, 1H, missing 
after deuteration), 7.29-7.46 (m, 10H). 13C NMR (100 MHz, CDCl3) δ 34.3 (q), 38.8 (t), 84.4 (s), 84.4 (s), 
119.1 (d), 120.3 (d), 120.5 (d), 122.2 (s), 122.6 (d), 122.9 (d), 128.4 (d), 128.5 (d), 128.7 (d), 131.8 (d), 
132.0 (d), 139.2 (s), 155.6 (s). IR (cm-1) max: 1637 (C=O). MS (%) ESI 265 [M+H]+. Anal. calcd for 
C17H16N2O: C, 77.25; H, 6.10; N, 10.60. Found: C,77.37; H, 5.89; N, 10.69. 
 
N’-Methyl-N’-[1-(4-methoxyphenyl)propyn-3-yl]-N-(4-nitrophenyl)urea (1o) 
 
Following GP3 with N-methylpropargylurea (1.0 mmol) The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 1o in 30% yield (102 mg, 
0.3 mmol). Pale orange oil. 1H NMR (400 MHz, CDCl3) δ 3.17 (s, 3H), 3.82 (s, 3H), 4.40 (s, 2H), 6.85 (d, J 
= 9.0 Hz, 2H), 7.18 (br s, 1H, missing after deuteration), 7.37 (d, J = 9.0 Hz, 2H), 7.58 (d, J = 9.0 Hz, 2H), 
8.15 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 30.5 (q), 39.1 (t), 55.3 (q), 81.9 (s), 85.0 (s), 113.3 
(d), 114.3 (s), 117.9 (d), 124.9 (d), 133.2 (d), 142.4 (s), 145.6 (s), 154.5 (s), 159.92 (s). IR (cm-1) max: 
1629 (C=O). MS (%) ESI 340 [M+H]+. Anal. calcd for C18H17N3O4: C, 63.71; H, 5.05; N, 12.38. Found: C, 
63.87; H, 4.81; N, 12.21. 
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General procedure (GP4) for stoichiometric intramolecular alkoxyhalogenation of alkynyl ureas. 
 
A solution of alkynyl urea (1.0 mmol) and CuX2 (1 mmol) in MeCN (14 mL) was heated at reflux for 6 h 
under air atmosphere. The solvent was removed under reduced pressure and the crude product was 
purified by silica gel column chromatography. 
 
(E)-5-(Chloromethylidene)-3-methyl-2-[(4-nitrophenyl)imino]-oxazolidine (2a) 
 
Following GP4 with urea 1a (1.0 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 2a in 87% yield 
(232 mg, 0.9 mmol). Pale yellow oil. 1H NMR (400 MHz, CDCl3)  3.14 (s, 3H), 4.32 (d, J = 3.0 Hz, 
2H), 6.00 (t, J = 3.0 Hz, 1H), 7.13 (d, J = 9.0 Hz, 2H), 8.14 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, 
CDCl3)  31.7 (q), 49.8 (t), 96.7 (d), 123.7 (d), 124.6 (d), 142.8 (s), 147.3(s), 150.6 (s), 152.8 (s). 
IR (cm-1) max: 1662 (C=N). MS (%) ESI 268 [M+H]+. Anal. calcd for C11H10ClN3O3: C, 49.36; H, 3.77; 
N, 15.70. Found: C, 49.59; H, 3.54; N, 15.85. 
 
(E)-5-(Bromomethylidene)-3-methyl-2-[(4-nitrophenyl)imino]-oxazolidine (3a) 
 
Following GP4 with urea 1a (1.0 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 3a in 94% yield 
(292 mg, 0.9 mmol). White solid, m.p.: 210-211 °C. 1H NMR (400 MHz, CDCl3)  3.03 (s, 3H), 
4.18 (d, J = 3.0 Hz, 2H), 5.90 (t, J = 3.0 Hz, 1H), 7.07 (d, J = 9.0 Hz, 2H), 8.07 (d, J = 9.0 Hz, 2H). 
13C NMR (100 MHz, CDCl3)  31.7 (q), 51.1 (t), 83.3 (d), 123.7 (d), 124.6 (d), 142.7 (s), 148.1 (s), 
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150.4 (s), 153.2 (s). IR (cm-1) max: 1658 (C=N). MS (%) ESI 312 [M+H]+. Anal. calcd for 
C11H10BrN3O3: C, 42.33; H, 3.23; N, 13.46. Found: C, 42.52; H, 3.47; N, 13.21. 
 
(E)-5-(Bromomethylidene)-2-[(4-chlorophenyl)imino]-3-methyl-oxazolidine (3d) 
 
Following GP4 with urea 1d (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 3d in 95% yield (285 mg, 0.9 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  3.03 (s, 3H), 4.16 (d, J = 3.0 Hz, 2H), 5.86 (t, J = 3.0 Hz, 1H), 6.97 (d, J = 
9.0 Hz, 2H), 7.21 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  31.7 (q), 51.1 (t), 82.5 (d), 124.7 (d), 
127.6 (s), 128.6 (d), 144.8 (s), 148.5 (s), 149.9 (s). IR (cm-1) max: 1653 (C=N). MS: m/z 301 (M+). Anal. 
calcd for C11H10BrClN2O: C, 43.81; H, 3.34; N, 9.29. Found: C, 43.90; H, 3.58; N, 9.55. 
 
(E)-3-Benzyl-6-(bromomethylidene)-2-[(2-methoxyphenyl)imino]-2,3,4,5-tetrahydro-2H-1,3-
oxazine (3m) 
 
Following GP4 with urea 1m (1.0 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 3m in 62% yield 
(239 mg, 0.6 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.74 (t, J = 6.0 Hz, 2H), 3.32 (t, J 
= 6.0 Hz, 2H), 3.81 (s, 3H), 4.82 (br s, 2H), 5.77 (s, 1H), 6.82-7.08 (m, 3H), 7.30-7.45 (m, 6H). 13C 
NMR (CDCl3) 25.1 (t), 41.9 (t), 53.3 (t), 56.0 (q), 89.1 (d), 114.6 (d), 123.5 (d), 127.8 (d), 128.3 
(d), 128.9 (d), 131.9 (s), 136.5 (s), 149.4 (s), 152.7 (s), 162.2 (s). IR (cm-1) max: 1641 (C=N). MS 
(%) ESI 387 [M+H]+. Anal. calcd for C19H19BrN2O2: C, 58.93; H, 4.95; N, 7.23. Found: C, 59.19; H, 
4.74; N, 7.49. 
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General procedure (GP5) for catalytic intramolecular alkoxyhalogenation of alkynyl ureas.  
 
A solution of alkynyl urea (1.0 mmol), CuCl2 (0.05 mmol) and the suitable NXS (1 mmol) in MeCN (14 
mL) was heated at reflux for 6 h under air atmosphere. The solvent was removed under reduced 
pressure and, when required, the crude product was purified by silica gel column chromatography. 
 
(E)-5-(Chloromethylidene)-3-methyl-2-(phenylimino)oxazolidine (2b) 
 
Following GP5 with urea 1b (1 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2b in 64% yield (142 mg, 0.6 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 3.01 (s, 3H), 4.17 (d, J = 3.0 Hz, 2H), 5.90 (t, J = 3.0 Hz, 1H), 7.03-7.09 
(m, 3H), 7.29 (t, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 31.6 (q), 49.7 (t), 95.7 (d), 122.7 (d), 123.3 
(d), 128.6 (d), 146.3 (s), 148.2 (s), 149.5 (s). IR (cm-1) max: 1643 (C=N). MS (%) ESI 223 [M+H]+. Anal. 
calcd for C11H11ClN2O: C, 59.33; H, 4.98; N, 12.58. Found: C, 59.45; H, 5.29; N, 12.28.  
 
(E)-5-(Chloromethylidene)-2-[(4-methoxyphenyl)imino]-3-methyloxazolidine (2c) 
 
Following GP5 with urea 1c (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2c in 82% yield (207 mg, 0.8 mmol). White 
solid, m.p.: 137 °C. 1H NMR (400 MHz, CDCl3) δ 3.01 (s, 3H), 3.76 (s, 3H), 4.19 (d, J = 3.0 Hz, 2H), 5.89 
(t, J = 3.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.97 (d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ31.8 (q), 
49.8 (t), 55.4 (q), 95.5 (d), 113.9 (d), 124.1 (d), 139.2 (s), 148.1 (s), 149.3 (s), 155.3 (s). IR (cm-1) max: 
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1657 (C=N). MS (%) ESI 253 [M+H]+. Anal. calcd for C12H13ClN2O2: C, 57.04; H, 5.19; N, 11.09. Found: C, 
57.21; H, 4.99; N, 11.37. 
 
(E)-5-(Chloromethylidene)-2-[(4-chlorophenyl)imino]-3-methyloxazolidine (2d) 
 
Following GP5 with urea 1d (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2d in 12% yield (30 mg, 0.1 mmol). White 
solid, m.p.: 188 °C. 1H NMR (400 MHz, CDCl3) δ 3.15 (s, 3H), 4.30 (d, J = 3.0 Hz, 2H), 5.97 (t, J = 3.0 Hz, 
1H), 7.04 (d, J = 9.0 Hz, 2H), 7.22 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ32.1 (q), 50.3 (t), 97.2 
(d), 124.8 (d), 128.8 (d), 142.4 (s), 147.4 (s), 151.2 (s), 167.3 (s). IR (cm-1) max: 1661 (C=N). MS (%) ESI 
257 [M+H]+. Anal. calcd for C11H10 Cl2N2O: C, 51.38; H, 3.92; N, 10.90. Found: C, 51.60; H, 3.73; N, 11.15. 
 
(E)-5-(Chloromethylidene)-3-methyl-2-[(1-naphthyl)imino]-oxazolidine (2e) 
 
Following GP5 with urea 1e (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2e in 98% yield (266 mg, 0.9 mmol). Pale 
yellow oil. 1H NMR (400 MHz, CDCl3)  3.12 (s, 3H), 4.20 (d, J = 3.0 Hz, 2H), 5.85 (t, J = 3.0 Hz, 
1H), 7.18 (d, J = 7.5 Hz, 1H), 7.43-7.51 (m, 3H), 7.59 (d, J = 8.0 Hz, 1H) 7.84 (dd, J = 6.5, 3.0 Hz, 
1H), 7.25 (dd, J = 6.5, 3.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) 31.8 (q), 49.9 (t), 95.7 (d), 117.9 
(d), 122.7 (d), 124.1 (d), 125.1 (d), 125.9 (d), 127.8 (d), 129.3 (s), 134.3 (s), 142.7 (s), 148.0 (s), 
149.6 (s). IR (cm-1) max: 1668 (C=N). MS (%) ESI 273 [M+H]+. Anal. calcd for C15H13ClN2O: C, 66.06; 
H, 4.80; N, 10.27. Found: C, 65.87; H, 5.11; N, 10.51. 
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(E)-2-[3,5-Bis(trifluoromethyl)phenylimino]-5-(chloromethylidene)-3-methyloxazolidine (2f)  
 
Following GP5 with urea 1f (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2f in 75% yield (268 mg, 0.7 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 3.10 (s, 3H), 4.30 (d, J = 3.0 Hz, 2H), 5.99 (t, J = 3.0 Hz, 1H), 7.50 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 31.9 (q), 50.2 (t), 97.9 (d), 116.6 (d), 123.3 (q, J = 271.0, Hz), 123.9 (d), 
131.9 (q, J = 33.0 Hz), 145.9 (s), 147.0 (s), 151.7 (s). IR (cm-1) max: 1668 (C=N). MS (%) ESI 359 [M+H]+. 
Anal. calcd for C13H9ClF6N2O: C, 43.53; H, 2.53; N, 7.81. Found C, 43.76; H, 2.29; N, 7.99. 
 
(E)-3-Benzyl-5-(chloromethylidene)-2-(phenylimino)oxazolidine (2g) 
 
Following GP5 with urea 1g (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2g in 98% yield (292 mg, 0.9 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 4.12 (d, J = 3.0 Hz, 2H), 4.74 (br s, 2H), 5.91 (t, J = 3.0 Hz, 1H), 7.06-7.11 
(m, 3H), 7.27-7.44 (m, 7H). 13C-NMR (100 MHz, CDCl3) δ 47.2 (t), 48.8 (t), 96.3 (d), 119.9 (d), 123.3 (d), 
123.7 (d), 128.1 (d), 128.4 (d), 128.9 (d), 145.3 (s), 148.1 (s), 149.9 (s), 171.1 (s). IR (cm-1) max: 1632 
(C=N). MS (%) ESI 299 [M+H]+. Anal. calcd for C17H15ClN2O: C, 68.34; H, 5.06; N, 9.38. Found: C, 68.58; 
H, 5.17; N, 9.21. 
 
(E)-3-Benzyl-5-(chloromethylidene)-2-[(4-nitrophenyl)imino]-oxazolidine (2h) 
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Following GP5 with urea 1h (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2h in 71% yield (243 mg, 0.7 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 4.16 (d, J = 3.0 Hz, 2H), 4.68 (s, 2H), 5.99 (t, J = 3.0 Hz, 1H), 7.17(d, J = 
9.0 Hz, 2H), 7.35-7.44 (m, 5H), 8.15 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 47.1 (t), 48.7 (t), 
97.0 (d), 123.8 (d), 124.7 (d), 124.9 (d), 125.1 (d), 128.3 (d), 128.6 (d), 135.0 (s), 142.8 (s), 147.5 (s), 
150.3 (s), 153.0 (s). IR (cm-1) max: 1590 (C=N). MS (%) ESI 344 [M+H]+. Anal. calcd for C17H14ClN3O3: C, 
59.40; H, 4.10; N, 12.22. Found: C, 59.58; H, 3.78; N, 12.31. 
 
(E)-3-Benzyl-5-(chloromethylidene)-2-[(4-chlorophenyl)imino]-oxazolidine (2i) 
 
Following GP5 with urea 1i (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2i in 85% yield (282 mg, 0.8 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 4.10 (d, J = 3.0 Hz, 2H), 4.63 (s, 2H), 5.92 (t, J = 3.0 Hz, 1H), 7.03 (d, J = 
9.0 Hz, 2H), 7.24 (d, J = 9.0 Hz, 2H), 7.37-7.41 (m, 5H). 13C-NMR (100 MHz, CDCl3) δ 47.1 (t), 48.7 (t), 
96.1 (d), 124.7 (d), 127.7 (s), 128.8 (d), 128.9 (d), 129.1 (d), 129.2 (d), 135.5 (s), 144.8 (s), 148.0 (s), 
149.3 (s). IR (cm-1) max: 1669 (C=N). MS (%) ESI 333 [M+H]+. Anal. calcd for C17H14Cl2N2O: C, 61.28; H, 
4.23; N, 8.41. Found: C, 61.11; H, 4.40; N, 8.69. 
 
(E)-3-Benzyl-6-(chloromethylidene)-2-(phenylimino)-2,3,4,5-tetrahydro-2H-1,3-oxazine (2j) 
 
Following GP5 with urea 1j (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2j in 28% yield (87 mg, 0.2 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 2.79 (td, J = 6.0, 1.5 Hz, 2H), 3.28 (t, J = 6.0 Hz, 2H), 4.82 (s, 2H), 5.88 (t, 
J = 1.5 Hz, 1H), 7.01-7.05 (m, 3H), 7.26-7.42 (m, 7H). 13C NMR (100 MHz, CDCl3) δ 23.4 (t), 41.8 (t), 53.3 
(t), 101.6 (d), 122.4 (d), 123.6 (d), 127.7 (d), 128.2 (d), 128.4 (d), 128.5 (d), 128.7 (d), 136.7 (s), 140.9 
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(s), 146.2 (s), 148.9 (s). IR (cm-1) max: 1641 (C=N). MS (%) ESI 313 [M+H]+. Anal. calcd for C22H19ClN2O: 
C, 69.12; H, 5.48; N, 8.96. Found: C, 69.31; H, 5.62; N, 8.65. 
 
(E)-3-Benzyl-6-(chloromethylidene)-2-[(4-nitrophenyl)imino]-2,3,4,5-tetrahydro-2H-1,3-oxazine (2k)  
 
Following GP5 with urea 1k (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2k in 56% yield (199 mg, 0.5 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 2.84 (t, J = 6.0 Hz, 2H), 3.36 (t, J = 6.0 Hz, 2H), 4.84 (s, 2H), 5.94 (br s, 
1H), 7.11 (d, J = 8.5 Hz, 2H), 7.34-7.40 (m, 5H), 8.15 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 22.9 
(t), 42.0 (t), 53.7 (t), 102.6 (d), 123.9 (d), 124.6 (d), 128.0 (d), 128.1 (d), 128.9 (d), 135.9 (s), 142.5 (s), 
145.1 (s), 147.1 (s), 148.3 (s). IR (cm-1) max: 1641 (C=N). MS (%) ESI 358 [M+H]+. Anal. calcd for 
C18H16ClN3O3: C, 60.42; H, 4.51; N, 11.74. Found: C, 60.71; H, 4.29; N, 11.95. 
 
(E)-3-Benzyl-6-(chloromethylidene)-2-(naphthylimino)-2,3,4,5-tetrahydro-2H-1,3-oxazine (2l) 
 
Following GP5 with urea 1l (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2l in 77% yield (278 mg, 0.8 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 2.81-2.85 (m, 2H), 3.37 (t, J = 6.0 Hz, 2H), 4.91 (s, 2H), 5.73 (s, 1H), 6.97 
(d, J = 8.0 Hz, 1H), 7.33-7.58 (m, 9H), 7.95-8.08 (m, 1H), 8.12-8.24 (m, 1H). 13C NMR (100 MHz, CDCl3) 
δ 23.3 (t), 42.2 (t), 53.6 (t), 101.6 (d), 113.8 (s), 117.9 (d), 124.2 (d), 124.7 (d), 125.0 (s), 125.4 (d), 126.0 
(d), 126.3 (d), 126.7 (d), 127.7 (d), 128.8 (d), 129.4 (s), 131.2 (s), 136.9 (s), 142.7 (s). IR (cm-1) max: 1641 
(C=N). MS (%) ESI 363 [M+H]+. Anal. calcd for C22H19ClN2O: C, 72.82; H, 5.28; N, 7.72. Found: C, 72.98; 
H, 5.12; N, 8.05. 
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(Z)-5-[Chloro(phenyl)methylidene]-3-methyl-2-(phenylimino)-oxazolidine (2n) 
 
Following GP5 with urea 1n (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 4:6) to afford 2n in 41% yield (122 mg, 0.4 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 3.13 (s, 3H), 4.41 (s, 2H), 7.24-7.46 (m, 10H). 13C NMR (100 MHz, CDCl3) 
δ 34.4 (q), 38.9 (t), 83.9 (s), 84.6 (s), 120.3 (d), 122.4 (s), 123.4 (d), 128.4 (d), 128.6 (d), 128.8 (d), 131.8 
(d), 137.6 (s), 138.8 (s), 155.5 (s). IR (cm-1) max: 1668 (C=N). MS (%) ESI 299 [M+H]+. Anal. calcd for 
C17H15ClN2O: C, 68.34; H, 5.06; N, 9.38. Found C, 68.19; H, 5.35; N, 9.62. 
 
(Z)-5-[Chloro(4-methoxyphenyl)methylidene]-3-methyl-2-[(4-nitrophenyl)imino]oxazolidine (2o) 
 
Following GP5 with urea 1o (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 2o in 37% yield (138 mg, 0.4 mmol). White 
solid. 1H NMR (400 MHz, CDCl3) δ 3.19 (s, 3H), 3.84 (s, 3H), 4.51 (s, 2H), 6.86 (d, J = 9.0 Hz, 2H), 7.21 (d, 
J = 9.0 Hz, 2H), 7.55 (d, J = 8.5 Hz, 2H), 8.13 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 31.8 (q), 
52.1 (t), 55.4 (q), 111.2 (s), 113.7 (d), 123.7 (d), 124.6 (d), 128.6 (d), 139.9 (s), 142.8 (s),145.6 (s),151.5 
(s),152.5 (s),159.7 (s). IR (cm-1) max: 1671 (C=N). MS (%) ESI 374 [M+H]+. Anal. calcd for C18H16ClN3O4: 
C, 57.84; H, 4.31; N, 11.24. Found C, 57.99; H, 4.04; N, 11.47. 
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(E)-5-(Bromomethylidene)-2-[3,5-bis(trifluoromethyl)phenylimino]-3-methyloxazolidine (3f) 
 
Following GP5 with urea 1f (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 3f in 74% yield (297 mg, 0.7 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) 3.08 (s, 3H), 4.24 (d, J = 3.0 Hz, 2H), 5.96 (t, J = 3.0 Hz, 1H), 7.47 
(br s, 3H). 13C NMR (100 MHz, CDCl3) 31.7 (q), 51.2 (t), 83.7 (d), 116.1 (d), 123.7 (d), 123.4 (q, 
J = 271.0 Hz), 131.8 (q, J = 32.5 Hz), 147.2 (s), 147.8 (s), 151.2 (s). IR (cm-1) max: 1653 (C=N). MS 
(%) ESI 403 [M+H]+. Anal. calcd for C13H9BrF6N2O: C, 38.73; H, 2.25; N, 6.95. Found: C, 38.43; H, 
2.06; N, 7.13. 
 
(E)-3-Benzyl-5-(bromomethylidene)-2-[(4-chlorophenyl)imino]-oxazolidine (3i) 
 
Following GP5 with urea 1i (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 1:4) to afford 3i in 42% yield (157 mg, 0.4 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  4.06 (d, J = 3.0 Hz, 2H), 4.68 (s, 2H), 5.89 (t, J = 3.0 Hz, 1H), 7.04 (d, J = 
8.5 Hz, 2H), 7.20-7.29 (m, 2H), 7.32-7.46 (m, 5H). 13C NMR (100 MHz, CDCl3) 29.7 (t), 48.8 (t), 83.7 
(d), 124.9 (d), 128.1 (d), 128.3 (d), 128.7 (d), 129.0 (d), 132.1 (s), 134.8 (s), 143.2 (s), 148.1 (s), 150.8 
(s). IR (cm-1) max: 1641 (C=N). MS: m/z 377 (M+). Anal. calcd for C17H14BrClN2O: C, 54.06; H, 3.74; N, 
7.42. Found: C, 54.10; H, 3.97; N, 7.65. 
 
(E)-5-(Iodomethylidene)-3-methyl-2-[(4-nitrophenyl)imino]-oxazolidine (4a) 
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Following GP5 with urea 1a (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 4a in 68% yield (244 mg, 0.7 mmol). White 
solid, m.p.: 133 °C. 1H NMR (400 MHz, CDCl3)  3.11 (s, 3H), 4.22 (d, J = 3.0 Hz, 2H), 5.80 (t, J = 3.0 Hz, 
1H), 7.13 (d, J = 9.0 Hz, 2H), 8.14 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) 31.6 (q), 50.5 (d), 53.4 
(t), 123.8 (d), 124.6 (d), 142.5 (s), 149.9 (s), 151.3 (s), 153.1 (s). IR (cm-1) max: 1642 (C=N). MS: m/z 359 
(M+). Anal. calcd for C11H10IN3O3: C, 36.79; H, 2.81; N, 11.70. Found: C, 37.02; H, 2.52; N, 11.91. 
 
(E)-5-(Iodomethylidene)-3-methyl-2-(phenylimino)oxazolidine (4b) 
 
Following GP5 with urea 1b (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 4b in 63% yield (197 mg, 0.6 mmol). Pale 
yellow oil. 1H NMR (400 MHz, CDCl3)  3.11 (s, 3H), 4.17 (d, J = 2.5 Hz, 2H), 5.80 (t, J = 3.0 Hz, 1H), 7.02-
7.08 (m, 2H), 7.25-7.30 (m, 3H). 13C NMR (100 MHz, CDCl3) 31.9 (q), 49.6 (d), 53.6 (t), 122.9 (d), 123.3 
(d), 128.7 (d), 145.3 (s), 150.5 (s), 150.6 (s). IR (cm-1) max: 1644 (C=N). MS: m/z 314 (M+). Anal. calcd 
for C11H11IN2O: C, 42.06; H, 3.53; N, 8.92. Found: C, 42.01; H, 3.77, N, 8.59. 
 
(E)-2-[(4-Chlorophenyl)imino]-5-(iodomethylidene)-3-methyloxazolidine (4d) 
 
Following GP5 with urea 1d (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 4d in 95% yield (330 mg, 0.9 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3) 2.97 (s, 3H), 4.08 (d, J = 2.5 Hz, 2H), 5.64 (t, J = 2.5 Hz, 1H), 6.95 
(dd, J = 7.0, 2.0 Hz, 1H), 7.18 (dd, J = 7.0, 2.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) 31.6 (q), 49.5 
(d), 53.4 (t), 124.8 (d), 128.5 (d), 137.6 (s), 144.9 (s), 150.5 (s), 178.2 (s) IR (cm-1) max: 1649 (C=N). 
MS (%) ESI 349 [M+H]+. Anal. calcd for C11H10ClIN2O: C, 37.90; H, 2.89; N, 8.04. Found: C, 38.12; 
H, 2.61; N, 8.29. 
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(E)-5-(Iodomethylidene)-2-[(1-naphthyl)imino]-3-methyloxazolidine (4e) 
 
Following GP5 with urea 1e (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 4e in 73% yield (266 mg, 0.7 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  3.08 (s, 3H), 4.05 (d, J = 2.5 Hz, 2H), 5.62 (t, J = 2.5 Hz, 1H), 7.23 (d, J = 
8.0 Hz, 2H), 7.46-7.55 (m, 3H), 7.61 (d, J = 8.0 Hz, 2H) 7.87-7.89 (m, 1H), 8.30-8.33 (m, 1H). 13C NMR 
(100 MHz, CDCl3) 31.7 (q), 49.4 (d), 53.5 (t), 118.0 (d), 122.7 (d), 124.2 (d), 125.1 (d), 125.9 (d), 126.0 
(d), 127.8 (d), 129.4 (s), 134.3 (s), 142.7 (s), 150.2 (s), 150.7 (s). IR (cm-1) max: 1653 (C=N). MS (%) ESI 
365 [M+H]+. Anal. calcd for C15H13IN2O: C, 49.47; H, 3.60; N, 7.69. Found: C, 49.22; H, 3.89; N, 7.83. 
 
(E)-3-Benzyl-2-[(chlorophenyl)imino]-5-(iodomethylidene)-oxazolidine (4i) 
 
Following GP5 with urea 1i (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 1:4) to afford 4i in 79% yield (334 mg, 0.8 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  3.99 (d, J = 3.0 Hz, 2H), 4.63 (s, 2H), 5.68 (t, J = 3.0 Hz, 1H), 7.06 (d, J = 
9.0 Hz, 2H), 7.24-7.27 (m, 2H), 7.34-7.43 (m, 5H). 13C NMR (100 MHz, CDCl3) 48.7 (t), 49.6 (d), 50.7 
(t), 124.8 (d), 128.1 (d), 128.2 (d), 128.6 (d), 128.9 (d), 127.7 (s), 135.6 (s) 144.8 (s), 149.9 (s), 150.6 (s). 
IR (cm-1) max: 1641 (C=N). MS (%) ESI 425 [M+H]+. Anal. calcd for C17H14ClIN2O: C, 48.08; H, 3.32; N, 
6.60. Found: C, 47.76; H, 3.57; N, 6.43. 
 
(E)-3-Benzyl-6-(iodomethylidene)-2-[(4-nitrophenyl)imino]-2,3,4,5-tetrahydro-2H-1,3-oxazine (4k) 
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Following GP5 with urea 1k (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 4k in 88% yield (395 mg, 0.9 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  2.83 (t, J = 6.0 Hz, 2H), 3.32 (t, J = 6.0 Hz, 2H), 4.78 (s, 2H), 5.77 (s, 1H), 
7.07 (dd, J = 7.0, 2.0 Hz, 2H), 7.33-7.39 (m, 5H), 8.13 (dd, J = 7.0, 2.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) 
27.3 (t), 42.3 (t), 53.4 (t), 58.2 (d), 123.9 (d), 124.5 (d), 127.9 (d), 128.1 (d), 128.8 (d), 136.2 (s), 142.1 
(s), 146.6 (s), 150.9 (s), 154.0 (s). IR (cm-1) max: 1641 (C=N). MS (%) ESI 450 [M+H]+. Anal. calcd for 
C18H16IN3O3: C, 48.12; H, 3.59; N, 9.35. Found: C, 48.15; H, 3.90; N, 9.19. 
 
(E)-3-Benzyl-5-(iodomethylidene)-2-[(2-methoxyphenyl)imino]-2,3,4,5-tetrahydro-2H-1,3-oxazine 
(4m) 
 
Following GP5 with urea 1m (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 4m in 54% yield (234 mg, 0.5 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  2.76 (td, J = 6.0, 1.0 Hz, 2H), 3.27 (t, J = 6.0 Hz, 2H), 3.82 (s, 3H), 4.89 
(br s, 2H), 5.64 (s, 1H), 6.87-6.92 (m, 2H), 7.02 (t, J = 7.0 Hz, 2H), 7.30-7.39 (m, 3H), 7.45 (d, J = 7.0 Hz, 
2H). 13C NMR (100 MHz, CDCl3) 27.8 (t), 42.3 (t), 53.7 (t), 55.8 (q), 58.1 (d), 111.3 (d), 120.8 (d), 124.6 
(d), 127.8 (d), 128.3 (d), 128.7 (d), 136.4 (s), 145.8 (s), 151.1 (s), 152.0 (s), 154.1 (s). IR (cm-1) max: 1653 
(C=N). MS (%) ESI 435 [M+H]+. Anal. calcd for C19H19IN2O2: C, 52.55; H, 4.41; N, 6.45. Found: C, 52.81; 
H, 4.59; N, 6.17. 
 
General procedure (GP6) for catalytic intramolecular alkoxychlorination of alkynyl amides.  
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A solution of alkynyl amide13 (1.0 mmol), CuCl2 (5 mol %) and NCS (1 mmol) in MeCN (14 mL) was 
stirred at room temperature under air atmosphere until all reagent consumption monitored by TLC 
(12-24 h). The solvent was removed under reduced pressure and the crude product was purified by 
silica gel column chromatography.  
 
(E)-5-(Chloromethylidene)-2-(4-nitrophenyl)-4,5-dihydrooxazole (6a) 
 
Following GP6 with amide 5a (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 6a in 76% yield (180 mg, 0.7 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  4.81 (d, J = 3.0 Hz, 2H), 6.13 (t, J = 3.0 Hz, 1H), 8.14-8.19 (m, 
2H), 8.30-8.34 (m, 2H). 13C NMR (100 MHz, CDCl3) 58.2 (t), 95.8 (d), 123.8 (d), 129.2 (d), 131.4 
(s), 131.9 (s), 149.9 (s), 162.0 (s). IR (cm-1) max: 1661 (C=N). MS (%) ESI 239 [M+H]+. Anal. calcd 
for C10H7ClN2O3: C, 50.33; H, 2.96; N, 11.74. Found: C, 50.51; H, 2.65; N, 11.88. 
 
(E)-5-(Chloromethylidene)-2-(4-methoxyphenyl)-4,5-dihydrooxazole (6b) 
 
Following GP6 with amide 5b (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 2:3) to afford 6b in 64% yield (142 mg, 0.6 mmol). Colorless 
oil. 1H NMR (400 MHz, CDCl3)  3.87 (s, 3H), 4.74 (br s, 2H), 6.07 (br s, 1H), 6.94 (d, J = 8.0 Hz, 
2H), 7.94 (d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  29.7 (t), 55.4 (q), 94.5 (d), 114.0 (d), 
114.2 (d), 117.7 (s), 118.4 (s), 129.9 (d), 162.7 (s), 163.0 (s). IR (cm-1) max: 1664 (C=N). MS (%) 
ESI 224 [M+H]+. Anal. calcd for C11H10ClNO2: C, 59.07; H, 4.51; N, 6.26. Found: C, 58.79; H, 4.78; 
N, 6.01. 
 
 
                                                 
13 a) Beccalli, E. M.; Borsini, E.; Broggini, G.; Palmisano, G.; Sottocornola, S. J. Org. Chem. 2008, 73, 4746. b) Hashmi, 
A. S. K.; Jaimes, M. C. B.; Schuster, A. M.; Rominger, F. J. Org. Chem. 2012, 77, 6394. 
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(E)-4-(Chloromethylidene)-3-oxa-2-phenyl-1-azaspiro[4,5]dec-1-ene (6g) 
 
Colorless oil (83 mg, 32%). 1H NMR (200 MHz, CDCl3) 1.23-2.05 (m, 8H), 2.35-2.50 (m, 2H), 6.07 
(s, 1H), 7.38-7.54 (m, 3H), 7.99 (d, J = 6.0 Hz, 2H). These data are in good agreement with those 
reported in the literature.10a 
 
General procedure (GP7) for catalytic intramolecular alkoxyiodination of alkynyl amides.  
 
A solution of alkynyl amide (1.0 mmol), CuCl2 (5 mol %) and NIS (1 mmol) in MeCN (14 mL) was stirred 
at room temperature under air atmosphere until all reagent disappeared monitored by TLC (12-24 h). 
The solvent was removed under reduced pressure and the crude product was purified by silica gel 
column chromatography. 
 
(E)-5-(Iodomethylidene)-2-(4-nitrophenyl)-4,5-dihydrooxazole (7a) 
 
Following GP7 with amide 5a (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 3:7) to afford 7a in 73% yield (240 mg, 0.7 mmol). White 
solid, m.p.: 125°C. 1H NMR (400 MHz, CDCl3)  4.68 (d, J = 3.0 Hz, 2H), 5.88 (t, J = 3.0 Hz, 1H), 
8.16 (d, J = 8.5 Hz, 2H), 8.32 (d, J = 8.5 Hz, 2H). 13C NMR (CDCl3)  48.3 (d), 61.4 (t), 123.8 (d), 
129.0 (d), 132.2 (s), 149.9 (s), 157.3 (s), 162.2 (s). IR (cm-1) max: 1661 (C=N). MS (%) ESI 331 
[M+H]+. Anal. calcd for C10H7IN2O3: C, 36.39; H, 2.14; N, 8.49. Found: C, 36.61; H, 1.88; N, 8.26. 
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(E)-5-(Iodomethylidene)-2-(thiophen-2-yl)-4,5-dihydrooxazole (7c) 
 
Pale yellow solid (218 mg, 75%). 1H NMR (300 MHz, CDCl3) 4.64 (d, J = 3.0 Hz, 2H), 5.84 (t, J = 3.0 
Hz, 1H), 7.16 (dd, J = 5.0, 3.5 Hz, 1H), 7.58 (dd, J = 5.0, 1.0 Hz, 1H), 7.77 (d, J = 3.5 Hz, 1H). These 
data are in good agreement with those reported in the literature.14 
 
(E)-2-(Furan-2-yl)-5-(iodomethylidene)-4,5-dihydrooxazole (7d) 
 
Grey solid (112 mg, 41%). 1H NMR (300 MHz, CDCl3) 4.64(d, J = 3.0 Hz, 2H), 5.83 (t, J = 3.0 Hz, 1H), 
6.56 (dd, J = 3.5, 2.0 Hz, 1H), 7.12 (d, J = 3.5 Hz, 1H), 7.63 (d, J = 2.0 Hz, 1H). These data are in 
good agreement with those reported in the literature.12 
 
(E)-5-(Iodomethylidene)-2-(methylpirrol-2-yl)-4,5-dihydrooxazole (7e) 
 
Following GP7 with amide 5e (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: Et2O / petroleum ether 1:9) to afford 7e in 52% yield (149 mg, 0.5 mmol). Pale yellow 
solid, m.p.: 108-109 °C. 1H NMR (200 MHz, CDCl3)  3.94 (s, 3H), 4.58 (d, J = 3.0 Hz, 2H), 5.69 (t, J = 3.0 
Hz, 1H), 6.15 (dd, J = 4.0, 2.5 Hz, 1H), 6.75-6.90 (m, 2H). 13C NMR (100 MHz, CDCl3) 37.1 (q), 46.9 (d), 
60.7 (t), 108.7 (d), 116.9 (d), 119.4 (s), 129.7 (d), 156.9 (s), 158.5 (s). IR (cm-1) max: 1645 (C=N). MS (%) 
ESI 289 [M+H]+. Anal. calcd for C9H9lN2O: C, 37.52; H, 3.15; N, 9.72. Found: C, 37.21; H, 3.41; N, 9.47. 
 
 
 
                                                 
14 Zhang, S.; Chen, Y.; Wang, J.; Pan, Y.; Xu, Z.; Tung, C.-H. Org. Chem. Front. 2015, 2, 578. 
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(E)-5-(Iodomethylidene)-2-(3,4,5-trimethoxyphenyl)-4,5-dihydrooxazole (7f) 
 
Following GP7 with amide 5f (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 1:4) to afford 7f in 71% yield (266 mg, 0.7 mmol). White 
solid, m.p.: 107-108 °C. 1H NMR (200 MHz, CDCl3)  3.89-3.96 (m, 9H), 4.69 (d, J = 3.0 Hz, 2H), 
7.16 (d, J = 3.0 Hz, 1H), 7.27-7.32 (m, 2H). 13C NMR (100 MHz, CDCl3) 35.0 (t), 56.6 (q), 61.2 
(d), 104.1 (d), 122.3 (s), 135.8 (s), 140.9 (s), 147.6 (s), 153.8 (s). IR (cm-1) max: 1671 (C=N). MS 
(%) ESI 376 [M+H]+. Anal. calcd for C13H14INO4: C, 41.62; H, 3.76; N, 3.73. Found: C, 41.35; H, 
4.03; N, 3.51. 
 
(E)-4-(Iodomethylidene)-2-phenyl-3-oxa-1-azaspiro[4.5]dec-1-ene (7g) 
 
Colorless oil (215 mg, 61%). 1H NMR (300 MHz, CDCl3)  1.23-2.07 (m, 8H), 2.49-2.59 (m, 2H), 5.74 
(s, 1H), 7.41-7.55 (m, 3H), 8.00 (d, J = 6.0 Hz, 2H). These data are in good agreement with those 
reported in the literature.12 
 
General procedure (GP8) for stoichiometric intramolecular alkoxylation of urea (1a) (path B, Scheme 
3). A solution of urea 1a (1.0 mmol), CuCl (1.0 mmol) in MeCN (14 mL) was stirred at reflux under 
oxygen atmosphere for 5 hours. The solvent was removed under reduced pressure and the crude 
product 8 was purified by silica gel column chromatography. 
 
General procedure (GP9) for catalytic intramolecular alkoxylation of urea (1a) (path D, Scheme 3).  
A solution of urea 1a (1.0 mmol), CuCl (10 mol %), LiCl (3.0 mmol) in MeCN (14 mL) was stirred at reflux 
under oxygen atmosphere for 5 hours. The solvent was removed under reduced pressure and the 
crude product 8 was purified by silica gel column chromatography. 
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3,5-Dimethyl-2-[(4-nitrophenyl)imino]-4,5-dihydrooxazole (8) 
 
Following GP8 with amide 1a (1.0 mmol). The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / petroleum ether 1:2) to afford 8 in 16% yield (37 mg, 0.2 mmol). Yellow oil.  
Following GP9 with amide 1a (1.0 mmol). The product 8 was afforded in 83% yield (193 mg, 0.8 mmol). 
1H NMR (400 MHz, CDCl3)  2.03 (d, J = 1.5 Hz, 3H), 3.29 (s, 3H), 6.11 (d, J = 1.5 Hz, 1H), 7.54 (d, J = 9.0 
Hz, 2H), 8.32 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)  11.4 (q), 30.2 (q), 110.4 (d), 117.6 (s), 124.5 
(d), 127.0 (d), 141.1 (s), 146.1 (s), 152.6 (s). IR (cm-1) max: 1641 (C=N). MS (%) ESI 234 [M+H]+. Anal. 
calcd for C11H11N3O3: C, 56.65; H, 4.75; N, 18.02. Found: C, 56.74; H, 5.06; N, 18.29. 
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1.2 Palladium(II)-Catalyzed Oxidative 
Alkoxyarylation Reactions of Alkenols 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 
An original and unexpected method to perform an alkoxylation / arylation sequence of 3-aza-5-
alkenols, under oxidative Pd-catalyzed conditions, has been described. The reaction, which involves 
PdCl2(CH3CN)2 as catalyst and a stoichiometric amount of aryl stannanes in presence of copper salt as 
oxidant, occurs selectively through a 7-endo-cyclization process with a resulting  1,1-
difunctionnalization (intramolecular alkoxylation, intermolecular arylation) of the starting terminal 
olefin. Conversely, when the reaction is run in absence of an aryl source, the same 7-endo-cyclization 
process was not observed confirming its peculiarity. 
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1.2.1. Introduction / Aim of This Work 
 
In the panorama of transition metal-catalyzed reactions, palladium-catalyzed heterocyclizations 
onto alkenes have a particular importance for synthetic chemists because of the complexity formed, 
the atom and economical approach and the prevalence of the heterocyclic products in bioactive 
targets.15  
 
The coordination of an alkene to a palladium(II) complex renders a typically electron-rich alkene 
more electrophilic. This π-complex formed can be attacked by a heteroatom nucleophile such as 
oxygen (water, alcohols, and acetate ions) or as nitrogen (amines, amides, carbamates).16 This 
sequence is named nucleopalladation (oxypalladation or aminopalladation). Then, the resulting σ-alkyl 
Pd(II) intermediate can participate in a range of subsequent transformations including β-hydride 
elimination (Wacker-type reaction), alkoxycarbonylation, Heck reaction, arylation or 
protodemetallation, leading to various functionalized heterocyclic scaffolds (Scheme 11). 
 
                                                 
15 For books on this subject, see: a) Bäckvall, J.-E. In Modern Oxidation Methods; Wiley-VCH: Weinheim, 2004. b) Tsuji, 
J. In Palladium Reagents and Catalysts, 2nd ed.; Wiley: New York, 2004. c) Negishi, E -I. In Handbook of 
Organopalladium Chemistry for Organic Synthesis; John Wiley & Sons, Inc.: New York, 2002. 
16 For a selection of reviews on nucleopalladation, see: a) Kočovský, P.; Bäckvall, J.-E. Chem. Eur. J. 2015, 21, 36. b) 
McDonald, R. I.; Liu, G.; Stahl, S. S. Chem. Rev. 2011, 111, 2981. c) Keith, J. A.; Henry, P. M. Angew. Chem. Int. Ed. 
2009, 48, 9038. d) Minatti, A.; Muñiz, K. Chem. Soc. Rev. 2007, 36, 1142. e) Beccalli, E. M.; Broggini, G.; Martinelli, M.; 
Sottocornola, S. Chem. Rev. 2007, 107, 5318. 
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Scheme 11: Different Possible Functionalizations of the -Alkylpalladium Intermediate. 
 
This research field has grown considerably and a range of palladium-catalyzed oxidation 
reactions are routinely used in synthetic chemistry laboratories. Thus, the last years, the research 
interest of the Broggini’s group has focused, inter alia, to the development of this type of various 
intramolecular palladium-catalyzed reactions affording heterocyclic products.17 For example, a 6-exo-
trig cyclization catalyzed by Pd(II) species has been described and allowing the synthesis of 1,4-oxazine 
derivatives from 3-aza-5-alkenols in mild aerobic conditions (Figure 3, path a).18 From a mechanistic 
point of view, after nucleopalladation involving a 6-exo-trig cyclization process, the σ-alkylpalladium 
complex undergoes a subsequent β-hydride elimination / isomerization sequence leading to the final 
                                                 
17 a) Broggini, G.; Beccalli, E. M.; Borelli, T.; Brusa, F.; Gazzola, S.; Mazza, A. Eur. J. Org. Chem. 2015, 4261-4268. b) 
Broggini, G.; Barbera, V.; Beccalli, E. M.; Chiacchio, U.; Fasana, A.; Galli, S.; Gazzola, S. Adv. Synth. Catal. 2013, 355, 
1640-1648. c) Borsini, E.; Broggini, G.; Fasana, A.; Galli, S.; Khansaa, M.; Piarulli, U.; Rigamonti, M. Adv. Synth. Catal. 
2011, 353, 985-994. 
18 Broggini, G.; Beccalli, E. M.; Borsini, E.; Fasana, A.; Zecchi, G. Synlett 2011, 227-230. 
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product and a Pd(0) species after HCl elimination. At this point, this later complex is reoxidized in 
presence of molecular oxygen. 
 
In the continuity of this study, in order to extend the applicability of this kind of starting 
materials (3-aza-5-alkenols), and to synthesize more functionalized heterocycles, we envisaged to trap 
the σ-alkylpalladium complex intermediate by a subsequent arylation step. Furthermore, we focused 
on the use of the couple palladium(II) / copper(II) as catalyst and oxidizing agent, respectively, since 
this couple has proved his efficiency during double functionalizations of C-C multiple bonds in one-pot 
processes.19 In the beginning of this study, we centered our attention, for the development of this 
oxidative cyclization of 3-aza-5-alkenols in alkoxyarylative conditions, with the use of arylstannanes. 
Furthermore, in that case with these arene sources (R3SnAr), we observed that the 7-endo-cyclization 
prevails to the most common 6-exo-one, and the arylation occurred in the same carbon than the 
alkoxylation (Figure 3, path b). Thus, in the presence of this aryl source, the mechanism should not 
follow the same elementary steps, namely an oxypalladation and a transmetalation. 
 
 
 
Figure 3: Possible Pd-Catalyzed exo- and endo-Cyclization of 3-Aza-5-alkenols. 
 
Before to present our efforts on optimization of this original Pd-catalyzed oxidative 
alkoxyarylations of alkenols, we will describe some examples of oxypalladation reactions developed 
on alkenes.20 It should be noted that this type of reaction is also reported from alkynes and allenes, 
but we will not present them in this part. 
                                                 
19 Beccalli, E. M.; Broggini, G.; Gazzola, S.; Mazza, A. Org. Biomol. Chem. 2014, 12, 6767-6789. 
20 For selected examples of intramolecular oxidative Pd-catalyzed reactions on alkenes, see: a) Chen, P.-Y.; Huang, K.-
S.; Tsai, C.-C.; Wang, T.-P.; Wang, E.-C. Org. Lett. 2012, 14, 4930-4933. b) Alonso, F.; Sanchez, D.; Soler, T.; Yus, M. 
Adv. Synth. Catal. 2008, 350, 2118-2126. c) Szolcsanyi, P.; Gracza, T. Chem. Commun. 2005, 3948-3950. For selected 
examples of analogous reactions on alkynes, see: d) Watanabe, K.; Iwata, Y.; Adachi, S.; Nishikawa, T.; Yoshida, Y.; 
Kameda, S.; Ide, M.; Saikaw, Y.; Nakata, M. J. Org. Chem. 2010, 75, 5573-5579. For selected examples of analogous 
reactions on allenes, see: e) Le Bras, J.; Muzart, J. Chem. Soc. Rev. 2014, 43, 3003-3040. f) Alcaide, B.; Almendros, P.; 
Rodriguez-Acebes, R. J. Org. Chem. 2006, 71, 2346-2351. For recent reviews on the development of the -
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Furthermore, given the unexpected structures of our final products, we will concentrate also 
in the presentation of original functionalizations of terminal alkenes achieved in presence of 
arylstannanes.21  
 
a) Oxypalladations 
The first intramolecular oxypalladation of alkenes was reported in 1984 and occurred jointly 
with a carbonylation. The process, catalyzed by a Pd(II) complex, starts with π-coordination to the 
double bond, followed by an intramolecular anti-oxypalladation. Then, the desired methyl ester is 
produced by trapping the resulting σ-alkylpalladium with a carbonylation / esterification sequence. 
The cycle is completed by reoxidation of the generated palladium(0) species in presence of Cu(II) salt 
as oxidizing agent (Scheme 12).22 
 
 
 
Scheme 12: Intramolecular Oxypalladation / Carbonylation of Alkenes. 
 
Usually, the intramolecular oxypalladation can take place via either an anti- or a syn-addition 
process of the nucleophile, which allows a stereocontrol of the reaction, and depends to structure of 
the starting material (neighboring group effects) or experimental conditions used.  
In the next example involving an oxypalladation followed by arylation, the stereochemical course is 
controlled by a phosphine ligand. Indeed, the reaction that involves the use of a monodentate 
phosphine led to syn-palladation via the alkoxide coordination to palladium, in contrast the use of a 
bidentate phosphine ligand, a strongly chelating agent which prevents the alkoxide coordination, 
afforded the product attributed to trans-oxypalladation (Scheme 13).23  
 
                                                 
alkylpalladium intermediat see: a) Kočovsky, P.; Bäckvall, J.-E. Chem. Eur. J. 2015, 21, 36. b) McDonald, R. I.; Liu, G.; 
Stahl, S. Chem. Rev. 2011, 111, 2981. 
21 a) Gligorich, K. M.; Cummings, S. A.; Sigman, M. S. J. Am. Chem. Soc. 2007, 129, 14193. b) Urkalan, K. B.; Sigman, M. 
S. Angew. Chem. Int. Ed. 2009, 48, 3146. c) Werner, E. W.; Urkalan, K. B.; Sigman, M. S. Org. Lett. 2010, 12, 2848-2851. 
d) Satterfield, A. D.; Kubota, A.; Sanford, M. S. Org. Lett. 2011, 13, 1076. 
22 Semmelhack, M. F.; Bodurov, C. J. Am. Chem. Soc. 1984, 106, 1496-1498. 
23 Nakhla, J. S.; Kampf, J. W.; Wolfe, J. P. J. Am. Chem. Soc. 2006, 128, 2893. 
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Scheme 13: Different Stereochemical Outcomes by Variation of the Achiral Ligand. 
 
In 1978, was also reported an example of enantioselective Pd(II)-catalyzed oxypalladation followed 
by β-hydride elimination from ortho-allyl phenols. The use of β-pinene as chiral ligand led to a low 
enantiomeric excess (Scheme 14).24 
 
 
 
Scheme 14: Enantioselective Oxypalladation / β-hydride Elimination. 
 
b) Functionalizations of alkenes  
For this part, we will focus only on examples involving the functionalization of alkenes in presence 
of arylstannanes.  
First of all, in 2007, Sigman presented a palladium(II)-catalyzed reductive coupling of styrene with 
organostannanes using a tandem alcohol (2-propanol) oxidation under aerobic conditions (Scheme 
15). To a mechanistic point of view, oxidation of 2-propanol with a Pd catalyst leads to the formation 
of a Pd(II)-hydride. Coordination and insertion of the alkene into this hydride complex yields a σ-alkyl 
intermediate. This latter undergoes a transmetalation and a subsequent reductive elimination which 
generates the reductive coupling product as well as the reduced catalyst Pd(0). This Pd(0) complex is 
reoxydized in presence of aerobic conditions (Scheme 15).19a 
 
                                                 
24 Hosokawa, T.; Miyagi, S.; Murahashi, S.-I-; Sonoda, A. J. Org. Chem. 43, 14, 1978, 2752-2757.  
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Scheme 15: Palladium-Catalyzed Reductive Coupling of Styrenes and Organostannanes. 
 
Two years later, Sigman19b reported a palladium-catalyzed oxidative difunctionalization of terminal 
alkenes with organostannanes and molecular oxygen. A cationic palladium complex catalyzes the 
transformations which can lead to 1,2- or 1,1-difunctionalization depending on the type of terminal 
double bond (conjugated or nonconjugated) (Scheme 16). The authors proposed an oxidative-Heck 
type reaction for the first arylation, while the second functionalization proceeds via a π-benzyl 
intermediate. 
 
 
 
Scheme 16: 1,2-Diarylation of Styrene. 
 
Following this study, the same author, in 2010, disclosed the scope of this palladium(II)-catalyzed 
oxidative 1,1-diarylation reaction of terminal olefins using aryl stannanes.19c 
 
 
Scheme 17: 1,1-Diarylation of Terminal Olefins. 
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Lastly, following the same concept, in 2011 Sanford19d described the 1,1-arylacetoxylation of 
different -olefins using organostannanes and hypervalent iodine oxidants (Scheme 18). In this case, 
the π-benzyl intermediate is oxidized by the hypervalent iodine. 
 
 
 
Scheme 18: 1,1-Aryloxygenation of Terminal Olefins. 
 
1.2.2. Optimization of the Conditions  
 
About our subject, we began our optimizations for the alkoxyarylation sequence by using the 
conditions described by the group of Jung for a Pd(II)-catalyzed aryl-alkenyl coupling (oxidative Heck-
type coupling) in presence of copper salt as oxidant and aryl stanannes.25 In conditions almost similar, 
our model substrate (3-aza-5-alkenol) 12a treated with 10 mol % of PdCl2(CH3CN)2, a stoichiometric 
amount of phenyl(tributyl)stannane, an excess of CuCl2 and NaOAc in tetrahydrofuran at room 
temperature for 24 hours, gave the 4-tosyl-7-phenyl-oxazepane 13a as the sole product (Scheme 19).  
 
 
 
Scheme 19: Alkoxyarylation Reaction of the 3-Aza-5-alkenol 12a. 
 
To improve this yield, we tested further conditions varying the palladium-catalyst, the oxidant, the 
solvent and also the temperature of the reaction. The results are presented on Table 5. Firstly, the 
reaction performed without base gave the desired oxazepane 13a in 78% yield (entry 2). The use of 
half the amount of palladium(II)-catalyst led to the expected product, however with a low yield (entry 
3). The reaction realized without Pd(II) catalyst furnished the unchanged starting material proving its 
                                                 
25 Parrish, J. P.; Jung, Y. C.; Shin, S. I.; Jung, K. W. J. Org. Chem. 2003, 67, 7127-7130. 
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essential role for the outcome of the sequence (entry 4). Then, other Pd(II)-catalysts such as Pd(OAc)2 
or Pd(TFA)2 were tested and shown a similar catalytic activity but lower yields were obtained (entries 
5-6). Different solvents were screened and, while DMF and dioxane were suitable solvents for the 
reaction, CH2Cl2 did not allow a complete convertion after 24 hours. Furthermore, a heating at 100 °C 
in DMF allowed increasing the yield from 61% to 86% (entries 7-10). Thereafter, we interested in the 
change of oxidant. Thus, an exclusive or prevalent formation of 6-methyl-4-tosyl-3,4-dihydro-2H-1,4-
oxazine (14) was due to the change of the oxidant agent from CuCl2 to Cu(OAc)2 or catalytic CuCl2 in 
molecular oxygen. This product arose from an alkoxylation / β-hydride elimination / isomerization 
sequence (entries 11-12).  
 
Finally, taking into account the data present in the literature we envisaged to modify also the aryl 
source employing organoboron reagents instead of arylstannanes.26 Performing the reaction in the 
best conditions showed in entry 2, both with PhB(OH)2 or 4-methylphenylboronic acid only starting 
material was recovered (entries 13-14). Furthermore, a heating at reflux gave only the formation of a 
complex mixture of products (entry 15). Then, following conditions successfully employed for the 
functionalization of alkenes reported by Mori,27 we treated the substrate 12a with 4-
methylphenylboronic acid in the presence of Pd(OAc)2 as catalyst, Cu(OAc)2 and LiOAc in DMF at 100 
°C (entry 16). After 18 hours as reaction time, the crude mixture revealed only the arylation product 
15, isolated in 36% yield. The same outcome of reaction was observed using PdCl2(CH3CN)2 as catalyst 
instead of Pd(OAc)2 (entry 17). Finally, we probed the conditions usefully exploited for the arylative 
cyclization of alkenyl amines, which are PdCl2(CH3CN)2 as catalyst with Cu(OAc)2, 4-
methylphenylboronic acid and Et3N as additive in MeCN at reflux (entry 18).28 However, despite the 
complete conversion of the substrate, product 13a was not detected in the crude mixture, from which 
only compound 15 was isolated in 44% yield. 
 
 
 
                                                 
26 a) Andappan, M. M. S.; Nilsson, P.; Von Schenck, H. J. Org. Chem. 2004, 69, 5212-5218. b) Jung, J. C.; Mishra, R. K.; 
Yoon, C. H.; Jung, K. W. Org. Lett. 2003, 5, 2231-2234. 
27 Du, X.; Suguro, M.; Hirabayashi, K.; Mori, A. Org. Lett. 2001, 3, 3313-3316. 
28 Zheng, J.; Huang, L.; Huang, C.; Wu, W.; Jiang, H. J. Org. Chem. 2015, 80, 1235-1242. 
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Entry Catalyst Oxidant Arylative agent Solvent Temp. 
(°C) 
Product 
(%)a 
1b PdCl2(CH3CN)2 CuCl2 Bu3SnPh THF 25 13a (75) 
2 PdCl2(CH3CN)2 CuCl2 Bu3SnPh THF 25 13a (78) 
3c PdCl2(CH3CN)2 CuCl2 Bu3SnPh THF 25 13a (62) 
4 - CuCl2 Bu3SnPh THF 25 S.M. 
5 Pd(OAc)2 CuCl2 Bu3SnPh THF 25 13a (64) 
6 Pd(TFA)2 CuCl2 Bu3SnPh THF 25 13a (67) 
7 PdCl2(CH3CN)2 CuCl2 Bu3SnPh DMF 25 13a (61) 
8 PdCl2(CH3CN)2 CuCl2 Bu3SnPh dioxane 25 13a (49) 
9 PdCl2(CH3CN)2 CuCl2 Bu3SnPh CH2Cl2 25 13a (13) 
10d PdCl2(CH3CN)2 CuCl2 Bu3SnPh DMF 100 13a (86) 
11 PdCl2(CH3CN)2 Cu(OAc)2 Bu3SnPh THF 25 14 (47) 
12e PdCl2(CH3CN)2 CuCl2/O2 Bu3SnPh THF 25 13a (8) + 14 (42) 
13 PdCl2(CH3CN)2 CuCl2 PhB(OH)2 THF 25 S.M. 
14 PdCl2(CH3CN)2 CuCl2 4-tolylB(OH)2 THF 25 S.M. 
15 PdCl2(CH3CN)2 CuCl2 PhB(OH)2 THF Reflux -f 
16g Pd(OAc)2 Cu(OAc)2 4-tolylB(OH)2 DMF 100 15 (36) 
17h PdCl2(CH3CN)2 Cu(OAc)2 4-tolylB(OH)2 DMF 100 15 (40) 
18i PdCl2(CH3CN)2 Cu(OAc)2 4-tolylB(OH)2 MeCN Reflux 15 (44) 
a Yields of isolated products. b Reaction performed in the presence of NaOAc (2 equiv). c 5 mol % of PdCl2(CH3CN)2 instead of 
10 mol %. d The reaction was completed after 8 h. e CuCl2 (10 mol %). f A complex mixture of tarry products was obtained. g 
12a (0.4 mmol), Pd(OAc)2 (10 mol %), Cu(OAc)2 (2 equiv), 4-tolylB(OH)2 (1 equiv), LiOAc (3 equiv), DMF (10 mL) at 100 °C for 
18 h. h Conditions (h) with PdCl2(CH3CN)2 (10 mol %) as catalyst. i 12a (0.4 mmol), PdCl2(CH3CN)2 (10 mol %), Cu(OAc)2 (3 
equiv), 4-tolylB(OH)2 (0.6 mmol), Et3N (2 equiv), MeCN (5 mL) at reflux for 24 h. 
 
Table 5: Optimization Conditions for 7-endo-trig-Alkoxyarylation Reaction. 
 
With these optimized conditions in hand, PdCl2(CH3CN)2 10 mol %, CuCl2 1 equivalent, PhSnBu3 1 
equivalent in THF at room temperature, the scope of this procedure was investigated. Due to the 
mildness of the procedure, we decided to keep these conditions even if in DMF at 100 °C the yield of 
the isolated product was partially increased.  
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1.2.3. Scope 
 
The efficient access to oxazepane ring via a selective 7-endo-trig cyclization, prompted us to extent 
this method to other 3-aza-5-alkenol derivatives. For that, the optimal alkoxyarylative conditions 
previously optimized were used in order to have evidences for a general behaviour of this catalytic 
system. The effect of the substitution on the sulfonyl moiety present on the nitrogen atom was 
investigated first (Scheme 20). Electron-withdrawing para-substitution, such as nitro (12b) or electron-
donating para-substitution, such as amine (12c) also led to the corresponding oxazepanes 13b and 13c 
in modest yields. 
 
 
 
Scheme 20: Alkoxylation Process on 3-Aza-5-alkenols 12b and 12c. 
 
Then, this method was extended to a more challenging diastereoselective variant from 3-aza-5-
alkenol compounds 12d-e, which arose from (+)-valinol and (+)-isoleucinol respectively. In the 
previously developed conditions, these two enantiopure alkenols led to the two diastereoisomeric 7-
membered ring products (13d-d’ and 13e-e’) in a separable mixture (1,8 / 1 and 1,2 / 1 respectively) 
(Scheme 21). Thus, this reaction was ineffective from the stereochemical point of view, but very 
selective under the 7-endo approach and the 1,1-difunctionalization of the terminal olefin.  
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Scheme 21: Enantiopure Chiral Substrates Cyclization. 
 
The X-ray crystal structure analysis of the compounds 13e’ allowed to confirm the oxazepane 
structure as well as to assign the S-configuration to the new stereocenter.29 The similarity of the 1H 
and 13C NMR spectra permitted the assignment of the absolute configuration to all diastereomers 
(Figure 4). 
 
 
 
Figure 4: ORTEP Drawing of Compound 13e’. 
 
 
 
                                                 
29 We acknowledge for the X-ray analysis Dr. Carlo Castellano, Chemistry Department, Università degli Studi di Milano. 
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1.2.4. Different Organotin Derivatives  
 
To better understand the central role of the PhSnBu3 as phenyl source, reactions with substrate 
12a and others organotin derivatives were carried out in the standard conditions of Table 5, Entry 2. 
On the one hand, 4-benzyloxyphenyl(tributyl)stannane performed well, affording the oxazepane 20 in 
80% via a 7-endo-trig process (Table 6, entry 1). On the other hand, furan-yl or thiophene-yl substituted 
stannanes, as well alkynyl or alkenyl(tributyl)stannanes gave only complex mixtures of degradation 
(entries 2-5). Thus, the overall results obtained suggest that only arylstannanes are efficient for this 
intramolecular alkoxylation reaction on 3-aza-5-alkenols. 
 
Entry R Time (h) Product 
1 
 
18 
 
2 
 
 
 
24 Degradation compounds 
3 
 
 
 
24 Degradation compounds 
4 
 
 
 
24 Degradation compounds 
5 
 
 
 
24 Degradation compounds 
a The reaction was performed under the conditions of Table 5, Entry 2: 12a (0.4 mmol), PdCl2(CH3CN)2 (10 mol %), CuCl2 (1.0 
equiv.), organotin derivative (1 equiv.), THF (5 mL) at room temperature. 
 
Table 6: Different Stannanes Employed for the Alkoxyarylation Reaction. 
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Given this limitation of reactivity to arylstannanes, and in order to generalize this unexpected 
cyclization involving only a 7-endo-trig process with a 1,1-difunctionalization of the double bond, we 
considered some extensions to other transformations can complete the catalytic process. 
 
1.2.5. Applicability of the 7-endo-Cyclization 
 
First, carbonylative conditions (1 atm) were used on the alkenols 12a,b with a catalytic amount of 
PdCl2(CH3CN)2 (5 mol %) and a stoichiometric amount of CuCl2 in methanol at room temperature for 
24 h. In these cases, an alkoxylation / carboalkoxylation sequence occuried. However, only the 6-exo-
trig cyclization took place, affording the corresponding 2-[(methoxycarbonyl)methyl]-morpholines 
(16a and 16b) with 65% and 74% yields, respectively (Scheme 22, equation 1).  
An alkoxychlorination process was also investigated under two different conditions based on the 
presence of PdCl2(CH3CN)2 as catalyst (Scheme 22, equations 2 and 3). Either experiment realized with 
an excess of CuCl2 in THF at room temperature or with NCS as the chlorine source in CH2Cl2 at room 
temperature, the cyclization occurred with formation of the 5-chloromethyl-morpholine 17, via here 
again a 6-exo-trig cyclization. 
Following our previously work on the arylation / esterification procedure performed on indolyl 
allylamides,30 we tested this sequence on the substrate 12a using our previous reported conditions. 
The best results were obtained by use of PdCl2(CH3CN)2 as catalyst and 3 equivalents of CuCl2 in DMA 
or in DMF at 150 °C. These trials led to the acetoxy-morpholine 18 and the formic ester 19 respectively, 
in mixture with the chloro-derivative 17 (Scheme 22, equations 4 and 5). Worthy of note, despite the 
low selectivity, the outcome of the reaction also supplied only 6-membered ring products.  
Finally, established conditions for Pd-catalyzed amino- or oxy-acetoxylation of alkenes in the 
presence of PhI(OAc)2 as oxidant were tested.31 It should be noted that for a mechanistic point of view, 
these sequences involve Pd(IV)-intermediates. In the event, the treatment of 12a with Pd(OAc)2 (10 
mol %), PhI(OAc)2 (2 equiv.), Bu4NOAc (1 equiv.) in acetonitrile at 60 °C for 24 h, selectively gave the 5-
acetoxymethyl-morpholine 18 with good yields (Scheme 22, equation 6). 
 
                                                 
30 Broggini, G.; Barbera, V.; Beccalli, E. M.; Borsini, E.; Galli, S.; Lanza, G.; Zecchi, H. Adv. Synth. Catal. 2012, 354, 159. 
31 a) Rajabi, J.; Lorion, M. M.; Ly, V.; Liron, F.; Oble, J.; Prestat, G.; Poli, G. Chem. Eur. J. 2014, 20, 1539. b) Manick, 
A.D.; Duret, G.; Tran, D. N.; berhal, F.; Prestat, G. Org. Chem. Front. 2014, 1, 1058. c) Martinez, C.; Wu, Y.; Weinstein, 
A. B.; Stahl, S. S.; Liu, G.; Mũniz, K. J. Org. Chem. 2013, 78, 6309. d) Alexanian, E. J.; Lee, C.; Sorensen, E. J. J. Am. Chem. 
Soc. 2005, 127, 7690. 
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Scheme 22: Different Synthetic Transformations. 
 
According these results collected in Scheme 22, which involved in all the cases a 6-exo-trig 
cyclization, we can confirm the exclusive behaviour of the Pd-catalyzed 7-endo-trig alkoxylation / 
arylation sequence using arylstannanes. 
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1.2.6. Mechanistic Investigations  
 
Given these results, which involved a 7-endo-trig process during the alkoxyarylation reaction or a 
6-exo-trig cyclization during the other oxypalladation / functionalization (carbonylation, acyloxylation, 
chloration) sequence; we suggested two different mechanistic pathways. 
 
First, for the well-documented sequences reported in the Scheme 22, we proposed that the 
reactions likely proceed via an intramolecular 6-exo-trig oxypalladation step, which affords the 
corresponding cyclic oxypalladated intermediate. This latter can either evolve along diverse pathways 
such as β-H elimination, oxidation by a strong oxidant like PhI(OAc)2, chloration in presence of chorine 
source and formylation in presence of DMF (Scheme 23). 
 
 
 
Scheme 23: Complexation of Pd(II) and Evolution of the -Alkylpalladium Intermediate. 
 
However, we cannot consider that this cyclic oxypalladated intermediate is trapped via a 
transmetalation step, since the reactions realized in presence of arylstannanes do not occur via a 6-
exo-trig cyclization but via a 7-endo-trig process. That why, a second mechanistic pathway could be 
postulated for the alkoxyarylation reaction. For that, we relied on some papers concerning the Pd-
catalyzed oxidative 1,1-diarylation of terminal olefins using aryl stannanes previously presented. 
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Thus, we suggested the formation of an intermediate Pd(Ar)Cl complex via a transmetalation 
between Bu3SnAr and the palladium(II) catalyst I.32 Then, a carbopalladation step followed by a 
reversible dehydropalladation led to the arylated intermediate III and a H[Pd]Cl complex probably still 
complexed to the double bond. Finally, we envisaged an olefin reinsertion to give a new Pd-π-benzyl 
complex IV, which can be trap intramolecularly by the hydroxy-moiety leading to the final product.  
 
 
 
Scheme 24: Proposed Mechanism for the 7-endo-trig Cyclization Depicted on Substrate 12a. 
 
Given that analogous reaction conditions are known to allow the arylchlorination of alkenes,33 
and in order to exclude the participation of a chlorophenyl derivative as possible first-formed 
intermediate before the cyclization, we investigated the behavior of the compound 21. This latter has 
been obtained during a reaction realized in standard conditions at 0 °C (Scheme 25). Then, two 
experiments have shown that the intramolecular displacement of the chlorine atom of 21 by the 
hydroxyl group was efficient only working at 120 °C in DMSO, whereas the couple palladium(II) / 
copper(II) as catalyst and oxidizing agent did not afford the cyclization.  
 
                                                 
32 For the transmetalation process between Bu3SnAr and palladium(II) species, see: Stille, J. K. Angew. Chem. Int. Ed. 
1986, 25, 508. 
33 a) Kalyani, D.; Sanford, M. S. J. Am. Chem. Soc. 2008, 130, 2150-2151. b) Kalyani, D.; Satterfield, A. D.; Sanford, M. 
S. J. Am. Chem. Soc. 2010, 132, 8419-8427. 
93 
 
 
 
Scheme 25: Investigating the Behavior of the Chlorophenyl Derivative. 
 
On the other hand, an hydroalkoxylation process on a first-formed arylated double bond 
intermediate was ruled out due to the unsuccessful Pd(II)-catalyzed oxidative cyclization performed 
on the derivative 15, which was prepared by a Mizoroki-Heck reaction in the Jeffery conditions from 
the substrate 12a (Scheme 26). 
 
 
 
Scheme 26: Unsuccessful Pd(II)-Catalyzed Oxidative Cyclization Performed on the Derivative 15. 
 
Following these experiments and based on reported mechanisms involving a Pd-π-benzyl complex 
obtained after an oxidative Heck coupling / olefin reinsertion sequence, we believe that the postulated 
mechanism in the Scheme 24 is the most likely. 
 
1.2.7. Conclusions 
 
In conclusion, we have developed a direct alkoxyarylation of unactivated 3-aza-5-alkenols in 
presence of arylstannanes as aryl source. Oxidative palladium-catalyzed conditions in presence of a 
copper(II) salt as oxidant provided expedient access to 7-endo-trig cyclizations. The originality of this 
process is linked to the seven-membered ring formation, which the alkoxylation and the arylation 
occurred in the same carbon.  
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In perspective, the scope of this process by varying the arylstannane partner, as well the 
starting material 3-aza-5-alkenol should be investigated in more details. Furthermore the ability of the 
catalytic system to promote this reaction in mild conditions at room temperature open up the 
possibility to develop a stereoselective process using chiral ligands. 
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Experimental Part 
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General methods  
 
Organic solvents were routinely dried and / or distilled prior to use and stored over molecular 
sieves under argon. Melting points were determined by the capillary method with a Büchi B-540 
apparatus and are uncorrected. 1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE 400 
MHz or a Varian Oxford 300 MHz spectrometer. Chemical shifts are given as δ values in ppm relative 
to residual solvent peaks (CHCl3 or DMSO-d6) as the internal reference. 13C NMR spectra are 1H-
decoupled and the determination of the multiplicities was achieved by the APT pulse sequence. 
Coupling constants (J) are given in Hertz (Hz). The 1H and 13C NMR spectra were completely assigned 
by using a combination of 13C APT and 2D NMR experiments (COSY and HSQC). Elemental analyses were 
executed on Perkin-Elmer CHN Analyzer Series II 2400. Thin-layer chromatographic separations were 
performed on Merck silica-gel 60-F254 pre-coated. Preparative separations were performed by flash 
chromatography by using Merck silica gel 0.035-0.070 mm. 
 
General procedure (GP10) for the preparation of compounds 9a,b-d,e. 
 
To a solution of aminoalcohol (1.0 equiv.), DMAP (0.1 mmol) and triethylamine (2.0 mmol) in CH2Cl2 
(2.0 M) at 0 °C, was added a solution of the suitable chloride dropwise (1.05 equiv.) in CH2Cl2 (10 mL). 
The resulting mixture was stirred at room temperature overnight. The precipitated was washed with 
water (3 x 25 mL) and brine (1 x 25 mL), then dried over Na2SO4, and concentrated at reduced pressure. 
The crude product was purified by silica gel column chromatography to afford the corresponding 
protected aminoalcohol 9.  
 
N-(4-Methylbenzenesulfonyl)-ethanolamine (9a) 
 
White solid (43% yield, 925 mg, 4.3 mmol), mp: 54-56 °C. 1H NMR (CDCl3, 300 MHz)  2.38 (s, 3H), 3.02 
(t, J = 5.0 Hz, 2H), 3.12-3.35 (m, 1H), 3.65 (t, J = 5.0 Hz, 2H), 5.63-6.01 (br s, 1H, missing after 
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deuteration), 7.26 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H). These spectroscopic data are in good 
agreement with those reported in the literature.34 
 
N-(4-Nitrobenzenesulfonyl)-ethanolamine (9b) 
 
Pale yellow solid (32% yield, 838 mg, 3.4 mmol), mp: 129-130 °C. 1H NMR (300 MHz, DMSO-d6) δ 2.86 
(t, J = 6.0 Hz, 2H), 3.37 (q, J = 5.5 Hz, 2H), 4.75 (t, J = 5.5 Hz, 1H), 7.91 (br, 1H, missing after deuteration), 
8.06 (d, J = 7.0 Hz, 2H), 8.42 (d, J = 7.0 Hz, 2H). These spectroscopic data are in good agreement with 
those reported in the literature.35 
 
(S)-N-(4-Methylbenzenesulfonyl)-valinol (9d) 
 
White solid (95% yield, 2.44 g, 9.5 mmol), mp: 87-89 °C. 1H NMR (CDCl3, 300 MHz)  0.75 (d, J = 6.5.Hz, 
6H), 1.67-1.81 (m, 1H), 2.40 (s, 3H), 2.56 (br s, 1H, missing after deuteration), 2.96-3.05 (m, 1H), 3.47-
3.61 (m, 2H), 5.35 (d, J = 8.5 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 2H). These spectroscopic 
data are in good agreement with those reported in the literature.36 
 
(S)-N-(4-Methylbenzenesulfonyl)-leucinol (9e) 
 
White solid (45% yield, 1.22 g, 4.5 mmol), mp: 99 °C. 1H NMR (CDCl3, 300 MHz)  0.63 (d, J = 6.5 Hz, 
3H), 0.76 (d, J = 6.5 Hz, 3H), 1.22-1.27 (m, 2H), 1.40-1.50 (m, 1H), 2.43 (s, 3H), 2.43-2.51 (br s, 1H, 
missing after deuteration), 3.25-3.33 (m, 1H), 3.45 (dd, J = 11.5 Hz, 1H), 3.58 (dd, J = 11.5 Hz, 1H), 5.17 
                                                 
34 Elliott, Luke D.; Wrigglesworth, Joe W.; Cox, B.; Lloyd-Jones, Guy C.; Booker-Milburn, Kevin I Org. Lett. 2011, 13, 
728-731. 
35 Sabot, C.; Guérard, K. C.; Canesi, S. Chem. Commun., 2009, 2941-2943. 
36 Gandon, L.; Russel, A.; Güveli, T.; Brodwolf, A.; Kariuki, B. M.; Spencer, N.; Snaith, J.S. J. Org. Chem. 2006, 71, 5198-
5207. 
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(d, J = 8.0 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.78-7.81 (dd, J = 11.5 Hz, 2H). These spectroscopic data are 
in good agreement with those reported in the literature.37 
 
General procedure (GP11) for the preparation of compounds 10a,b-d,e. 
 
A solution of the corresponding compound 9 (1.0 equiv.), tert-butyldimethylsilyl chloride (2.0 equiv.) 
and imidazole (2.0 equiv.) in DMF (0.2 M) was stirred at room temperature overnight. The precipitate 
was hydrolized with brine (20 mL), extracted three times with Et2O (3 x 20 mL) and dried over Na2SO4 
and concentrated at reduced pressure. The crude product was purified by silica gel column 
chromatography to afford the corresponding O-(tert-butyldimethylsilyl)-N-protected aminoalcohol 10.  
 
O-(tert-Butyldimethylsilyl)-N-(4-methylbenzenesulfonyl)-ethanolamine (10a) 
 
Colorless oil (72% yield, 2.37 g, 7.2 mmol). 1H NMR (CDCl3, 400 MHz)  0.00 (s, 6H), 0.84 (s, 9H), 2.42 
(s, 3H), 3.04 (dd, J = 5.5, 11.0 Hz, 2H), 3.61 (t, J = 5.5 Hz, 2H), 4.88 (br s, 1H, missing after deuteration), 
7.31 (d, J = 8.0 Hz, 2H), 7.75 (d, J = 8.0 Hz, 2H). These spectroscopic data are in good agreement with 
those reported in the literature.38 
 
O-(tert-Butyldimenthylsilyl)-N-(4-nitrobenzenesulfonyl)-ethanolamine (10b) 
 
White solid (94% yield, 3.53 g, 9.8 mmol), mp: 72 °C. 1H (600 MHz, CDCl3) δ 0.02 (s, 6H), 0.84 (s, 9H), 
3.12 (q, J = 5.3 Hz, 2H), 3.65 (t, J = 5.3 Hz, 1H), 4.95 (t, J = 5.3 Hz, 1H), 8.06 (d, J = 9.4 Hz, 2H), 8.37 (d, J 
= 9.4 Hz, 2H). These spectroscopic data are in good agreement with those reported in the literature.29 
 
 
 
                                                 
37 Wunnermann, S.; Frolich, R.; Hoppe, D. Eur. J. Org. Chem. 2008, 4, 684. 
38 Sato, Y.; Saito, N.; Mori, M. Tetrahedron 1998, 54, 1153-1168. 
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(S)-O-(tert-Butyldimethylsilyl)-N-(4-methylbenzenesulfonyl)-valinol (10d) 
 
White solid (70% yield, 2.60 g, 7.0 mmol), mp: 87-89 °C. 1H NMR (300 MHz, CDCl3) δ -0.06 (s, 3H), -0.05 
(s, 3H), 0.75 (d, J = 6.5 Hz, 6H), 0.89 (s, 9H), 1.67-1.81 (m, 1H), 2.40 (s, 3H), 2.56 (br s, 1H, missing after 
deuteration), 2.96-3.05 (m, 1H), 3.47-3.61 (m, 2H), 5.35 (d, J = 8.5 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 7.77 
(d, J = 8.0 Hz, 2H). These spectroscopic data are in good agreement with those reported in the 
literature.30 
 
(S)-O-(tert-Butyldimethylsilyl)-N-(4-methylbenzenesulfonyl)-leucinol (10e) 
 
Colorless oil (67% yield, 2.57 g, 6.6 mmol). 1H NMR (CDCl3, 300 MHz)  -0.06 (s, 3H), -0.05 (s, 3H), 0.75-
0.81 (m, 6H) 0.83 (s, 9H), 1.18-1.42 (m, 2H), 1.50-1.65 (m, 1H), 2.43 (s, 3H), 3.08-3.16 (m, 1H), 3.54-
3.57 (m, 2H), 4.76 (d, J = 8.5 Hz, 1H), 7.31 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 2H). These spectroscopic 
data are in good agreement with those reported in the literature.30 
 
General procedure (GP12) for the preparation of compounds 11a,b-d,e. 
 
In a mixture of sodium hydride (1.5 equiv.) in THF (10 mL) at 0 °C under Argon atmosphere, KI was 
added (1.05 equiv.) and a solution of the corresponding compound 10 (1.0 equiv.) in THF (10 mL) was 
dropped.  
The reaction mixture was stirred for 30 minutes at room temperature, then cooled at 0 °C. A solution 
of allyl bromide (1.05 equiv.) in THF (5 mL) was dropped and the mixture was stirred at room 
temperature overnight.  
The mixture was concentrated at reduced pressure, washed with water (30 mL), extracted three times 
with diethyleter (3 x 30 mL). Dried on Na2SO4, and concentrated at reduced pressure. The crude 
product was purified by silica gel column chromatography to afford the corresponding compound 11. 
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N-Allyl-O-(tert-butyldimethylsilyl)-N-(4-benzenesulfonyl)-ethanolamine (11a) 
 
Following GP12 with aminoalcohol 10a (1.0 equiv, 0.3 mmol) and allyl bromide (1.05 equiv., 0.24mL, 
0.3 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 2:8) to afford 11a in 91% yield (3.36 g, 9.1 mmol). Colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 0.00 (s, 6H), 0.84 (s, 9H), 2.39 (s, 3H), 3.18 (t, J = 8.0 Hz, 2H), 3.68 (t, J = 8.0 Hz, 2H), 3.84 (d, J 
= 8.0 Hz, 2H), 5.08-5.14 (m, 2H), 5.58-5.62 (m, 1H), 7.26 (d, J = 4.0 Hz, 2H), 7.67 (d, J = 4.0 Hz, 2H). 13C 
NMR (100 MHz, CDCl3) δ -5.4 (q), 21.5 (q), 26.0 (q), 45.1 (s), 49.8 (t), 52.2 (t), 61.1 (t), 119.4 (t), 127.1 
(d), 127.3 (d), 129.8 (d), 133.0 (s), 143.7 (s). MS: (m/z) 369 (M+). Anal. Calcd for C18H31NO3SSi: C, 58.50; 
H, 8.45; N, 3.79. Found: C, 58.69; H, 8.16; N, 4.05. 
 
N-Allyl-O-(tert-butyldimethylsilyl)-N-(4-nitrobenzenesulfonyl)-ethanolamine (11b) 
 
Following GP12 with aminoalcohol 10b (1.0 equiv, 0.2 mmol) and allyl bromide (1.05 equiv., 0.24 mL, 
0.2 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 8:2) to afford 11b in 80% yield (3.32 g, 8.3 mmol). Colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 0.00 (s, 6H), 0.83 (s, 9H), 3.29 (t, J = 6.0 Hz, 2H), 3.72 (t, J = 6.0 Hz, 2H), 3.94 (d, J = 6.0 Hz, 2H), 
5.12-5.17 (m, 2H), 5.56-5.66 (m, 1H), 8.00 (d, J = 9.0 Hz, 2H), 8.31 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ -5.5 (q), 18.1 (s), 25.8 (q), 48.9 (t), 51.7 (t), 61.9 (t), 119.4 (t), 124.3 (d), 128.3 (d), 132.4 (d), 
146.3 (s), 149.9 (s). MS: (m/z) 402 (M+). Anal. Calcd for C17H30N2O5SSi: C, 50.72; H, 7.51; N, 6.96. Found: 
C, 50.93; H, 7.28; N, 6.72. 
 
(S)-N-Allyl-O-(tert-butyldimethylsilyl)-N-(4-methylbenzenesulfonyl)-valinol (11d) 
 
Following GP12 with aminoalcohol 10d (1.0 equiv, 2.7 mmol) and allyl bromide (1.05 equiv., 0.24 mL, 
2.8 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 1:9) to afford 11d in 60% yield (2.46 g, 6.0 mmol). Orange oil. 1H NMR (400 MHz, 
CDCl3) δ 0.01 (s, 6H), 0.88 (s, 9H), 0.94-0.99 (m, 6H), 1.96-2.07 (m, 1H), 2.45 (s, 3H), 3.58-3.60 (m, 1H), 
3.61 (d, J = 8.5 Hz, 1H), 3.71-3.75 (m, 1H), 3.85-3.90 (m, 1H), 3.98-4.04 (m, 1H), 5.07 (d, J = 8.0 Hz, 1H), 
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5.18 (d, J = 8.0 Hz, 1H), 5.89-5.93 (m, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.0 Hz, 2H). 13C NMR (100 
MHz, CDCl3) δ -5.8 (q), 18.1 (s), 19.9 (q), 20.7 (q), 25.7 (q), 27.5 (d), 47.9 (t), 63.3 (t), 65.7 (d), 116.4 (t), 
127.4 (d), 129.3 (d), 136.5 (s), 142.6 (s). MS: (m/z) 411 (M+). Anal. Calcd for C21H37NO3SSi: C, 61.27; H, 
9.06; N, 3.40. Found: C, 61.35; H, 8.78; N, 3.16. 
 
(S)-N-Allyl-O-(tert-butyldimethylsylil)-N-(4-methylbenzenesulfonyl)-leucinol (11e) 
 
Following GP12 with aminoalcohol 10e (1.0 equiv, 0.2 mmol) and allyl bromide (1.05 equiv. 0.24 mL, 
0.2 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 2:8) to afford 11e in 65% yield (2.76 g, 6.5 mmol). Colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 0.01 (s, 6H), 0.80-0.84 (m, 6H), 0.84 (s, 9H), 1.39 (t, J = 6.0 Hz, 2H), 1.48 (m, 1H), 2.40 (s, 3H), 
3.52-3.55 (m, 2H), 3.84-3.89 (m, 3H), 5.04-5.17 (m, 2H), 5.76-5.84 (m, 1H), 7.25 (d, J = 8.0 Hz, 2H), 7.72 
(d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ -5.6 (q), 17.9 (s), 22.1 (q), 22.8 (q), 24.3 (q), 25.8 (d), 
38.8 (t), 47.2 (t), 57.7 (d), 64.8 (t), 116.7 (t), 127.3 (d), 129.4 (d), 136.6 (d), 138.6 (s), 142.8 (s). MS: 
(m/z) 425 (M+). Anal. Calcd for C22H39NO3SSi: C, 62.07; H, 9.23; N, 3.29. Found: C, 62.31; H, 8.94; N, 
3.47. 
 
General procedure (GP13) for the preparation of compounds 12a-e. 
 
A mixture of the corresponding compound 11 (1.0 equiv.) and tetrabutylammonium fluoride (1.2 
equiv.) in THF (0.2 M) was stirred at room temperature for 3 h. The solvent was evaporated at reduced 
pressure, water was added (20 mL) and the reaction mixture was extracted three times with CH2Cl2 (3 
x 25 mL), then dried over Na2SO4, and the mixture concentrated at reduced pressure. The crude 
product was purified by silica gel column chromatography to afford the corresponding product 12.  
 
N-Allyl-N-(4-methylbenzenesulfonyl)-ethanolamine (12a) 
 
103 
 
Pale yellow oil (79% yield, 2.01 g, 7.8 mmol). 1H NMR (400 MHz, CDCl3) δ 2.03 (br s, 1H, missing after 
deuteration), 2.31 (t, J = 5.5 Hz, 2H), 2.45 (s, 3H), 3.70 (t, J = 5.5 Hz, 2H), 3.87 (d, J = 6.5 Hz, 2H), 5.14-
5.21 (m, 2H), 5.58-5.71 (m, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.75 (d, J = 8.0 Hz, 2H). These spectroscopic 
data are in good agreement with those reported in the literature.39 
 
N-Allyl-N-(4-nitrobenzenesulfonyl)-ethanolamine (12b) 
 
Following GP13 with 11b (1.0 equiv, 1.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 1:1) to afford 12b in 40% yield (1.14 g, 
4.0 mmol). Yellow oil. 1H NMR (400 MHz, CDCl3) δ 3.28 (t, J = 5.5 Hz, 2H), 3.71 (t, J = 5.5 Hz, 2H), 3.87 
(d, J = 6.5 Hz, 2H), 5.15 (dd, J = 2.5, 13.5 Hz, 2H), 5.54-5.64 (m, 1H), 7.97 (d, J = 8.0 Hz, 2H), 8.30 (d, J = 
8.0, 2H). 13C NMR (100 MHz, CDCl3) δ 49.7 (t), 51.7 (t), 60.8 (t), 119.7 (t), 124.1 (d); 128.2 (d), 132.1 (d), 
137.1 (s), 163.9 (s). MS: (m/z) 286 (M+). Anal. Calcd for C11H14N2O5S: C, 46.15; H, 4.93; N, 9.78. Found: 
C, 45.89; H, 5.07; N, 9.55.  
 
N-Allyl-N-(4-aminobenzenesulfonyl)-ethanolamine (12c) 
 
Following GP13 with 11b40 (1.0 equiv., 1.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / petroleum ether 1:1) to afford 12c in 22% yield (563 mg, 
2.2 mmol). Dark yellow oil. 1H NMR (400 MHz, CDCl3) δ 3.54 (t, J = 6.0 Hz, 2H), 3.81 (t, J = 6.0 Hz, 2H), 
4.03-4.04 (m, 2H), 5.08 (dd, J = 2.5, 13.0 Hz, 2H), 5.72-5.79 (m, 1H), 6.58 (d, J = 9.5 Hz, 2H), 7.94 (d, J = 
9.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 52.9 (t), 53.7 (t), 60.0 (t), 110.6 (d), 116.9 (t), 126.2 (d), 131.7 
(d), 136.9 (s), 153.3 (s). MS: (m/z) 256 (M+). Anal. Calcd for C11H16N2O3S: C, 51.55; H, 6.29; N, 10.93. 
Found: C, 51.43; H, 6.53; N, 11.19.  
 
 
                                                 
39 Poornachandran, M.; Raghunathan, R. Tetrahedron 2008, 64, 6461-6474. 
40 Both 12b and 12c derive from 11b using GP13. The N-Allyl-N-(4-aminobenzenesulfonyl)-ethanolamine is obtained 
carrying the deprotection for 24 hours instead that for 3 hours.  
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(S)-N-Allyl-N-(4-methylbenzenesulfonyl)-valinol (12d) 
 
Yellow oil (96% yield, 2.85 g, 9.6 mmol). 1H NMR (300 MHz, CDCl3) δ 0.62 (d, J = 8.5 Hz, 3H), 0.84 (d, J 
= 8.0 Hz, 3H), 1.99 (m, 1H), 2.34 (s, 3H), 3.42 (dd, J = 10.0, 4.5 Hz, 1H), 3.68 (dd, J = 9.0, 5.0 Hz, 2H), 
3.89 (dd, J = 9.0, 5.0 Hz, 1H), 4.15 (dd, J = 9.0, 5.0 Hz, 1H), 5.13 (m, 2H), 5.82 (m, 1H), 7.21 (d, J = 8.0, 
2H), 7.67 (d, J = 8.0 Hz, 2H). These spectroscopic data are in good agreement with those reported in 
the literature.41 
 
(S)-N-Allyl-N-(4-methylbenzenesulfonyl)-leucinol (12e) 
 
Colorless oil (73% yield, 2.27 g, 7.3 mmol). 1H NMR (300 MHz, CDCl3) δ 0.69 (t, J = 6.5 Hz, 6H), 1.15 (t, J 
= 7.0 Hz, 2H), 1.26-1.37 (m, 1H), 2.33 (s, 3H), 3.47 (br s, 2H), 3.66-3.74 (m, 1H), 3.78-3.87 (m, 2H), 5.03-
5.17 (m, 2H), 5.72-5.85 (m, 1H), 7.21 (d, J = 8.0 Hz, 2H), 7.68 (d, J = 8.0 Hz, 2H). These spectroscopic 
data are in good agreement with those reported in the literature.42 
 
General procedure (GP14) for the preparation of oxazepanes 13a-e’ and 20. 
 
A mixture of the corresponding allylaminoalcohol 12 (1.0 equiv.), PdCl2(CH3CN)2 (10 mol %), CuCl2 (1.0 
equiv.), and the suitable aryl tributyl stannane (1.0 equiv.) in THF (0.2 M) was stirred at room 
temperature for 18-24 h. The solvent was evaporated under reduced pressure, water was added (10 
mL) then it was extracted three times with CH2Cl2 (3 x 10 mL), then dried over Na2SO4, and the solvent 
                                                 
41 Aurich, H. G.; Gentes, C.; Harms, K. Tetrahedron 1995, 51, 10497. 
42 Bera, S.; Panda, G. ACS Comb. Sci. 2012, 14, 1-4. 
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was removed under reduced pressure. The crude product was purified by silica gel column 
chromatography to afford the corresponding oxazepane 13 or 20.  
 
7-Phenyl-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (13a) 
 
Following GP14 with 12a (1.0 equiv, 0.75 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.24 mL, 
0.74 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 4:6) to afford 13a in 78% yield (258 mg, 0.08 mmol). White solid, mp: 104-106 °C. 1H 
NMR (400 MHz, CDCl3) δ 2.10-2.20 (m, 1H), 2.25-2.40 (m, 1H), 2.45 (s, 3H); 3.25 (ddd, J = 13.0, 10.0, 
3.0 Hz, 1H), 3.34 (ddd, J = 12.5, 7.5, 4.5 Hz, 1H), 3.63 (dt, J = 13.0, 6.0 Hz, 1H), 3.71 (dt, J = 13.5, 3.0 Hz, 
1H), 3.78 (ddd, J = 12.5, 7.5, 4.5 Hz, 1H), 4.11 (dt, J = 13.0, 3.0 Hz, 1H), 4.68 (dd, J = 9.5, 4.5 Hz, 1H), 
7.40-7.20 (m, 7H), 7.72 (d, J = 8.5, 2H). These spectroscopic data are in good agreement with those 
reported in the literature.43 
 
7-Phenyl-4-(4-nitrobenzenesulfonyl)-1,4-oxazepane (13b)  
 
Following GP14 with 12b (1.0 equiv, 0.28 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.09 mL, 
0.28 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 4:6) to afford 13b in 62% yield (224 mg, 0.06 mmol). White solid, mp: 112-113 °C. 1H 
NMR (400 MHz, CDCl3) δ 1.92-2.03 (m, 1H), 2.24-2.31 (m, 1H), 3.27 (ddd, J = 13.0, 10.0, 3.0 Hz, 1H), 
3.35-3.42 (m, 1H), 3.54-3.59 (m, 1H), 3.67 (dt, J = 13.5, 3.0 Hz, 1H), 3.73 (ddd, J = 12.5, 7.5, 4.5 Hz, 1H), 
4.08 (dt, J = 13.0, 3.0 Hz, 1H), 4.62 (dd, J = 9.5, 4.5 Hz, 1H), 7.14-7.28 (m, 5H), 7.94 (d, J = 8.5, 2H), 8.33 
(d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 37.9 (t), 46.3 (t), 51.7 (t), 69.9 (t), 81.6 (d), 124.5 (d), 
125.5 (d), 127.6 (d), 128.1 (d), 128.5 (d), 142.4 (s), 149.9 (s), 150.0 (s). MS: (m/z) 362 (M+). Anal. Calcd 
for C17H18N2O5S: C, 56.34; H, 5.01; N, 7.73. Found: C, 56.11; H, 5.27; N, 7.48.  
 
 
 
 
                                                 
43 Gharpure, S., Prasad, J. V. K. Eur. J. Org. Chem. 2013, 2076-2079. 
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4-(4-Aminobenzenesulfonyl)-7-phenyl-1,4-oxazepane (13c) 
 
Following GP14 with 12c (1.0 equiv, 0.3 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.09 mL, 0.3 
mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 1:1) to afford 13c in 67% yield (222 mg, 0.07 mmol). Pale orange solid, mp: 93 °C. 1H 
NMR (400 MHz, CDCl3) δ 1.88-1.92 (m, 1H), 1.99-2.07 (m, 1H), 2.65-2.77 (m, 2H), 3.40-3.55 (m, 2H), 
4.07-4.22 (m, 2H), 5.15 (dd, J = 9.0 Hz, 1H), 6.29 (d, J = 9.0 Hz, 2H), 7.11-7.27 (m, 5H), 8.01 (d, J = 9.0 
Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 30.6 (t), 33.9 (t), 46.8 (t), 65.0 (t), 89.2 (d), 111.0 (d), 126.2 (d), 
126.3 (d), 128.4 (d), 128.6 (d), 137.4 (s), 140.8 (s), 149.4 (s). MS: (m/z) 332 (M+). Anal. Calcd for 
C17H20N2O3S: C, 61.42; H, 6.06; N, 8.43. Found: C, 61.47; H, 5.81; N, 8.65.  
 
(3S,7R)-3-Isopropyl-7-phenyl-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (13d) 
 
Following GP14 with 12d (1.0 equiv, 0.02 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.24 mL, 
0.02 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 4:6) to afford 13d in 44% yield (164 mg, 0.04 mmol). White solid, mp: 84-86 °C. 1H 
NMR (400 MHz, CDCl3) δ 0.96 (s, 6H), 1.42-1.44 (m, 1H), 1.63-1.65 (m, 2H), 2.45 (s, 3H), 3.41-3.46 (m, 
2H), 3.55-3.60 (m, 2H), 4.23 (dd, J = 11.5, 13.0 Hz, 1H), 4.53 (dd, J = 2.5, 8.0 Hz, 1H), 7.22-7.25 (m, 2H), 
7.30-7.33 (m, 5H), 7.75 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 13.4 (q), 20.1 (q), 26.9 (d), 37.5 
(t), 40.5 (d), 65.2 (d), 71.4 (t), 81.6 (d), 125.4 (d), 127.1 (d), 127.2 (d), 128.3 (d), 129.6 (d), 138.1 (s), 
143.1 (s), 143.3 (s). MS: (m/z) 373 (M+). Anal. Calcd for C21H27NO3S: C, 67.53; H, 7.29; N, 3.75. Found: 
C, 67.38; H, 7.57; N, 3.82.  
 
(3S,7R)-3-isopropyl-7-phenyl-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (13d’) 
 
Following GP14 with 12d (1.0 equiv, 0.02 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.24 mL, 
0.02 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
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petroleum ether 4:6) to afford 13d’ in 24% yield (89 mg, 0.02 mmol). White solid, mp: 103-105 °C. 1H 
NMR (400 MHz, CDCl3) δ 0.98 (s, 3H), 1.00 (s, 3H), 1.71-1.73 (m, 1H), 1.81-1.85 (m, 1H), 2.11 (dd, J = 
7.5, 14.5 Hz, 1H), 2.45 (s, 3H), 3.35 (ddd, J = 1.5, 12.0, 16.0 Hz, 1H), 3.61 (dd, J = 5.0, 13.5 Hz, 1H), 3.98 
(td, J = 5.5, 8.5 Hz, 1H), 4.08-4.13 (m, 1H), 4.19 (dd, J = 8.5, 13.5 Hz, 1H), 4.38 (dd, J = 7.5, 11.5 Hz, 1H), 
6.87 (dd, J = 6.0, 8.0 Hz, 2H), 7.20-7.32 (m, 5H), 7.80 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 
18.4 (q), 20.2 (q), 30.1 (d), 36.2 (t), 42.6 (t), 63.8 (d), 69.7 (t), 84.1 (d), 125.7 (d), 127.4 (d), 127.6 (d), 
128.1 (d), 129.6 (d), 139.7 (s), 142.3 (s), 142.9 (s). MS: (m/z) 373 (M+). Anal. Calcd for C21H27NO3S: C, 
67.53; H, 7.29; N, 3.75. Found: C, 67.44; H, 7.51; N, 3.57.  
 
(3S,7R)-3-Isobutyl-7-phenyl-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (13e) 
 
Following GP14 with 12e (1.0 equiv, 0.54 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.18 mL, 
0.54 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 1:9) to afford 13e in 47% yield (181 mg, 0.05 mmol). White solid, mp: 118-120 °C. 1H 
NMR (400 MHz, CDCl3) δ 0.84 (s, 6H), 1.42-1.49 (m, 1H), 1.60-1.66 (m, 1H), 1.95-2.01 (m, 1H), 2.32-2.43 
(m, 1H), 2.44 (s, 3H), 3.31-3.38 (m, 1H), 3.41-3.45 (m, 1H), 3.65-3.74 (m, 2H), 3.94 (dd, J = 2.0, 13.0 Hz, 
1H), 4.03-4.07 (m, 1H), 4.56 (dd, J = 5.0, 8.5 Hz, 1H), 7.26-7.32 (m, 7H), 7.73-7.75 (m, 2H). 13C NMR (100 
MHz, CDCl3) δ 22.4 (q), 22.8 (q), 24.6 (d), 38.0 (t), 39.3 (t), 40.2 (t), 56.6 (d), 73.5 (t), 81.9 (d), 125.4 (d), 
127.0 (d), 127.3 (d), 128.4 (d), 129.5 (s), 129.6 (d), 137.9 (s), 143.2 (s). MS: (m/z) 387 (M+). Anal. Calcd 
for C22H29NO3S: C, 68.18; H, 7.54; N, 3.61. Found: C, 68.15; H, 7.76; N, 3.85.  
 
(3S,7R)-3-Isobutyl-7-phenyl-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (13e’) 
 
Following GP14 with 12e (1.0 equiv, 0.54 mmol) and phenyl(tributyl) stannane (1.0 equiv., 0.18 mL, 
0.54 mmol). The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
petroleum ether 1:9) to afford 13e’ in 38% yield (147 mg, 0.04 mmol). White solid, mp: 123-124 °C. 1H 
NMR (400 MHz, CDCl3) δ 0.92 (s, 6H), 1.31-1.37 (m, 1H), 1.45-1.52 (m, 1H), 1.65 (td, J = 6.5, 13.5 Hz, 
1H), 1.75 (dt, J = 4.0, 14.0 Hz, 1H), 1.82-1.92 (m, 1H), 2.45 (s, 3H), 3.30-3.43 (m, 2H), 4.02-4.06 (m, 1H), 
4.16 (dd, J = 5.5, 13.5 Hz, 1H), 4.23-4.30 (m, 1H), 4.35-4.39 (dd, J = 4.0, 11.5 Hz, 1H), 6.90 (dd, J = 3.0, 
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7.5 Hz, 2H), 7.21-7.32 (m, 5H), 7.79 (d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 22.3 (q), 23.1 (q), 
24.6 (d), 36.7 (t), 40.5 (t), 41.3 (t), 56.5 (d), 72.0 (t), 84.3 (d), 125.7 (d), 127.5 (d), 128.2 (d), 129.6 (d), 
139.5 (s), 142.3 (s), 142.9 (s). MS: (m/z) 387 (M+). Anal. Calcd for C22H29NO3S: C, 68.18; H, 7.54; N, 3.61. 
Found: C, 68.01; H, 7.79; N, 3.87.  
 
7-[4-(Benzyloxy)phenyl]-4-(4-methylbenzenesulfonyl)-1,4-oxazepane (20) 
 
Following GP14 with 12a (1.0 equiv, 0.39 mmol) and (4-benzyloxyphenyl)tributyl stannane (1.0 equiv., 
0.16 mL, 0.39 mmol). The crude produt was purified by flash chromatography on silica gel (eluent: 
AcOEt / petroleum ether 3:7) to afford 20 in 80% yield (349 mg, 0.08 mmol). White solid, mp: 140 °C. 
1H NMR (400 MHz, CDCl3) δ 1.93-1.99 (m, 1H), 2.16-2.21 (m, 1H), 2.37 (s, 3H), 3.15-3.19 (m, 1H), 3.23-
3.29 (m, 1H), 3.48-3.54 (m, 1H), 3.58-3.70 (m, 2H), 3.99 (dt, J = 13.0, 3.0 Hz, 1H), 4.54 (dd, J = 5.5, 9.5 
Hz, 1H), 4.97 (s, 2H), 6.85 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 7.24-7.35 (m, 7H), 7.63 (d, J = 8.0 
Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 21.5 (q), 37.6 (t), 46.2 (t), 51.7 (t), 69.8 (t), 70.0 (t), 81.1 (d), 114.8 
(d), 126.9 (d), 127.0 (d), 127.4 (d), 127.9 (d), 128.6 (d), 129.8 (d), 135.3 (s), 135.9 (s), 136.9 (s), 143.4 
(s), 158.1 (s). MS: (m/z) 437 (M+). Anal. Calcd for C25H27NO4S: C, 68.63; H, 6.22; N, 3.20. Found: C, 68.74; 
H, 5.98; N, 3.47.  
 
Procedure for the synthesis of compound 14.  
 
A mixture of N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv, 0.47 mmol) and 
PdCl2(CH3CN)2 (10 mol %) was stirred at room temperature for 24 hours under oxygen atmosphere. 
The solvent was evaporated under reduced pressure, water was added (10 mL) then it was extracted 
three times with CH2Cl2 (3 x 10 mL), then dried over Na2SO4, and the solvent was removed under 
reduced pressure. The crude product was purified by silica gel column chromatography to afford the 
corresponding compound 14.  
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6-Methyl-4-(4-methylbenzenesulfonyl)-3,4-dihydro-2H-1,4-oxazine (14) 
 
Colorless oil (81% yield, 8 mg, 0.003 mmol). 1H NMR (400 MHz, CDCl3) δ 1.73 (s, 3H), 2.43 (s, 3H), 3.45 
(t, J = 4.5 Hz, 2H), 3.59 (t, J = 4.5 Hz, 2H), 5.83 (s, 1H), 7.32 (t, J = 8.0 Hz, 2H), 7.66 (t, J = 8.0 Hz, 2H). 13C 
NMR (100 MHz, CDCl3): δ 17.8 (q), 21.5 (q), 42.8 (t), 63.0 (t), 100.0 (d), 127.4 (d), 129.8 (d), 133.9 (s), 
140.3 (s), 143.8 (s). These spectroscopic data are in good agreement with those reported in the 
literature. 
 
Procedure for the synthesis of compound 15. 
 
A mixture of N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv, 0.47 mmol) and 
phenyl iodobenzene (1.0 equiv., 0.052 mL, 0.47 mmol) was stirred in DMF at 50 °C for 24 hours. An 
acqueous solution of NH4Cl was added (10 mL) then it was extracted three times with Et2O (3 x 10 mL), 
then dried over Na2SO4, and the solvent was removed under reduced pressure. The crude product was 
purified by silica gel column chromatography to afford the corresponding compound 15.  
 
N-Cinnamyl-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide (15) 
 
White solid (80% yield, 124 mg, 0.4 mmol), mp: 54-58 °C. 1H NMR (400 MHz, CDCl3) δ 2.43 (s, 3H), 3.29 
(t, J = 5.5 Hz, 2H), 3.75 (t, J = 5.0 Hz, 2H), 4.02 (dd, J = 1.0, 7.0 Hz, 2H), 5.98 (dt, J = 6.5, 16.0 Hz, 1H), 
6.45 (d, J = 16.0 Hz, 1H), 7.28 (m, 7H), 7.74 (d, J = 8.5 Hz, 2H). These spectroscopic data are in good 
agreement with those reported in the literature.44 
 
 
 
 
                                                 
44 Bezason, M.; Pottel, J.; Bilbeisi, R.; Tomieux, S.; Cueto, M.; Moitessier, N. J. Org. Chem. 2013, 78, 872-885. 
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General procedure (GP15) for the preparation of compounds 16a-b. 
 
A mixture of the corresponding compound 12 (1.0 equiv.), PdCl2(CH3CN)2 (10 mol %) and CuCl2 (1.0 
equiv.) in MeOH (0.2 M) was stirred in CO atmosphere at room temperature for 24 h. The solvent was 
evaporated at reduced pressure, then water was added (10 mL) and the reaction mixture was 
extracted three times with CH2Cl2 (3 x 25mL), dried over Na2SO4, and the product concentrate at 
reduced pressure. The crude product was purified by silica gel column chromatography to afford the 
corresponding morpholine 16.  
 
2-[(Methoxycarbonyl)methyl]-4-(4-methylbenzenesulfonyl)morpholine (16a) 
 
Following GP15 with N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv, 0.3 mmol). 
The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 
1:3) to afford 16a in 65% yield (203 mg, 0.06 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3) δ 2.17 (t, 
J = 11.0 Hz, 1H), 2.14-2.46 (m, 3H), 2.42 (s, 3H), 3.48 (d, J = 11.5 Hz, 1H), 3.60-3.70 (m, 2H), 3.68 (s, 3H), 
3.85-3.89 (m, 1H), 3.95-4.00 (m, 1H), 7.33 (d, J = 8.5 Hz, 2H), 7.62 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ 21.5 (q), 38.1 (t), 45.2 (t), 49.6 (t), 51.9 (d), 65.9 (t), 71.7 (d), 127.8 (d), 129.8 (d), 132.2 (s), 
144.0 (s), 170.4 (s). MS: (m/z) 313 (M+). Anal. Calcd for C14H19NO5S: C, 53.66; H, 6.11; N, 4.47. Found: 
C, 53.89; H, 6.16; N, 4.68. 
 
2-[(Methoxycarbonyl)methyl]-4-(4-nitrobenzenesulfonyl)morpholine (16b) 
 
Following GP15 with N-Allyl-N-(4-nitrobenzenesulfonyl)-aminoethanol 12b (1.0 equiv, 0.3 mmol). The 
crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 4:6) 
to afford 16b in 74% yield (266 mg, 0.08 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3) δ 2.22 (t, J = 
11.0 Hz, 1H), 2.19-2.48 (m, 3H), 3.52 (d, J = 12.0 Hz, 1H), 3.59-3.66 (m, 2H), 3.60 (s, 3H), 3.83-3.92 (m, 
2H), 7.88 (d, J = 9.0 Hz, 2H), 8.34 (d, J = 9.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 37.9 (t), 45.2 (t), 49.5 
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(t), 52.1 (q), 65.8 (t), 71.8 (d), 124.6 (d), 128.9 (d), 130.3 (s), 141.7 (s), 170.2 (s). MS: (m/z) 344 (M+). 
Anal. Calcd for C13H16N2O7S: C, 45.35; H, 4.68; N, 8.14. Found: C, 45.07; H, 4.91; N, 7.98. 
 
Procedure for the synthesis of compound 17 using NCS as chlorine source. 
 
A mixture of N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv.), PdCl2(CH3CN)2 (10 
mol %) and NCS (1.2 equiv.) in CH2Cl2 (0.2 M) was stirred under nitrogen atmosphere at room 
temperature for 24 h. After the total consumption of starting material the reaction was quenched with 
a saturated aqueous solution of ammonium chloride, washed with an aqueous NaOH 3M solution, 
then with brine. The combined aqueous layers were extracted with CH2Cl2. The organic phase was 
dried over Na2SO4, filtered and concentrated at reduced pressure. The crude product was purified by 
silica gel column chromatography to afford the corresponding morpholine 17 (42% yield, 121 mg).  
 
Procedure for the synthesis of compound 17 using CuCl2 as chlorine source. 
 
A mixture of N-allyl-N-(p-toluenesulfonyl)-aminoethanol 12a (1.0 equiv.), PdCl2(CH3CN)2 (10 mol %) 
and CuCl2 (3 equiv.) in THF (0.2 M) was stirred under air atmosphere at room temperature for 24 h. 
After the total consumption of starting material the reaction was quenched with a saturated aqueous 
solution of ammonium chloride, washed with an aqueous NaOH 3M solution, then with brine. The 
combined aqueous layers were extracted with CH2Cl2. The organic phase was dried over Na2SO4, 
filtered and concentrated at reduced pressure. The crude product was purified by silica gel column 
chromatography to afford the corresponding morpholine 17 (51% yield, 147 mg).  
 
2-(Chloromethyl)-4-(4-methylbenzenesulfonyl)-morpholine (17) 
 
The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 
4:6) to afford 17. Colorless oil. 1H NMR (400 MHz, CDCl3) δ 1.95-2.11 (m, 1H), 2.12 (s, 3H), 2.12-2.15 
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(m, 1H), 2.95-3.05 (m, 2H), 3.21-3.43 (m, 4H), 3.72 (d, J = 11.5 Hz, 1H), 6.90 (d, J = 8.5 Hz, 2H), 7.66 (d, 
J = 8.5 Hz, 2H). 13C-NMR (CDCl3): δ 21.1 (q), 43.9 (t), 45.5 (t), 48.3 (t), 65.7 (t), 74.3 (d), 128.0 (d), 129.7 
(d), 133.4 (s), 143.4 (s). MS: (m/z) 289 (M+). Anal. Calcd for C12H16ClN3OS: C, 49.74; H, 5.57; N, 4.83. 
Found: C, 49.79; H, 5.38; N, 5.08. 
 
Procedure for the synthesis of compound 18. 
 
A mixture of N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv.), Pd(OAc)2 (10 mol %), 
PhI(OAc)2 (2.0 equiv.) and Bu4NOAc (1.0 equiv.) in CH3CN (0.2 M) was stirred at 60 °C for 24 h. After 
completion, the reaction was dissolved in CH2Cl2 (5 mL) and washed with water (5 mL). The resulting 
organic extract was washed with brine, separated and the brine layer was extracted with CH2Cl2 (10 
mL). The combined organics were dried over Na2SO4 and concentrated at reduced pressure. The crude 
product was purified by silica gel column chromatography to afford the corresponding product 18.  
 
5-Acetoxymethyl-morpholine (18) 
 
The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 
3:7) to afford 18 in 42% yield (10 mg, 0.03 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.00 (s, 
3H), 2.11 (dd, J = 4.0, 11.0 Hz, 1H), 2.35 (dd, J = 3.5, 10.0 Hz, 1H), 2.38 (s, 3H), 3.46 (d, J = 11.5 Hz, 1H), 
3.54 (d, J = 11.0 Hz, 1H), 3.59-3.65 (m, 1H), 3.69-3.75 (m, 1H), 3.87 (dd, J = 10.0, 11.5 Hz, 1H), 3.92-4.03 
(m, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.57 (d, J = 8.0 Hz, 2H). 13C-NMR (100 MHz, CDCl3) 20.8 (q), 21.6 (q), 
45.4 (t), 47.4 (t), 64.2 (t), 65.9 (t), 73.0 (d), 127.9 (d), 129.8 (d), 132.1 (s), 144.1 (s), 170.6 (s). MS: (m/z) 
313 (M+). Anal. Calcd for C14H19NO5S: C, 53.66; H, 6.11; N, 4.47. Found: C, 53.39; H, 6.30; N, 4.73. 
 
Procedure for the synthesis of compound 19. 
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A mixture of N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv.), PdCl2(CH3CN)2 (10 
mol %) and CuCl2 (3 equiv.) in DMF (0.2 M) was stirred under air atmosphere at 150 °C for 18 h. After 
completion, the mixture was dissolved in Et2O and washed for three times with an aqueous solution 
of NH4Cl (20 mL x 3). The combined organic phases were dried over Na2SO4 and concentrated at 
reduced pressure. The crude product was purified by silica gel column chromatography to afford the 
corresponding morpholine 19.  
 
[4-(4-Methylbenzenesulfonyl)-morpholin-2-yl]methyl formate (19) 
 
The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 
1:1) to afford 19 in 35% yield (104 mg, 0.04 mmol). Colorless oil. 1H NMR (400 MHz, CDCl3)  2.12-2.17 
(m, 1H), 2.39 (s, 3H), 3.36-3.67 (m, 5H), 3.86-3.90 (m, 1H), 4.09 (d, J = 5.0 Hz, 2H), 7.29 (d, J = 8.5 Hz, 
2H), 7.57 (d, J = 8.5 Hz, 2H), 7.97 (s, 1H). 13C-NMR (100 MHz, CDCl3) 21.6 (q), 45.3 (t), 47.1 (t), 63.5 
(t), 66.0 (t), 72.7 (d), 127.9 (d), 129.9 (d), 131.9 (s), 144.2 (s), 160.4 (s). MS: (m/z) 299 (M+). Anal. Calcd 
for C13H17NO5S: C, 52.16; H, 5.72; N, 4.68. Found: C, 51.98; H, 5.97; N, 4.42. 
 
Procedure for the synthesis of compound 21. 
 
A mixture of the N-allyl-N-(4-methylbenzenesulfonyl)-aminoethanol 12a (1.0 equiv.), PdCl2(CH3CN)2 
(10 mol %), CuCl2 (1 equiv.), and phenyl(tributyl) stannane (1 equiv.) in THF (0.2 M) was stirred at 0 °C 
for 6 h. The solvent was evaporated under reduced pressure, water was added (10 mL) then it was 
extracted three times with CH2Cl2 (3 x 10 mL), then dried over Na2SO4, and the solvent was removed 
under reduced pressure. The crude product was purified by silica gel column chromatography to afford 
the corresponding oxazepane 13a and the compound 21.  
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N-(3-Chloro-3-phenylpropyl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide (21) 
 
The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / petroleum ether 
1:1) to afford 21 in 30% yield (110 mg, 0.03 mmol). Pale yellow oil. 1H NMR (400 MHz, CDCl3)  2.34-
2.40 (m, 2H), 2.43 (s, 3H), 3.24-3.27 (m, 2H), 3.30-3.34 (m, 2H), 3.72-3.78 (m, 2H), 4.92 (dd, J = 8.0, 1.0 
Hz, 1H), 7.28-7.36 (m, 7H), 7.67-7.70 (m, 2H). 13C-NMR (100 MHz, CDCl3)  21.5 (q), 39.3 (t), 47.9 (t), 
51.7 (t), 60.7 (d), 61.3 (t), 126.8 (d), 127.3 (d), 128.5 (d), 128.7 (d), 129.8 (d), 135.6 (s), 140.8 (s), 143.7 
(s). MS: (m/z) 367 (M+). Anal. Calcd for C18H22ClNO3S: C, 58.77; H, 6.03; N, 3.81. Found: C, 59.01; H, 
5.78; N, 3.87. 
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Chapter 2 
 
Intermolecular Pd-Catalyzed Allylic Amination 
of ,-Unsaturated Compounds 
 
 
 
 
Abstract  
Two complementary Pd-catalyzed protocols enabling the -selective intermolecular allylic amination 
of but-3-enoic acid derivatives are reported. These transformations can be successfully achieved via 
either a direct Pd(II)-catalyzed protocol or by way of a one-pot Pd(II) / Pd(0)-catalyzed sequence, 
depending on the nature of the nitrogen nucleophile used. 
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Introduction  
 
In the last ten years, efforts to develop increasingly effective step-economical syntheses have 
been highly pursued in organic chemistry. One way to reach this goal is to reduce the number of steps 
for a required transformation via activation of normally non reactive C-H bonds, instead of passing 
through the classical pre-oxidized functional groups.45 However, C-H bonds are ubiquitous in organic 
molecules, and their activation, even if possible, may raise selectivity issues. C-H bonds have high 
kinetic barriers and their reactivity strongly depends on the hybridization of the carbon atom. In 
particular, due to their low polarity and acidity, C(sp)3-H bonds are among the most difficult to activate, 
with the exception of those situated in allylic positions (Table 7).  
 
Type of 
C-H 
C(sp) C(sp2)arom C(sp2)vinyl C(sp3)1° C(sp3)2° C(sp3)3° C(sp3)allylic 
Structure  
      
BDE 
(kj/mol) 
552.2 473.0 460.2 410.8 397.9 389.9 361.1 
pKa ~25 43 44 ~50 ~50 ~50 43 
 
Table 7: Bond-Dissociation Energy of Selected Hydrocarbon C-H Bonds (kJ/mol) and pKa.46 
 
Consequentially, a special interest has been directed toward the development of direct 
functionalization of allylic C-H bonds.  
Among the transition metals able to promote such activation, palladium is the most attractive 
one, due to its low toxicity, its great tolerance towards a large number of functional groups, permitting 
to avoid protection chemistry, and its relative insensitivity toward water and oxygen. In this frame, 
                                                 
45 a) Roudesly, F.; Oble, J.; Poli, G. J. Mol. Cat. A. Chem. 2016, in press, DOI: 10.1016/j.molcata.2016.06.020. b)  
Yu, J.-Q. Catalytic Transformations via C-H Activation, vols 1 and 2, Science of Synthesis, Thieme, 2016. 
46  McMillen, D. F.; Golden, D. M. Ann. Rev. Phys. Chem. 1982, 33, 493.  
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some examples of direct Pd-catalyzed allylic functionalizations have been recently reported, mainly 
concerning acetoxylation47 and amination.48 
 
2.1. Pioneering Works  
 
The first example of preparation of the -allylpalladium chloride dimer starting from a 
stoichiometric amount of PdCl2 and methylpropane or allylic alcohol was reported independently by 
Hüttel49 and Hafner50 in 1959 (Scheme 27).  
 
 
 
Scheme 27: First Generation of -Allylpalladium Complex from Pd(II). 
 
Only a few years later, Tsuji51 reported the first synthetic use of these -allylpalladium 
complexes as allylating agents, permitting the formation of a carbon-carbon bond. For example, he 
showed that diethyl malonate could react smoothly with the dimer, affording the allylated product 
(Scheme 28).  
 
 
 
Scheme 28: First Use of -Allylpalladium Complexes. 
 
                                                 
47 For review dealing with early works, see: a) Muzart, J.; Bull. Soc. Chim. Fr. 1986, 65-77; b) Rawlinson, D. J.; 
Sosnovsky, G. Synthesis 1973, 567-603; c) Akermark, B.; Zetterberg, K.; Handbook of Organopalladium Chemistry for 
Organic Synthesis (Ed.: E.-i. Negishi), John Wiley & Sons, New York, 2002, p.1875-1885; d) Hosokawa, T.; Murahashi, 
S.-I. Other Intramolecular Oxypalladation-Dehydropalladations Reactions, in: Handbook of Organopalladium 
Chemistry for Organic Synthesis (Ed.: E. Negishi), John Wiley & Sons, New York, 2002, vol.2, p. 2141-2159; e) Henry, 
P.M. Palladium Catalyzed Oxidation of Hydrocarbons, D. Reidel Publishing Co., Dordrecht, The Netherlands, 1980.  
48 For a recent review, see: Ramirez, T.A.; Zhao, B.; Shi, B. Chem. Soc. Rev. 2012, 41, 931-942.  
49 a) Hüttel, R.; Kratzer, J. Angew. Chem. 1959, 71, 456. b) Hüttel, R.; Bechter, M. Angew. Chem. 1959, 71, 456. c) 
Hüttel, R.; Kratzer, J.; Bechter, M. Chem. Ber. 1961, 94, 766. 
50 Smidt, J.; Hafner, W. Angew. Chem. 1959, 71, 284. 
51 Tsuji, J.; Takahashi, H.; Morikawa, M. Tetrahedron Lett. 1965, 6, 4387. 
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In 1973, Trost52 described another use of this complex in synthesis, combining Hüttel’s PdCl2-
mediated activation with the reactivity proposed by Tsuji. However, the stoichiometric use of the metal 
and the lack of regioselectivity (the allylic malonates were obtained in a mixture with 63% yield) limited 
the interest towards this synthetic procedure (Scheme 29).  
 
 
 
Scheme 29: Non Selective Synthesis of Allylated Malonates. 
 
In 1982 Uemura53 reported the first palladium(II)-catalyzed allylation, in which TeO2 and t-BuO2H 
were used as in situ co-oxidizing agents in the context of an oxidative Pd(II)-catalyzed allylation 
(Scheme 30). 
 
 
 
Scheme 30: First Oxidative Allylation Pd(II)-Catalyzed. 
 
The above allylation probably represented the first oxidative Pd(II)-catalyzed allylation, as 
opposed to the previously described one, based on oxidative addition of a Pd(0) complex to an alkene 
bearing an allylic leaving group (Scheme 31). 
 
                                                 
52 a) Trost, B. M.; Fullerton, T. J. J. Am. Soc. Rev. 1973, 95, 292. b) Trost, B. M.; Weber, L. J. Am. Soc. Rev. 1975, 97, 
1611. 
53 Uemura, S.; Fukuzawa, S. I.; Toshimitsu, A.; Okano, M. Tetrahedron Lett. 1982, 23, 87. 
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Scheme 31: Possible Pd-Catalyzed Allylation Path. 
 
Both the paths involve a common π-allyl Pd intermediate. However, while the former path (top 
of the scheme) generates the allylic intermediate via oxidative addition of an alkene bearing an allylic 
leaving group to a Pd(0) complex, the latter path (bottom of the scheme) requires interaction between 
an alkene bearing an allylic H atom and a Pd(II) complex. In both cases the π-allyl Pd complex can be 
trapped by various nucleophiles, which produces the allylated produt and a Pd(0) complex. While the 
former path is a redox neutral process, the latter one is an oxidative process, the initial PdII species 
ending-up up as a Pd0 complex. Therefore, if catalysis is desired for this path, a terminal oxidizing agent 
(TOx) is needed, so as to bring the zero-valent Pd back to the original oxidation state. Such oxidant 
could be, for example, CuCl2, as firstly reported in 1959 by Smidt54 in the Wacker process, or 
benzoquinone, as reported at the same time by Moiseev et al.55  
 
A number of direct inter- or intra-molecular functionalizations of the C-H allylic bond are 
achievable through oxidative Pd(II)-catalysis, using oxygen-, nitrogen- or carbon-based nucleophiles.56 
A list of selected examples is reported in the following paragraphs. 
 
 
 
                                                 
54 Smidt, J.; Hafner, W. Angew. Chem. 1959, 71, 284. 
55 Moiseev, I. I.; Vargaftik, M. N.; Syrkin, Y. K. Dokl. Akad. Nauk SSSR 1960, 133, 377. 
56 Liron, F.; Oble, J.; Lorion, M. M.; Poli, G. Eur. J. Org. Chem. 2014, 5863. 
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2.2. Direct Intermolecular Allylic Oxylation Reactions  
 
Among the huge number of Pd(II)-catalyzed allylation processes reported in the literature, a 
good number are oxidative protocols, possibly relying on allylic C-H activation. 
 
Åkermark57 described the first Pd(II)-catalyzed allylic acetoxylation of cyclic and acyclic olefins 
using BQ / MnO2 as the oxidizing system (Scheme 32).  
 
 
 
Scheme 32: Allylic Acetoxylation Reported by Åkermark. 
 
At that time, the mechanism of this acetoxypalladiation could not be unambiguously 
determined, as it was not clear if it involved a C-H allylic activation or an acetoxypalladation / 
dehydropalladiation sequence. 
To clarify this issue, Bäckvall58 subsequently addressed a related study on a deuterated 
substrate. In particular, 1,2-dideuteriocyclohex-1-ene afforded a 1:1 ratio of - and -acetoxylation 
products, that was only in accord with intermediate C-H activation path (Scheme 33). Which 
demonstrated that the acetoxylation of cyclohexene involves a C-H activation mechanism.  
 
 
 
Scheme 33: Allylic Oxidation of 1,2-Dideuterocyclohexene. 
                                                 
57  Hansonn, S.; Heumann, A.; Rein, T.; Åkermark, B. J. Org. Chem. 1990, 55, 975-984. 
58 a) H. Grennberg, V. Simon, J.-E. Bäckvall, J. Chem. Soc. Chem. Commun. 1994, 265–266. b) Grennberg, H.;  
Bäckvall, J.-E. Chem. Eur. J. 1998, 4, 1083–1089. 
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Later, Mortreux59 studied the oxidation of limonene and showed that in both cases of 
acetoxylation and methoxylation the reaction occurred with highly regio- and stereoselectivity 
(Scheme 34).  
 
 
 
Scheme 34: Allylic Etherification of Limonene. 
 
The variation of the palladium source resulted in a change of diasteroselectivity (Table 8). 
 
[Pd] Compound A Compound B 
Pd(OAc)2 7% 93% 
Li2PdCl4 87% Traces 
 
Table 8: Diasteroselectivity as a Function of the Pd Source in the Allylic Mehtoxylation of Limonene. 
 
Thereafter, Gusevskaya60 demonstrated that the presence of the extracyclic unsaturation in 
limonene could direct the formation of the -allyl complex. Indeed, carvomenthene, which is devoid 
of the extracyclic unsaturation did not undergo allylic acetoxylation, even at high temperatures 
(Scheme 35). 
 
                                                 
59 El Firdoussi, L.; Baqqa, A.; Allaoud, S.; Ait Allal, B.; Karim, A.; Castanet, Y.; Mortreux, A. J. Mol. Catal. A 1998, 135, 
11–22. 
60 Speziali, M. G.; Robles-Dutenhefner, P.A.; Gusevskaya, E. V. Organometallics 2007, 26, 4003–4009. 
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Scheme 35: Influence of an Additional Olefin.  
 
More recently, White et al. found that direct allylic oxidation of terminal alkenes could be 
performed in a regioselective manner to give the linear or the branched allylic acetate, depending on 
the reaction conditions. The use of DMSO as co-solvent led to the linear allylic acetate, whereas the 
presence of a 1,2-disulfoxide ligand such as SS-2 led to the preferential formation of the branched 
product (Scheme 36).61  
 
 
 
Scheme 36: Influence of the Type of Sulfoxide on the Regioselectivity of Pd(II)-Catalyzed Allylic 
Acetoxylation. 
 
                                                 
61 a) Chen, M. S.; White, M. C. J. Am. Chem. Soc. 2004, 126, 1346-1347; b) Delcamp, J. H.; White, M. C. J. Am. Chem. 
Soc. 2006, 128, 15076-15077; c) Chen, M. S.; Prabagaran, N.; Labenz, N. A.; White, M. C. J. Am. Chem. Soc. 2005, 127, 
6970-6971. 
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To better understand the mechanism involved and the role of the sulfoxide ligand, White’s team 
realized several studies.62 For example, treatment of 1-undecene with Pd(OAc)2, BQ and acetic acid in 
dioxane as solvent does not give allylic acetoxylation acetoxylation in the absence of the sulfoxide 
ligand. In contrast, in the presence of the disulfoxide ligand SS-2 or the monosulfoxide ligand S-2 the 
allylation product is obtained in almost the same yield and with the same regioselectivity (Scheme 37). 
 
 
 
Scheme 37: Influence of the Sulfoxide Ligands. 
 
Different working models have been advanced to account for the different regioselectivities 
observed as a function of the sulfoxide ligand used. The branched product, obtained when a disulfoxide 
ligand is employed, is postulated to derive from an inner sphere attack of acetate anion at the allyl 
internal position of the neutral BQ-coordinated 3-allyl complex (Scheme 38, top). Instead, the linear 
E-configurated allylic product, obtained as major isomer when using DMSO, is proposed to derive from 
an outer sphere attack of acetate anion to a cationic 3-allyl complex (Scheme 38, bottom). 
 
 
 
Scheme 38: Proposed Scenario for the Pd(II)-Catalyzed Acetoxylation of Terminal Alkenes in the 
Presence of Sulfoxide Ligands. 
                                                 
62 Chen, M.S.; Prabagaran, N.; labenz, N.A.; White, M.C. J. Am. Chem. Soc. 2005, 127, 6970. 
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Stambuli reported an alkoxythioether ligand L1 was able to promote the Pd-catalyzed linear 
allylic acetoxylation of terminal alkenes (Scheme 39). A set of experiments excluded the involvement 
of a branched-to-linear equilibration of the allylic acetate product as well as of a 3-allyl complex. The 
same team showed later that tetrahydrotiophene L2 behaved even better than the previously found 
alkoxythioether ligand (Scheme 39).63 
 
 
 
Scheme 39: Pd(II)-Catalyzed Allylic Acetoxylation in the Presence of Thioether-Based Ligands. 
 
Le Bras and Muzart developed a process for allylic acyloxylation of terminal alkenes under basic 
conditions achieving very good regio- and stereoselectivities in favor of the linear and E-configured 
products (Scheme 40).64  
 
 
 
Scheme 40: Acyloxylation of Homoallylic Benzyl Alcohol. 
 
The mechanism is supposed to involve a complex, in which the palladium coordination sphere 
is saturated by the acyloxy ligand.  
 
 
                                                 
63 Le, C.C.; Kunchithapatham, K.; Henderson, W.H.; Check, C.T.; Stambuli, J.P. Chem. Eur. J. 2013, 19, 11153-11157. 
64 Thiery, E.; Aouf, C.; Belloy, J.; Harakat, D.; Le Bras, J.; Muzart, J. J. Org. Chem. 2010, 75, 1771-1774. 
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2.3. Direct Intermolacular Allylic Amination Reactions  
 
The groups of White and Liu developed at the same time protocols of direct Pd-catalyzed allylic 
aminations, using both terminal alkenes and N-tosylcarbamates as nitrogen nucleophiles. 
 
On one hand, Liu et al. reported an aerobic oxidative amination protocol using molecular oxygen 
in dimethylacetamide affording linear derivatives via an allylic C-H activation (Scheme 41).65  
 
 
 
Scheme 41: Intermolecular Direct Allylic Amination Reaction in Aerobic Conditions. 
 
Besides the allylic product, a considerable amount of non-allylic amide was obtained (70 / 30 
allylic non allylic). A possible reason for the formation of this isomer was judged by the authors to stem 
from the slow reoxidation step of Pd(0) by molecular oxygen. The same group later developed a new, 
more efficient oxidizing system, based on naphthoquinone (NQ) and PhI(OPiv)2 that allowed to lower 
the allylic / non-allylic ratio to 93 / 7 (Scheme 42).66  
 
 
 
Scheme 42: Intermolecular Direct Allylic Amination using NQ / PhI(OPiv)2 as Oxidizing System. 
 
                                                 
65 Liu, G.; Yin, G.; Wu, L. Angew. Chem. Int. Ed. 2008, 47, 4733-4736. Angew. Chem. 2008, 120, 4811. 
66 Yin, G.; Wu, Y.; Liu, G.; J. Am. Chem. Soc. 2010, 132, 11978-11987. 
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Control experiments confirmed that a π-allylpalladium intermediate is involved in the 
mechanism and that the C-H activation and the nucleophilic trapping steps are irreversible. 
 
On the other hand, Christina White disclosed a related PdII-catalyzed direct allylic amination of 
terminal alkenes based on the use of CrIII(salen)-Cl as a second catalyst.67 In this case, the reaction 
affords exclusively the linear product (Scheme 43). 
 
 
 
Scheme 43: Direct Allylic Intermolecular Amination Reaction. 
 
The same group later developed an alternative protocol for direct allylic amination using a 
Brønsted base instead of the previously described CrIII-salen-Cl Lewis acid.68 Optimal yields of linear 
derivatives are obtained with the Hunig’s base (DIPEA) as additive in tert-butyl methyl ether (TBME) as 
solvent (Scheme 44). 
 
 
 
Scheme 44: Brøensted-Base-Promoted Allylic C-H Amination. 
 
More recently, the Hartwig’s group reported an enantioselective strategy based on the one-
pot two-step (Pd / Ir catalysis) conversion of terminal alkenes into branched allylic amines through the 
                                                 
67 Reed, S. A.; White, M. C. J. Am. Chem. Soc. 2008, 130, 3316-3318. 
68 Rice, G. T.; White, M. C. J. Am. Chem. Soc. 2009, 131, 11707-11711. 
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intermediacy of linear allyic benzoates.69 The first Pd-catalyzed step may be considered as a variant of 
the Cu(II)-catalyzed Kharasch-Sosnovsky reaction.70 
 
 
 
Scheme 45: Enantioselective Strategy Based on the One-Pot Two-Step Conversion of Terminal 
Alkenes. 
 
2.4. Aim of This Work  
 
As we saw, the development of reactions that directly and selectively convert C-H bonds into C-
N bonds, avoiding the preparation and handling of oxidized intermediates, is highly desirable. In this 
frame, -olefins can be considered an ideal low-cost starting material for such catalytic 
functionalizations to produce more complex structures for fine chemistry purposes. Even if some 
palladium-catalyzed allylic aminations on olefins are already known, a number of challenging variations 
are still waiting for improvement. In particular, at the best of our knowledge, Szabò reported the only 
example of an allylic oxylation of but-3-enoates. In this case, a hypervalent iodine species was used as 
the terminal oxidizing. The authors propose for this transformation a Pd(II) / Pd(IV) mechanism 
involving a highly electrophilic 3-allyl-palladium Pd(IV) complex (Scheme 46). 
 
                                                 
69 Sharma, A.; Hartwig, J. F. J. Am. Chem. Soc. 2013, 135, 17983-17989. 
70 Beckwith, A. L. J. Zavitsas, A. A. J. Am. Chem. Soc. 1986, 108, 8230-8234. 
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Scheme 46: Allylic Acetoxylation Using a Hypervalent Iodine Species as Terminal Oxidant 
(TOx). 
 
Accordingly, we decided to develop a hitherto unknown method for the dehydrogenative Pd-
catalyzed allylic amination of butenoic acid derivative. In particular, we reasoned that the allylic C-H 
activation of a but-3-enoic acid (B3A) derivative is expected to afford the corresponding π-
allylpalladium complex more readily than the but-2-enoic acid B2A derivative for two reasons: a) the 
B3A isomer, being non conjugated, is less stable and more reactive than the B2A, b) Pd-catalyzed allylic 
activations are known only on terminal alkenes. Subsequent in situ direct trapping of the π-allyl 
complex I with a suitable nitrogen nucleophile71 should afford the desired allylic amination product -
AB2 or -AB3. Alternatively, trapping of I by an acyloxy ligand (step III) or via an acyloxypalladation / 
dehydropalladation sequence (step IV and V) may lead to products II or II72 which may in turn be 
converted into - or -amino but-2-enoic derivatives (step VI) via a redox-neutral Pd(0)- or Pd(II)-
catalyzed allylic amination (Scheme 47). 
 
                                                 
71 For a review on the basics of the Pd-catalyzed allylation reactions, see: Poli, G.; Prestat, G.; Liron, F.; Kammere-
Pentier, C.; Kazmaier, U. Top. Organomet. Chem. 2011, 38, 1. 
72 For an example assumed to take place via this mechanism, see: Bottarelli, P.; Costa, M.; Della Ca’, N.; Fava, E. 
Tetrahedron Lett. 2013, 54, 2362. 
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Scheme 47: Possible Synthetic Routes to Allylic Amination of B3A Derivatives. 
 
Pursuing our interest in the synthesis of nitrogen containing scaffolds via palladium-catalyzed 
allylic amination,73 we decided to focus our attention on the synthesis of -AB2 derivatives from B3A 
compounds via either a direct oxidative path {Pd(II) / [Ox]} or a one-pot consecutive path {Pd(II) / 
[Ox]+Pd(0)}. 
 
2.5. Direct Oxidative Path {Pd(II) / [Ox]} 
2.5.1. First Experiments and Optimization  
 
Our investigation began with the study of the direct Pd(II)-catalyzed strategy, choosing the 
reaction between benzyl amide 22a and N-tosyl-carbamate A as the model transformation. The 
                                                 
73 (a) Lorion, M. M.; Duarte, F. J. S.; Calhorda, M. J.; Oble, J.; Poli, G. Org. Lett. 2016, 18, 1020. (b) Duarte, F. J. S.; Poli, 
G.; Calhorda M. J. ACS Catal. 2016, 6, 1772. (c) Lorion, M. M.; Oble, J. Poli, G. Pure Appl. Chem. 2016, 88, 381-389 (d) 
Rajabi, J.; Lorion, M. M.; Ly, V. L.; Liron, F.; Oble, J.; Prestat, G.; Poli, G. Chem. Eur. J. 2014, 20, 1539. (e) Lorion, M. M.; 
Nahra, F.; Ly, V. L.; Mealli, C.; Mesaoudi, A.; Liron, F.; Oble, J.; Poli, G. Chem. Today. 2014, 32, 30. (f) Nahra, F.; Liron, 
F.; Prestat, G.; Mealli, C.; Messaoudi, A.; Poli, G. Chem. Eur. J. 2009, 15, 11078.  
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reaction conditions developed by White74 and coworkers [Pd(OAc)2 (10 mol %), SS-2 (15 mol %), N,N-
diisopropylethylamine (DIPEA)(6 mol %) and benzoquinone (BQ) (2 equiv.)] for a similar allylic 
amination using the same nucleophile was taken as a starting point (Scheme 48).  
 
 
Scheme 48: Model Transformation. 
 
Use of TBME as the solvent at reflux for 72 hours afforded the desired -AB2 aminated product 
23a in 72% yield, with no traces of the -AB3 isomer (Table 9, entry 1). Interestingly, similar results 
could also be obtained running the reaction without the disulfoxide ligand SS-2 (entry 2). Change of 
solvent to THF or DMSO, with or without disulfoxide ligand, did not improve the yields (entries 3, 4, 5). 
To our satisfaction, switch to acetonitrile as solvent at reflux for 24 hours increased the yield to 95% 
(entry 6). 
 
Entry Ligand Solvent Time (t) Yield (%) 
1 SS-2 15 mol % TBME 72 72 
2 - TBME 72 75 
3 SS-2 15 mol % THF 72 53 
4 - THF 18 66 
5 - DMSO 24 50 
6 - CH3CN 24 95 
 
Table 9: Optimization of Pd(II)-Catalyzed Direct Amination. 
 
With the optimized conditions in hand [Pd(OAc)2 10 mol %, DIPEA 6 mol %, BQ (2 equiv.) in 
CH3CN (0.2 M) at reflux for 24 h] we turned to study the scope of the amination of other B3A derivatives 
with N-tosyl-carbamate A.  
 
                                                 
74 Qi, X.; Rice, G. T.; lall, M. S.; Plummer, M. S.; White, M. C. Tetrahedron, 2010, 66, 4816. 
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2.5.2. Scope:  
Substitution on the B3A derivative  
 
The effect of the substitution on the aromatic ring of various N-benzyl 3-butenamides was 
initially investigated. 
 
Electron-donors in para-position such as in (22b-c) gave the corresponding -AB2 amides in 
moderate yields (~35%), probably due to instability of the products in the oxidizing medium, while a 
donor in meta-position reestablished a satisfactory 84% yield (22d).  
Two contrasting behaviors were observed with para electron-withdrawing groups. While the nitro 
group afforded only low yields of the desired product (22e) (due to troublesome product isolation), 
the trifluoromethyl group gave the desired -AB2 amide in good yield (22f).  
N-Furfuryl (22g), N-phenyl (22h), and N-phenylethyl B3A secondary amides (22i) led to the expected 
derivatives in good to moderate yields (Scheme 49). 
 
 
 
Scheme 49: Scope of the Pd(II)-Catalyzed Allylic Amination with N-Tosyl-carbamate A. 
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In sharp contrast to the above mentioned secondary amides, tertiary amides did not display 
any reactivity (22j–k) (Figure 5). 
 
 
 
Figure 5: Unreactive Tertiary Amides Tested. 
 
Next, the same reaction could be successfully extended to a ketone (22l) and an ester (22m) 
(Scheme 49). 
 
 
 
 
 
Scheme 49: Extension of the Reaction to a Ketone and an Ester. 
 
The Nitrogen Nucleophiles 
 
Variation of the nitrogen nucleophile was studied next. Without surprise, reaction of N-tosyl-
acetamide B with the model allyl amide 22a gave the desired -AB2 amide 24a in 61% yield (Scheme 
50). 
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Scheme 50: Scope of Pd(II)-Catalyzed Allylic Amination with N-Tosyl-acetamide B. 
 
Saccharin C was also tested, which reacted with five different B3A derivatives to afford the 
corresponding -AB2 amides in moderate to good yields (25a-e) (Scheme 51)  
 
 
 
 
Scheme 51: Scope of Pd(II)-Catalyzed Allylic Amination with Saccharin C.  
 
Moderate yields of the expected -AB2 products could be also isolated when using N-sulfinyl-
carbamate D as nitrogen nucleophile (Scheme 52).  
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Scheme 52: Scope of Pd(II)-Catalyzed Allylic Amination with N-Sulfinyl-Carbamate D. 
 
In contrast, N-tosylamine, phthalimide and camphorsultam gave no reaction when submitted 
to reaction conditions analogous to those above mentioned (Figure 6).  
 
 
 
Figure 6: Nucleophiles Tested. 
 
These results suggest that the ideal pKa for the nitrogen nucleophiles is in the window 5-6, 
while nucleophiles with higher pKa values do not work (Figure 7). 
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Figure 7: Window of Necessary pKa. 
 
2.6. Sequential One-Pot Pd(II) / Pd(0) Protocol 
 
As anticipated in Scheme 47, a second strategy we pursued involved a two-step procedure 
entailing an initial oxidative Pd(II)-catalyzed allylic acyloxylation of the B3A derivates, followed by a 
Pd(0)-catalyzed amination.  
 
2.6.1. 1st step: Oxidative Allylic Acyloxylation  
 
Although both the above mentioned reactions are known as separate transformations, prior to 
our study no attempt to run them in serial was reported. Indeed, the oxidative Pd(II) allylic 
acetoxylation of alkene is a very well established reaction (see above), as well as the Pd(0)-catalyzed 
allylation of nitrogen nucleophiles such as N-phthalimide (pKa of 8.3).75 
Our starting point was a protocol by Le Bras and Muzart, which reported a dehydrogenative 
Pd(II)-catalyzed acyloxylation using the couple LiOH / RCOOH.76  
                                                 
75 Science of Synthesis, Houben-Weyl Methods of Molecular Transformations, Thieme ED. 2005, Vol 22, Chapt21.2 F. 
A. Luzzio, in Product Class 2: Triacylamines, Imines (Diacylamines), and Related Compounds, p 259. 
76 Thiery, E.; Aouf, C.; Belloy, J.; Harakat, D.; Le Bras, J.; Muzart, J. J. Org. Chem. 2010, 75, 1771. 
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As previously done for the direct Pd(II)-catalyzed amination protocol, the B3A amide 22a was 
chosen as model molecule to perform some preliminary screening to assess the influence of the nature 
and the amount of the added carboxylic acid. 
After a few trials, we decided to use 10 equivalent of carboxylic acid as optimal amount to 
perform the reaction (Scheme 53). 
 
 
 
Scheme 53: Screening of the Carboxylic Acid Amount. 
 
The best conditions to perform the pivaloxylation step turned out to be: pivalic acid (10.0 
equiv.), LiOH monohydrate (2.0 equiv.), Pd(OAc)2 (10 mol %) and BQ (2.0 equiv.) in acetonitrile at 40 
°C for 20-24 h (Scheme 54).  
 
 
 
Scheme 54: Pd(II)-Catalyzed Allylic Pivaloxylation Step. 
 
Gratifyingly, this protocol was effective with all the secondary and tertiary amides tested 
(22a,k), as well as with an ester (22m), giving the corresponding -oxylated but-2-enyl acid derivatives 
(-OB2A) in good yields (35–98% yield). 
Keton (22l), in contrast to what previously observed in the direct amination, gave an 
unseparable mixture of two of the expected 4-pivaloxy-1-phenylbut-2-en-1-one (27la) and 3,4-
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dipivaloxy-1-phenylbutan-1-one (27lb), deriving from the conjugate addition of pivalate anion to the 
-unsaturated ketone (27la). 
 
 
Scheme 55: Inseparable Mixture of Compounds. 
 
2.6.2. 2nd step: Isohypsic Pd(0)-Catalyzed Amination  
 
Once optimized the first pivaloxylation step, we focused on the second part of the 
transformation: the isohypsic Pd(0)-catalyzed amination. Pursuing the idea of eventually merge the 
double processes in a single operation, this second step was first tried in acetonitrile as solvent and 
with Pd(OAc)2 as catalyst.  
It is important to highlight that a Pd(0)-catalyzed allylation reaction normally requires a phosphine 
ligand to prevent the dimerization of the transient -allyl complex and, when Pd(OAc)2 pre-catalys is 
used, to reduce the metal to the real Pd(0) catalyst. Moreover, in some cases also a base is needed to 
carry out a preliminary deprotonation of the nucleophile.77 The pivaloxylation step needed a 
considerable amount of pivalic acid. Therefore, in order to obtain basic / buffered conditions in the 
second step of the final one-pot reaction, addition of an excess amount of base was necessary. 
Accordingly, we decided to use 11.5 equivalents of a base in the reaction between of phthalimide with 
-OB2A 27a (Table 10), selected as our model isohypsic allylation reaction.  
 
 
 
 
                                                 
77 Giambastiani, G.; Poli, G. J. Org. Chem. 1998, 63, 9608. 
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Entry Ligand(x %) 
PhthNH 
(y equiv.) 
Base Yield (%)a 
1 PPh3 (40) 1.5 NEt3 SM 
2 DPPE (20) 1.5 NEt3 SM 
3 DPPF (20) 1.5 NEt3 28 
4 XANTPHOS (20) 1.5 NEt3 25 
5 BINAP (20) 1.5 NEt3 30 
6b BINAP (20) 1.5 NEt3 34 
7 BINAP (20) 1.5 DIPEA 40 
8c BINAP (20) 3.0 DIPEA 83 
a Isolated yields, b Reaction time = 48 h, c Reaction conditions: Substrate 27a (1.0 equiv.), phtalimide (3.0 equiv.), Pd(OAc)2 
(10 mol %), (+)-BINAP (20 mol %), DIPEA (11.5 equiv.) in acetonitrile (0.2 M). 
 
Table 10: Optimization of the Pd(0)-Catalyzed Amination of 27a with Phtalimide. 
 
Triethylamine was first tested as the base. The use of the monodentate Ph3P (entry 1) or of the 
bidentate dppe (entry 2) gave no reaction, only starting material being recovered. Instead, the use of 
the bidentate ligands DPPF, XANTPHOS and BINAP afforded the expected -AB2A product 28a in 
moderate yields (entries 3-5). Judging BINAP as the most promising ligand, we stuck to this ligand as 
to screen further conditions. However, increase of the reaction time to 48 hours did not produce any 
significant change in the yield (entry 6).  
Switch of the base from NEt3 to DIPEA (Hunig’s base) brought about a moderate yield 
improvement (entry 7). Finally, raising the amount of phthalimide to 3.0 equivalents allowed isolating 
28a in satisfactory yield (83%) (entry 8).  
 
Once obtained the best conditions for both the separated steps, we moved to merge the two 
protocols into a single operation. The initial allylic pivaloxylation was carried out on 22a following the 
conditions of Scheme 54, at 40 °C during 8 hours. Then, without any work-up, DIPEA, phthalimide and 
BINAP were added and the resulting mixture was brought to reflux for further 18 hours. This one-pot 
protocol gave the desired -AB2 derivative 28a with an excellent 90% yield (Scheme 56). 
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Scheme 56: Sequential One-Pot Pd(II) / Pd(0) Catalyzed Allylic Amination on Model Substrate 22a. 
 
This sequential protocol was next tested on other B3A amides. Electron-donor groups in para-
position of a B3A N-benzyl amide gave the expected -AB2 products in moderate yields (entry 1-2), 
while the product was afforded in more satisfactory yield in the case of a meta-substitution (entry 3). 
However, the use of electron withdrawing groups in para-position was not tolerated (entry 4-5), and 
in the final crude mixture was detected only the acyloxylated compound derived from the first step of 
the procedure. Also N-furfuryl-, N-phenyl- and N-phenylethyl B3A amides gave the corresponding -
AB2 product in good to moderate yields (entry 6-8). As seen with the direct amination, no reaction 
occurred with a tertiary amide or an ester (entry 9-10). 
 
Entry B3A Substrate -AB2 Product Yield (%) 
1 
 
28b 22 
2 
 
28c 53 
3 
 
28d 76 
4 
 
28e Tracesa 
5 
 
28f 0b 
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6 
 
28g 20 
7 
 
28h 32c 
8 
 
28i 82 
9 
 
28j 0d 
10 
 
28m 0d 
a Reaction conditions: (a) pivalic acid (10.0 equiv), LiOH·H2O (2.0 equiv); (b) Pd(OAc)2 (10 mol %), BQ (2.0 equiv), starting 
material (1 equiv), MeCN (0.2 M); (c) phthalimide (3.0 equiv), (+)-BINAP (20 mol %), DIPEA (11.5 equiv). b Yield of isolated 
product. c Only pivaloxylated compound 26 was detected at the end of the reaction. d Phthalimide (1.5 equiv) was used. 
 
Table 11: Scope of the Sequential One-Pot Pd(II) / Pd(0)-Catalyzed Allylic Amination. 
 
Albeit still speculative, these results can be explained on the basis of an H-bond directed 
addition of phthalimide anion on the distal allyl terminus of the transient -allylpalladium complex.78  
However, the H-bond may be disrupted if the amide’s substituent is too electron-withdrawing, 
as in the case of amides 22e and 22f (entries 5 and 6, Table 11). This working model is also in accord 
with the fact that tertiary amides and esters, lacking the directing H atom, are completely inert (Figure 
8). 
 
                                                 
78 For a precedent of H-bond-directed addition of phthalimide to -allylpalladium moieties, see: a) Cook, G. R.; Yu, H.; 
Sankaranarayanan, S.; Shanker, P. S. J. Am. Chem. Soc. 2003, 125, 5115. b) Cook, G. R.; Shanker, P. S.; Pararajasingham, 
K. Angew. Chem. Int. Ed. 1999, 38, 110.  
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Figure 8: Working Model for the Addition of Phthalimide Enolate in the Transient Intermediate. 
 
2.7. Conclusions  
 
To conclude, in this chapter we developed two complementary strategies for the palladium-
catalyzed dehydrogenative amination of B3A derivatives, allowing to build-up various -AB2 products. 
The acidity of the NH function in the nitrogen nucleophiles determines the appropriate protocol to 
select. Namely: a direct oxidative Pd(II)-catalyzed allylic amination in the case of the more acidic N-
nucleophiles, and a one-pot Pd(II)-catalyzed pivaloxylation / Pd(0)-catalyzed amination sequence for 
the less acidic phthalimides. 
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Experimental Part 
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General methods 
 
Unless otherwise mentioned, all reactions were carried out under an argon atmosphere. Glassware 
was flame-dried under an argon gas flow prior to use. Reactions were run in flasks or sealed tubes with 
magnetic stirring. Reagents and solvents were purchased from commercial sources and used as 
received. CH2Cl2, THF, MeCN and DMF were dried on a Mbraun purification system MB SPS-800. 
Nucleophiles were synthesized according to literature procedures: TsNHCOOMe,79 TsNHCOMe,80 t-
BuSONHCOOMe.81 TLC was performed on Merck 60 F254 silica gel and revealed with either a ultra-
violet lamp ( = 254 nm) or a specific color reagent (potassium permanganate, p-anisaldehyde, etc.).  
Silica gel (Merck Geduran® SI 60, 40-63 mm) was used for flash column chromatography. 
Preparative thin layer chromatography was realized with PLC silica gel 60 F254 (1 mm, 20x20 cm.). 
Melting points were measured in capillary tubes on Stuart Scientific SMP3 apparatus and are 
uncorrected. IR spectra were recorded on a Brucker Tensor 27 (ATR diamond) and reported as 
characteristic bands (cm-1).  
NMR spectra (1H, 13C) were recorded on a Bruker AM 300 MHz or a Bruker AVANCE 400 MHz 
spectrometers. NMR experiments were carried out in deuterochloroform (CDCl3) and 
deuterodimethylsulfoxyde (DMSO-d6). Chemical shifts are given in parts per million (ppm) using the 
CDCl3 residual signal as reference (1H = 7.26 ppm, 13C = 77.2 ppm), and the DMSO-d6 residual signal 
as reference (1H = 2.50 ppm, 13C = 39.5 ppm). The terms m, s, d, t, and q represent multiplet, singlet, 
doublet, triplet and quadruplet, respectively. Coupling costants (J) are given in Hertz (Hz). The 1H and 
13C NMR spectra were completely assigned by using a combination of 13C DEPT and 2D NMR 
experiments (COSY, HSQC and HMBC). High-resolution mass spectra (HRMS) were recorded at the 
institute Parisien de Chimie Moléculaire (FR 2769) (electrospray source). 
  
                                                 
79 Reed, S. A.; Mazzotti, A. R.; White, M. C. J. Am. Chem. Soc. 2009, 131, 11701.  
80 Xie, W.; Yang, J.; Wang, B.; Li, B. J. Org. Chem. 2014, 79, 8278. 
81 Mistico, L.; Ay, E.; Huynh, V.; Bourderioux, A.; Chaumeil, H.; Chemla, F.; Ferrerira, F.; Oble, J.; Péerez-Luna, A.; Poli, 
G.; Prestat, G. J. Organomet. Chem. 2014, 76, 124. 
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General procedure (GP16) for the synthesis of allyl-amides 22a-j. 
 
To a stirred solution of corresponding amine (1.0 or 2.0 equiv.) in CH2Cl2 (0.2 M) were added at 0 °C 
DCC (1.3 equiv.), DMAP (0.13 equiv.) and 3-butenoic acid (1.3 equiv.) The reaction mixture was stirred 
for 10 minutes at 0 °C, then for 24 hours at room temperature. The precipitate was filtered off and 
washed with CH2Cl2 (25 mL). Then the organic layer was hydrolyzed with saturated aqueous NaHCO3, 
extracted and dried over MgSO4 and concentrated at reduced pressure. The crude product was purified 
by silica gel column chromatography to afford the corresponding allyl-amide 22. 
 
N-Benzyl-3-butenamide (22a) 
 
Following GP16 with benzylamine (1 equiv., 10.02 mL, 9.3 mmol). The crude product was purified by 
flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22a in quantitative yield 
(1.9 g, 10.8 mmol). White solid. 1H NMR (CDCl3, 400 MHz)  3.09 (td, J = 1.5, 7.0 Hz, 2H), 4.48 (d, J = 6.0 
Hz, 2H), 5.23-5.29 (m, 2H), 5.91-6.07 (m, 2H), 7.29-7.40 (m, 5H). These spectroscopic data are in good 
agreement with those reported in the literature.82 
 
N-(4-Methylbenzyl)-3-butenamide (22b) 
 
Following GP16 with 4-methylbenzylamine (1 equiv., 500 mg, 4.1 mmol). The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22b in 76% 
yield (588 mg, 3.11 mmol). White solid, mp: 100-102 °C. 1H NMR (CDCl3, 400 MHz)  2.26 (s, 3H), 2.97 
(dt, J = 7.0, 1.5 Hz, 2H), 4.32 (d, J = 5.5 Hz, 2H), 5.11-5.17 (m, 2H), 5.77 (br s, 1H), 5.86 (ddt, J = 16.5, 
10.5, 7.0 Hz, 1H), 7.05-7.10 (m, 4H). 13C NMR (CDCl3, 100 MHz)  21.1 (q), 41.6 (t), 43.4 (t), 119.9 (t), 
                                                 
82 Orliac, A.; Gomez Pardo, D.; Bombrun, A.; Cossy, J. Org. Lett. 2013, 15, 902. 
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127.8 (d), 129.4 (d), 131.3 (d), 135.1 (s), 137.3 (s), 170.2 (s). IR (cm-1) : 3291, 1626, 1532, 1412. HRMS 
(ESI) m/z calcd for C12H15NNaO [M+Na]+: 212.1046, found: 212.1046. 
 
N-(4-Methoxybenzyl)-3-butenamide (22c) 
 
Following GP16 with 4-methoxybenzylamine (1 equiv., 0.47 mL, 3.64 mmol). The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22c in 96% 
yield (715 mg, 3.5 mmol). White solid, mp: 88-90 °C. 1H NMR (CDCl3, 400 MHz)  3.06 (dt, J = 7.0, 1.5 
Hz, 2H), 3.82 (s, 3H), 4.40 (d, J = 5.5 Hz, 2H), 5.21-5.26 (m, 2H), 5.81 (br s, 1H), 5.90-6.01 (m, 1H), 6.87-
6.91 (m, 2H), 7.20-7.25 (m, 2H). 13C NMR (CDCl3, 100 MHz)  41.6 (t), 43.2 (t), 55.3 (q), 114.1 (d), 119.9 
(t), 129.1 (d), 130.2 (s), 131.3 (d), 159.1 (s), 170.2 (s). IR (cm-1) : 3285, 1636, 1548, 1511, 1300, 1173. 
HRMS (ESI) m/z calcd for C12H15NNaO2 [M+Na]+: 228.0995, found: 228.0992. 
 
N-(3-Methoxybenzyl)-3-butenamide (22d) 
 
Following GP16 with 3-methoxybenzylamine (1 equiv., 0.47 mL, 3.6 mmol). The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22d in 82% 
yield (611 mg, 2.97 mmol). Orange oil. 1H NMR (CDCl3, 400 MHz)  3.06 (dt, J = 7.0, 1.5 Hz, 2H), 3.81 (s, 
3H), 4.42 (d, J = 6.0 Hz, 2H), 5.21-5.26 (m, 2H), 5.91-5.99 (m, 1H), 6.01 (m, 1H), 6.82-6.87 (m, 3H), 7.23-
7.28 (m, 1H). 13C NMR (CDCl3, 100 MHz)  41.6 (t), 43.6 (t), 55.2 (q), 112.9 (d), 113.3 (d), 119.8 (t), 119.9 
(d), 129.7 (d), 131.3 (d), 139.7 (s), 159.8 (s), 170.4 (s). IR (cm-1) : 3180, 1575, 1541, 1320. HRMS (ESI) 
m/z calcd for C12H15LiNO2 [M+Li]2+: 212.1258, found: 212.1264.  
 
N-(4-Nitrobenzyl)-3-butenamide (22e)  
 
Following GP16 with 4-nitrobenzylamine hydrochloride (1 equiv., 300 mg, 1.6 mmol) and DMAP (1.2 
equiv., 233 mg, 1.9 mmol). The crude product was purified by flash chromatography on silica gel 
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(eluent: AcOEt / CycloHexane 1:1) to afford 22e in 60% yield (200 mg, 0.91 mmol). White solid, mp: 
83-85 °C. 1H NMR (CDCl3, 400 MHz)  3.13 (dt, J = 7.0, 1.0 Hz, 2H), 4.57 (d, J = 6.0 Hz, 2H), 5.27-5.32 (m, 
2H), 5.98 (tdd, J = 7.0, 10.0, 17.5 Hz, 1H), 6.05 (br s, 1H), 7.44-7.47 (m, 2H), 8.19-8.23 (m, 2H). 13C NMR 
(CDCl3, 100 MHz)  41.5 (t), 42.8 (t), 120.5 (t), 123.9 (d), 128.2 (d), 130.9 (d), 145.1 (s), 145.7 (s), 170.6 
(s). IR (cm-1) : 3229, 3055, 2926, 1638, 1601, 1545, 1509, 1345. HRMS (ESI) m/z calcd for C11H12N2NaO3 
[M+Na]+: 243.0740, found: 243.0743. 
 
N-(4-(Trifluoromethyl)benzyl)but-3-enamide (22f) 
 
Following GP16 with 4-(trifluoromethyl)benzylamine (1 equiv., 500 mg, 5.8 mmol). The crude product 
was purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22f in 
70% yield (990 mg, 4.07 mmol). White solid, mp: 118-120 °C. 1H NMR (CDCl3, 400 MHz)  3.09 (dt, J = 
7.0, 1.5 Hz, 1H), 4.50 (d, J = 6.0 Hz, 2H), 5.23-5.29 (m, 2H), 5.96 (ddt, J = 17.5, 10.5, 7.0 Hz, 1H), 6.09 (br 
s, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.60 (d, J = 8.0 Hz, 2H). 13C NMR (CDCl3, 100 MHz)  41.5 (t), 43.0 (t), 
120.2 (t), 125.6 (s), 125.7 (d), 127.8 (d), 131.1 (s), 142.3 (d), 170.6 (s). 31F NMR (CDCl3):  - 62.54. IR (cm-
1) : 3476, 1647, 1545, 1328, 1029. HRMS (ESI) m/z calcd for C12H12F3NNaO [M+Na]+: 266.0763, found: 
266.0761.  
 
N-(2-Furanylmethyl)-3-butenamide (22g) 
 
Following GP16 with furfurylamine (2 equiv., 1.03 mL, 11.6 mmol). The crude product was purified by 
flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22g in 52% yield (490 
mg, 2.97 mmol). White solid. 1H NMR (CDCl3, 400 MHz)  2.96 (t, J = 5.5 Hz, 2H), 4.31-4.38 (m, 2H), 
5.09-5.15 (m, 2H), 5.79-5.95 (m, 1H), 6.14 (q, J = 3.0 Hz, 1H), 6.25-6.27 (m, 1H), 6.95 (br s, 1H), 7.27 (q, 
J = 2.5 Hz, 1H). These spectroscopic data are in good agreement with those reported in the literature.83 
 
 
                                                 
83 Jacobi, P. A.; Li, Y. J. Am. Chem. Soc. 2001, 123, 9307. 
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N-Phenyl-3-butenamide (22h) 
 
Following GP16 with aniline (2 equiv., 1.05 mL, 5.8 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 4:6) to afford 22h in 68% yield (630 mg, 3.9 
mmol). White solid. 1H NMR (CDCl3, 400 MHz)  3.21 (td, J = 1.0, 7.0 Hz, 2H), 5.31-5.37 (m, 2H), 6.06 
(ddd, J = 7.0, 11.1, 16.0 Hz, 1H), 7.13 (t, J = 7.5 Hz, 1H), 7.29-7.37 (m, 2H), 7.53-7.56 (m, 3H). These 
spectroscopic data are in good agreement with those reported in the literature.84 
 
N-Phenethyl-3-butenamide (22i) 
 
Following GP16 with phenylethylamine (2 equiv., 1.46 mL, 11.0 mmol). The crude product was purified 
by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22i in 40% yield (424 
mg, 2.24 mmol). Pale yellow solid, mp: 63-65 °C. 1H NMR (CDCl3, 400 MHz)  2.83 (t, J = 7.0 Hz, 2H), 
2.97 (td, J = 1.5, 7.0 Hz, 2H), 3.50 (q, J = 7.0 Hz, 2H), 5.16-5.23 (m, 2H), 5.89 (ddd, J = 7.0, 10.5, 17.5 Hz, 
1H), 6.08 (br s, 1H), 7.17-7.35 (m, 5H). 13C NMR (CDCl3, 100 MHz)  35.6 (t), 40.6 (t), 41.7 (t), 119.8 (t), 
126.5 (d), 128.6 (d), 128.7 (d), 131.3 (d), 138.8 (s), 170.4 (s). IR (cm-1) : 3264, 3078, 2930, 1633, 1552. 
HRMS (ESI) m/z calcd for C12H15NNaO [M+Na]+: 212.1046, found: 212.1039. 
 
N,N-Dibenzyl-3-butenamide (22j) 
 
Following GP16 with dibenzylamine (1 equiv., 0.31 mL, 1.6 mmol). The crude product was purified by 
flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 22j in 69% yield (290 
mg, 1.1 mmol). Yellow oil. 1H NMR (CDCl3, 400 MHz)  3.28 (dt, J = 6.5, 1.5 Hz, 2H), 4.49 (s, 2H), 4.65 
(s, 2H), 5.14-5.24 (m, 2H), 6.09 (ddd, J = 6.5, 10.0, 17.0, 1H), 7.20-7.43 (m, 10H). 13C NMR (CDCl3, 100 
                                                 
84 Abdou, A. M.; Botros, S.; Hassan, R. A.; Kamel, M. M.; Taber, D. F.; Taher, A. T. Tetrahedron 2015, 71, 139.  
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MHz)  38.7 (t), 53.1 (t), 117.9 (t), 126.4 (t), 127.5 (d), 127.7 (d), 128.2 (d), 128.4 (d), 128.6 (d), 129.0 
(d), 131.7 (d), 136.4 (s), 137.3 (s), 171.5 (s). IR (cm-1) : 3027, 2919, 1646, 1418, 696. HRMS (ESI) m/z 
calcd for C18H19NNaO [M+Na]+: 288.1359, found: 288.1361. 
 
Procedure for the synthesis of N-methoxy-N-methylbut-3-enamide (22k)  
 
Thionyl chloride (2 equiv.) was added dropwise to the 3-butenoic acid (1 equiv.). The mixture was 
stirred for 4 hours at 60 °C, carefully evaporated and immediately used without purification. 
 
 
A mixture of N,O-dimethylhydroxylamine hydrochloride (1 equiv., 604 mg, 6.2 mmol) and 
triethylamine (2 equiv., 12.4 mmol, 1.72 mL) in dichloromethane (30 mL) was stirred for 2 hours at 
room temperature; then, at 0 °C, the but-3-enoyl chloride freshly prepared (1 equiv., 648 mg, 6.2 
mmol) was added dropwise and the mixture was stirred for 10 minutes at 0 °C, then at rt overnight. 
The mixture was hydrolyzed with a HCl 1N solution, then with a saturated aqueous NaHCO3 solution 
and water. The organic layer was extracted and dried over MgSO4, filtered and concentrated at 
reduced pressure. The crude product was purified by silica gel column chromatography (eluent: AcOEt 
/ CycloHexane 6:4) to afford the amide 22k in 54% yield (430 mg, 3.33 mmol).  
 
 
Pale yellow oil. 1H NMR (CDCl3, 400 MHz)  3.18 (s, 3H), 3.23 (d, J = 7.0 Hz, 2H), 3.69 (s, 3H), 5.15-5.16 
(m, 1H), 5.18-5.19 (m, 1H), 5.92-6.02 (m, 1H). 13C NMR (CDCl3, 100 MHz)  25.2 (q), 37.2 (t), 61.3 (q), 
118.1 (t), 131.2 (d), 172.4 (s). IR (cm-1) : 2969, 1664, 1381, 1176, 1002. HRMS (ESI) m/z calcd for 
C6H11NNaO2 [M+Na]+: 152.0687, found: 152.0682. 
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Procedure for the synthesis of Phenyl Allyl Ketone (22l)  
 
Under air atmosphere, at 20 °C, to a solution of 1-phenylbut-3-en-1-ol (1 equiv., 300 mg, 2.02 mmol) 
in acetone (10 mL) was added using a dropping funnel a solution of Jones reagent (1.5 mL). After 10 
minutes, the time required for change the color of the solution from orange to blue, the mixture was 
hydrolyzed with water and extracted with diethyl ether. Then the organic layer was washed with 
saturated aqueous NaHCO3, extracted and dried over MgSO4 and concentrated at reduced pressure. 
The crude product was purified by silica gel column chromatography (eluent: AcOEt / CycloHexane 1:1) 
to afford the ketone 22l in 80% yield (235 mg, 1.61 mmol).  
 
 
Colorless oil. 1H NMR (CDCl3, 400 MHz)  3.76 (td, J = 1.5, 8.0 Hz, 2H), 5.18-5.27 (m, 2H), 6.09 (tdd, J = 
7.0, 10.5, 17.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.97 (d, J = 7.5 Hz, 2H). These 
spectroscopic data are in good agreement with those reported in the literature.85  
 
General procedure (GP17) for the Pd(II)-catalyzed direct amination. 
 
In a sealed tube, but-3-enoic acid derivative 22 (1 equiv.) was dissolved in CH3CN (0.2 M) and 
subsequently Pd(OAc)2 (10 mol %), nucleophile (2 equiv.) DIPEA (6 mol %) and BQ (2 equiv.) were added 
to the mixture. Then the reaction was stirred at reflux for 16-24 hours and, after cooling to r.t., was 
hydrolyzed with a saturated aqueous K2CO3 solution and diluted with Et2O. The organic layer was 
extracted, dried over MgSO4, filtered and concentrated under reduced pressure. The crude product 
                                                 
85 Moriyama, K.; Takemura, M.; Togo, H. J. Org. Chem. 2014, 79, 6094.  
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was purified by silica gel column chromatography (eluent: AcOEt / CycloHexane) to afford the 
aminated compound 23, 24, 25 or 26 depending on the nucleophile used.86  
 
Methyl (E)-(4-(benzylamino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23a) 
 
Following GP17 with amide 22a (1 equiv., 100 mg, 0.57 mmol) and methyl tosylcarbamate A (2 equiv., 
260 mg, 1.13 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23a in 95% yield (219 mg, 0.54 mmol). White solid, mp: 
145-146 °C. 1H NMR (CDCl3, 400 MHz)  2.46 (s, 3H), 3.73 (s, 3H), 4.55 (dd, J = 6.0, 2.0 Hz, 2H), 4.63 (dd, 
J = 5.0, 2.0 Hz, 2H), 5.84 (br s, 1H), 6.03 (dt, J = 15.0, 2.0 Hz, 1H), 6.91 (dt, J = 15.0, 5.5 Hz, 1H), 7.35 (m, 
7H), 7.86 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 43.8 (t), 47.4 (t), 54.0 (q), 125.4 (d), 127.6 (d), 
128.0 (d), 128.6 (d), 128.8 (d), 129.4 (d), 136.0 (s), 137.9 (s), 138.3 (s), 145.0 (d), 152.4 (s), 164.5 (s). IR 
(cm-1) : 3317, 1737, 1673, 1634, 1440, 1165, 981, 700. HRMS (ESI) m/z calcd for C20H22N2NaO5S 
[M+Na]+: 425.1142, found: 425.1149. 
 
Methyl (E)-(4-((4-methylbenzyl)amino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23b) 
 
Following GP17 with amide 22b (1 equiv., 100 mg, 0.53 mmol) and methyl tosylcarbamate A (2 equiv., 
242 mg, 1.06 mmol) for 16 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23b in 34% yield (34 mg, 0.082 mmol). Beige solid, mp: 
171-172 °C. 1H NMR (CDCl3, 400 MHz)  2.36 (s, 3H), 2.44 (s, 3H), 3.71 (s, 3H), 4.48 (d, J = 5.5 Hz, 2H), 
4.60 (dd, J = 2.0, 5.5 Hz, 2H), 5.82 (br s, 1H), 6.00 (td, J = 2.0, 15.0 Hz, 1H), 6.78 (td, J = 5.5, 15.5 Hz, 1H), 
7.16-7.22 (m, 4H), 7.28-7.33 (m, 2H), 7.83-7.86 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.1 (q), 21.6 (t), 
43.6 (t), 47.4 (q), 54.1 (d), 125.5 (d), 128.0 (d), 128.6 (d), 129.4 (d), 134.9 (s), 136.0 (s), 137.4 (s), 138.2 
(s), 144.9 (d), 152.4 (s), 164.5 (s). IR (cm-1) : 3292, 2926, 1623, 1359, 1232, 1168. HRMS (ESI) m/z calcd 
for C21H24N2NaO5S [M+Na]+: 439.1298, found: 439.1305. 
 
                                                 
86 Sometimes, traces of HBQ (less than 5%) are present in the product. 
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Methyl (E)-(4-((4-methoxybenzyl)amino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23c) 
 
Following GP17 with amide 22c (1 equiv., 100 mg, 0.49 mmol) and methyl tosylcarbamate A (2 equiv., 
223 mg, 0.97 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23c in 35% yield (73 mg, 0.17 mmol). White solid, mp: 
158-159 °C. 1H NMR (CDCl3, 400 MHz)  2.44 (s, 3H), 3.71 (s, 3H), 3.83 (s, 3H), 4.47 (d, J = 6.0 Hz, 2H), 
4.61 (dd, J = 2.0, 5.5 Hz, 2H), 5.73 (br s, 1H), 6.00 (td, J = 2.0, 15.0 Hz, 1H), 6.85-6.92 (m, 3H), 7.24-7.33 
(m, 4H), 7.82-7.86 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.7 (q), 43.3 (t), 47.4 (t), 54.1 (q), 55.3 (q), 
114.1 (d), 125.5 (d), 128.6 (d), 129.4 (d), 129.5 (s), 130.0 (d), 136.0 (s), 138.2 (s), 145.0 (d), 152.4 (s), 
159.2 (s), 164.4 (s). IR (cm-1) : 3297, 2960, 1744, 1624, 1515, 1358, 1168, 770. HRMS (ESI) m/z calcd 
for C21H24N2NaO6S [M+Na]+: 455.1247, found: 455.1260. 
 
Methyl (E)-(4-((3-methoxybenzyl)amino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23d) 
 
Following GP17 with amide 22d (1 equiv., 100 mg, 0.49 mmol) and methyl tosylcarbamate A (2 equiv., 
223 mg, 0.97 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23d in 84% yield (176 mg, 0.4 mmol). White solid, mp: 
127-128 °C. 1H NMR (CDCl3, 400 MHz)  2.42 (s, 3H), 3.68 (s, 3H), 3.79 (s, 3H), 4.46 (d, J = 6.0 Hz, 2H), 
4.58 (dd, J = 2.0, 5.5 Hz, 2H), 6.04 (td, J = 2.0, 15.5 Hz, 1H), 6.22 (t, J = 6.0 Hz, 1H), 6.83-6.88 (m, 4H), 
7.28-7.31 (m, 3H), 7.80-7.83 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 43.6 (t), 47.4 (t), 54.0 (q), 
55.2 (q), 113.0 (d), 113.5 (d), 120.1 (d), 125.6 (d), 128.5 (d), 129.5 (d), 129.7 (d), 135.9 (s), 138.1 (s), 
139.6 (s), 145.0 (d), 152.3 (s), 159.9 (s), 164.7 (s). IR (cm-1) : 3292, 2955, 1744, 1627, 1357, 1165, 765. 
HRMS (ESI) m/z calcd for C21H24N2NaO6S [M+Na]+: 455.1247, found: 455.1232. 
 
Methyl (E)-(4-((4-nitrobenzyl)amino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23e) 
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Following GP17 with amide 22e (1 equiv., 100 mg, 0.45 mmol) and methyl tosylcarbamate A (2 equiv., 
208 mg, 0.98 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23e in 10% yield (16 mg, 0.036 mmol). Pale yellow solid, 
mp: 182-184 °C. 1H NMR (CDCl3, 400 MHz)  2.37 (s, 3H), 3.62 (s, 3H), 4.52-4.55 (m, 4H), 6.00-6.05 (m, 
2H), 6.86 (td, J = 5.0, 15.0 Hz, 1H), 7.24 (d, J = 8.0 Hz, 2H), 7.38-7.40 (m, 2H), 7.74-7.76 (m, 2H), 8.10-
8.14 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.7 (q), 43.0 (t), 47.5 (t), 54.1 (q), 123.9 (d), 124.7 (d), 128.4 
(d), 128.5 (d), 129.5 (d), 135.9 (s), 139.4 (s), 145.1 (d), 145.5 (s), 147.4 (s), 153.3 (s), 164.9 (s). IR (cm-1) 
: 3304, 2921, 1743, 1626, 1517, 1346, 1164, 776. HRMS (ESI) m/z calcd for C20H21N3NaO7S [M+Na]+: 
470.0992, found: 470.1004. 
 
Methyl (E)-(4-oxo-4-((4-(trifluoromethyl)benzyl)amino)but-2-en-1-yl)(tosyl)carbamate (23f)  
 
Following GP17 with amide 22f (1 equiv., 100 mg, 0.41 mmol) and methyl tosylcarbamate A (2 equiv., 
188 mg, 0.82 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23f in 74% yield (142 mg, 0.30 mmol). White solid, mp: 
173-174 °C. 1H NMR (CDCl3, 400 MHz)  2.35 (s, 3H), 3.62 (s, 3H), 4.49 (d, J = 6.0 Hz, 2H), 4.52 (dd, J = 
5.0, 2.0 Hz, 2H), 5.91 (br s, 1H), 5.98 (dt, J = 15.0, 1.5 Hz, 1H), 6.83 (dt, J = 15.5, 5.0 Hz, 1H), 7.22-7.24 
(m, 2H), 7.33-7.36 (m 2H), 7.52-7.54 (m, 2H), 7.74-7.76 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 
43.2 (t), 47.4 (t), 54.1 (q), 116.1 (d), 125.0 (s), 125.6 (d), 125.7 (d), 128.0 (d), 128.5 (s), 129.5 (d), 135.9 
(s), 138.9 (s), 142.0 (s), 145.0 (d), 152.3 (s), 164.8 (s). 19F NMR (CDCl3, 282 MHz)  - 62.53. IR (cm-1) : 
3316, 2925, 1737, 1676, 1636, 1361, 1169, 911, 733. HRMS (ESI) m/z calcd for C21H21F3N2NaO5S 
[M+Na]+: 493.1015, found: 493.1012. 
 
Methyl (E)-(4-((furan-2-ylmethyl)amino)-4-oxobut-2-en-1-yl)(tosyl)carbamate (23g) 
 
Following GP17 with amide 22g (1 equiv., 100 mg, 0.60 mmol) and methyl tosylcarbamate A (2 equiv., 
277 mg, 1.2 mmol) for 24 hours. The crude product was purified by flash chromatography on silica gel 
(eluent: AcOEt / CycloHexane 7:3) to afford 23g in 46% yield (109 mg, 0.28 mmol). Brown oil. 1H NMR 
(CDCl3, 400 MHz)  2.35 (s, 3H), 3.61 (s, 3H), 4.42 (d, J = 5.5 Hz, 2H), 4.51 (dd, J = 2.0, 5.5 Hz, 2H), 5.93 
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(td, J = 2.0, 15.5 Hz, 1H), 5.96 (br s, 1H), 6.17-6.19 (m, 1H), 6.25 (dd, J = 2.0, 3.5 Hz, 1H), 6.78 (td, J = 
5.0, 15.5 Hz, 1H), 7.22-7.24 (m, 2H), 7.28 (dd, J = 1.0, 2.0 Hz, 1H), 7.73-7.76 (m, 2H). 13C NMR (CDCl3, 
100 MHz)  21.7 (q), 36.6 (t), 47.4 (t), 54.0 (q), 107.7 (d), 110.5 (d), 125.2 (d), 128.5 (d), 129.5 (s), 135.9 
(s), 138.5 (d), 142.3 (d), 145.0 (d), 150.9 (s), 152.4 (s), 164.6 (s). IR (cm-1) : 3304, 2956, 1747, 1628, 
1357, 1165, 759. HRMS (ESI) m/z calcd for C18H20N2NaO6S [M+Na]+ : 415.0934, found: 415.0938. 
 
Methyl (E)-(4-oxo-4-(phenylamino)but-2-en-1-yl)(tosyl)carbamate (23h) 
 
Following GP17 with amide 22h (1 equiv., 50 mg, 0.31 mmol) and methyl tosylcarbamate A (2 equiv., 
142 mg, 0.62 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23h in 90% yield (52 mg, 0.14 mmol). Brown solid, mp: 
153-155 °C. 1H NMR (CDCl3, 400 MHz)  2.34 (s, 3H), 3.63 (s, 3H), 4.56 (dd, J = 2.0, 5.0 Hz, 2H), 6.14 (td, 
J = 2.0, 15.0 Hz, 1H), 6.89 (td, J = 5.0, 15.0 Hz, 1H), 7.04 (t, J = 7.5 Hz, 1H), 7.18-7.26 (m, 4H), 7.49 (d, J 
= 8.0 Hz, 2H), 7.62 (br s, 1H), 7.75-7.78 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 47.5 (t), 54.1 (q), 
119.9 (d), 124.4 (d), 126.0 (d), 128.5 (d), 129.0 (d), 129.5 (d), 135.9 (s), 136.3 (s), 139.2 (s), 145.0 (d), 
152.4 (s), 162.9 (s). IR (cm-1) : 3353, 2916, 1689, 1536, 1440, 1254, 1185, 1080. HRMS (ESI) m/z calcd 
for C19H20N2NaO5S [M+Na]+: 411.0985, found: 411.0975. 
 
Methyl (E)-(4-oxo-4-(phenethylamino)but-2-en-1-yl)(tosyl)carbamate (23i) 
 
Following GP17 with amide 22i (1 equiv., 100 mg, 0.53 mmol) and methyl tosylcarbamate A (2 equiv., 
243 mg, 1.01 mmol) for 24 hours. The crude product was purified by flash chromatography on silica 
gel (eluent: AcOEt / CycloHexane 1:1) to afford 23i in 41% yield (90 mg, 0.22 mmol). White solid, mp: 
145-147 °C. 1H NMR (CDCl3, 400 MHz)  2.36 (s, 3H), 2.78 (t, J = 7.0 Hz, 2H), 3.50-3.56 (m, 2H), 3.61 (s, 
3H), 4.50 (dd, J = 2.0, 5.5 Hz, 2H), 5.48 (br s, 1H), 5.85 (td, J = 2.0, 15.5 Hz, 1H), 6.74 (td, J = 5.5, 15.5 
Hz, 1H), 7.12-7.27 (m, 7H), 7.73-7.76 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.7 (q), 35.6 (t), 40.7 (t), 
47.3 (t), 54.0 (q), 125.6 (d), 126.6 (d), 128.5 (d), 128.7 (d), 128.8 (d), 129.4 (d), 135.9 (s), 137.9 (s), 138.7 
(s), 144.9 (d), 152.4 (s), 164.7 (s). IR (cm-1) : 3309, 3026, 2960, 1745, 1627, 1546, 1398, 1128, 907. 
HRMS (ESI) m/z calcd for C21H24N2NaO5S [M+Na]+: 439.1298, found: 439.1311. 
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Methyl (E)-(4-oxo-4-phenylbut-2-en-1-yl)(tosyl)carbamate (23l) 
 
Following GP17 with phenyl allyl ketone 22l (1 equiv., 100 mg, 0.68 mmol) and methyl tosylcarbamate 
A (2 equiv., 309 mg, 1.35 mmol) for 24 hours. The residue was taken up in DCM and treated with an 
equal volume of 1N KOH for 15 minutes. After decantation and phase separation, the organic layer 
was drid over MgSO4 and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 23l in 40% yield (102 mg, 0.27 
mmol). Brown oil. 1H NMR (CDCl3, 400 MHz)  2.45 (s, 3H), 3.74 (s, 3H), 4.76 (dd, J = 2.0, 6.0 Hz, 2H), 
7.02 (td, J = 6.0, 15.5 Hz, 1H), 7.13 (td, J = 2.0, 15.5 Hz, 1H), 7.31-7.37 (m, 2H), 7.49-7.52 (m, 2H), 7.57-
7.62 (m, 1H), 7.87-7.93 (m, 2H), 7.95 (td, J = 2.0, 9.0 Hz, 2H). 13C NMR (CDCl3, 100 MHz)  21.7 (q), 47.9 
(t), 54.2 (q), 126.8 (d), 128.6 (d), 128.7 (d), 129.5 (d), 133.1 (s), 136.0 (d), 137.3 (s), 141.8 (s), 145.1 (d), 
152.4 (s), 189.7 (s). IR (cm-1) : 2958, 1737, 1676, 1359, 1169, 907, 729. HRMS (ESI) m/z calcd for 
C19H19NNaO5S [M+Na]+: 396.0876, found: 396.0884. 
 
Methyl (E)-4-[(N-(methoxycarbonyl)-4-methylphenyl)sulfonamido]but-2-enoate (23m) 
 
Following GP17 with methyl but-3-enoate (1 equiv., 50 mg, 0.5 mmol) and methyl tosylcarbamate A (2 
equiv., 228 mg, 0.99 mmol) for 48 hours. The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 23m in 93% yield (137 mg, 0.42 mmol). Beige 
solid, mp: 132-133 °C. 1H NMR (CDCl3, 400 MHz)  2.47 (s, 3H), 3.73 (s, 3H), 3.77 (s, 3H), 4.62 (dd, J = 
2.0, 3.5 Hz, 2H), 6.04 (td, J = 2.0, 15.5 Hz, 1H), 6.94 (td, J = 5.5, 15.5 Hz, 1H), 7.34-7.36 (m, 2H), 7.84-
7.86 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 47.2 (t), 51.7 (q), 54.1 (q), 123.0 (d), 128.6 (d), 129.5 
(d), 135.9 (s), 142.2 (s), 145.1 (d), 152.3 (s), 166.2 (s). IR (cm-1) : 2955, 1749, 1716, 1435, 1356, 1167. 
HRMS (ESI) m/z calcd for C14H17NNaO6S [M+Na]+: 350.0669, found: 350.0668. 
 
(E)-N-Benzyl-4-(N-tosylacetamido)but-2-enamide (24a) 
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Following GP17 with amide 22a (1 equiv., 100 mg, 0.57 mmol) and N-tosylacetamide B (2 equiv., 261 
mg, 1.14 mmol) for 24 hours. The crude product was purified by flash chromatography on silica gel 
(eluent: AcOEt / CycloHexane 1:1) to afford 24a in 61% yield (133 mg, 0.34 mmol). Beige solid, mp: 
161-162 °C. 1H NMR (CDCl3, 400 MHz)  2.24 (s, 3H), 2.36 (s, 3H), 4.43 (d, J = 6.0 Hz, 2H), 4.51 (dd, J = 
2.0, 5.0 Hz, 2H), 5.69 (br s, 1H), 5.88 (dt, J = 15.0, 2.0 Hz, 1H), 6.77 (dt, J = 15.0, 5.0 Hz, 1H), 7.21-7.30 
(m, 7H), 7.69-7.72 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.6 (q), 24.6 (q), 43.8 (t), 47.0 (t), 125.7 (d), 
127.7 (d), 127.8 (d), 128.0 (d), 128.8 (d), 129.9 (s), 136.4 (s), 137.9 (s), 138.1 (d), 138.6 (d), 145.3 (s), 
164.5 (s). IR (cm-1) : 3315, 2923, 1705, 1635, 1557, 1355, 1242, 1154. HRMS (ESI) m/z calcd for 
C20H22N2NaO4S [M+Na]+ : 409.1192, found: 409.1178. 
 
(E)-N-Benzyl-4-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)but-2-enamide (25a) 
 
Following GP17 with amide 22a (1 equiv., 100 mg, 0.57 mmol) and saccharin C (2 equiv., 208 mg, 1.14 
mmol) for 48 hours. The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 25a in 40% yield (80 mg, 0.02 mmol). White solid, mp: 149-150 °C. 
1H NMR (CDCl3, 400 MHz)  4.40-4.44 (m, 4H), 5.75 (br s, 1H), 6.01 (td, J = 2.0, 15.0 Hz, 1H), 6.84 (td, J 
= 5.5, 15.5 Hz, 1H), 7.17-7.27 (m, 5H), 7.75-7.87 (m, 3H), 7.98-8.00 (m, 1H). 13C NMR (CDCl3, 100 MHz) 
 39.2 (t), 43.8 (t), 121.1 (d), 125.3 (d), 126.7 (d), 127.1 (d), 127.6 (d), 127.9 (s), 128.7 (d), 134.5 (d), 
135.0 (d), 135.6 (s), 137.7 (s), 137.8 (d), 158.5 (s), 164.2 (s). IR (cm-1) : 3312, 1744, 1625, 1325, 1185, 
973, 752. HRMS (ESI) m/z calcd for C18H16N2NaO4S [M+Na]+: 379.0723, found: 379.0709. 
 
(E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-methylbenzyl)but-2-enamide (25b) 
 
Following GP17 with amide 22b (1 equiv., 100 mg, 0.53 mmol) and saccharin C (2 equiv., 193 mg, 1.05 
mmol) for 24 hours. The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 25b in 33% yield (64 mg, 0.17 mmol). White solid, mp: 171-172 °C. 
1H NMR (CDCl3, 400 MHz)  2.25 (s, 3H), 4.37 (d, J = 5.5 Hz, 2H), 4.41 (dd, J = 2.0, 5.5 Hz, 2H), 5.66 (br 
s, 1H), 5.99 (td, J = 2.0, 15.0 Hz, 1H), 6.83 (td, J = 5.5, 15.0 Hz, 1H), 7.04-7.10 (m, 4H), 7.77-7.87 (m, 3H), 
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7.98-8.01 (m, 1H). 13C NMR (CDCl3, 100 MHz)  21.1 (q), 39.2 (t), 43.6 (t), 121.1 (d), 125.3 (d), 126.8 (d), 
127.1 (d), 127.9 (s), 129.4 (d), 134.5 (d), 134.7 (s), 135.0 (d), 135.5 (s), 137.3 (s), 137.7 (d), 158.5 (s), 
164.2 (s). IR (cm-1) : 3291, 2922, 1731, 1621, 1334, 1186. HRMS (ESI) m/z calcd for C19H18N2NaO4S 
[M+Na]+: 393.0879, found: 393.0876. 
 
(E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-methoxybenzyl)but-2-enamide (25c) 
 
Following GP17 with amide 22c (1 equiv., 100 mg, 0.49 mmol) and saccharin C (2 equiv., 178 mg, 0.97 
mmol) for 24 hours. The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 25c in 57% yield (106 mg, 0.27 mmol). White solid, mp: 164-165 °C. 
1H NMR (CDCl3, 400 MHz)  3.80 (s, 3H), 4.44 (d, J = 5.5 Hz, 2H), 4.51 (dd, J = 2.0, 5.5 Hz, 2H), 5.74 (br 
s, 1H), 6.08 (td, J = 2.0, 15.0 Hz, 1H), 6.85-6.88 (m, 2H), 6.93 (td, J = 5.5, 15.5 Hz, 1H), 7.20-7.23 (m, 2H), 
7.85-7.97 (m, 3H), 8.09 (ddd, J = 1.0, 1.5, 7.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz)  39.2 (t), 43.3 (t), 55.3 
(q), 114.1 (d), 121.2 (d), 125.3 (d), 126.7 (d), 127.1 (s), 129.3 (s), 129.9 (d), 134.5 (d), 135.0 (d), 135.5 
(s), 137.7 (d), 158.5 (s), 159.1 (s), 164.1 (s). IR (cm-1) : 3293, 2933, 1734, 1513, 1182, 909, 730. HRMS 
(ESI) m/z calcd for C19H18N2NaO5S [M+Na]+ : 409.0829, found: 409.0836. 
 
(E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(3-methoxybenzyl)but-2-enamide (25d) 
 
Following GP17 with amide 22d (1 equiv., 100 mg, 0.48 mmol) and saccharin C (2 equiv., 178 mg, 0.97 
mmol) for 48 hours. The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 25d in 82% yield (154 mg, 0.4 mmol). White solid, mp: 138-140 °C. 
1H NMR (CDCl3, 400 MHz)  3.80 (s, 3H), 4.48 (d, J = 6.0 Hz, 2H), 4.52 (dd, J = 2.0, 5.5 Hz, 2H), 5.80 (br 
s, 1H), 6.10 (td, J = 2.0, 15.2 Hz, 1H); 6.82-6.84 (m, 3H), 6.93 (td, J = 5.5, 15.5 Hz, 1H), 7.25 (dd, J = 7.5, 
9.0 Hz, 1H), 7.87-7.95 (m, 3H), 8.02-8.11 (m, 1H). 13C NMR (CDCl3, 100 MHz)  39.2 (t), 43.8 (t), 55.2 
(q), 113.2 (d), 113.4 (d), 120.2 (d), 121.0 (d), 125.4 (d), 126.7 (d), 127.1 (s), 129.8 (d), 134.5 (d), 135.0 
(d), 135.7 (s), 137.8 (s), 139.3 (d), 158.5 (s), 159.9 (s), 164.2 (s). IR (cm-1) : 3287, 2921, 1731, 1625, 
1331, 1213, 1013. HRMS (ESI) m/z calcd for C19H18N2NaO5S [M+Na]+: 409.0829, found: 409.0840. 
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(E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-nitrobenzyl)but-2-enamide (25e) 
 
Following GP17 with amide 22e (1 equiv., 65 mg, 0.29 mmol) and saccharin C (2 equiv., 108 mg, 0.59 
mmol) for 48 hours. The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 25e in 30% yield (35 mg, 0.09 mmol). Beige solid, mp: 168-169 °C. 
1H NMR (CDCl3, 400 MHz)  4.44 (dd, J = 2.0, 5.5 Hz, 2H), 4.52 (d, J = 6.5 Hz, 2H), 5.93 (br s, 1H), 6.07 
(td, J = 2.0, 15.5 Hz, 1H), 6.88 (td, J = 5.5, 15.5 Hz, 1H), 7.35-7.39 (m, 2H), 7.77-7.89 (m, 3H), 8.00 (ddd, 
J = 7.5, 1.5, 1.0 Hz, 1H), 8.08-8.11 (m, 2H). 13C NMR (CDCl3, 100 MHz)  39.2 (t), 42.9 (t), 121.1 (d), 123.9 
(d), 125.4 (d), 126.1 (d), 127.0 (s), 128.3 (d), 134.6 (d), 135.1 (d), 136.6 (s), 137.7 (d), 145.4 (s), 147.4 
(s), 158.6 (s), 164.5 (s). IR (cm-1) : 3291, 2924, 1735, 1519, 1344, 1259, 968, 730. HRMS (ESI) m/z calcd 
for C18H15N3NaO6S [M+Na]+: 424.0574, found: 424.0584. 
 
Methyl (E)-(4-(benzylamino)-4-oxobut-2-en-1-yl)(tert-butylsulfinyl)carbamate (26a) 
 
Following GP17 with amide 22d (1 equiv., 100 mg, 0.57 mmol) and N-tert-butylsulfinyl carbamate D (2 
equiv., 204 mg, 1.14 mmol) for 48 hours. The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 26a in 47% yield (93 mg, 0.26 mmol). Yellow oil. 
1H NMR (CDCl3, 400 MHz)  1.21 (s, 9H), 3.77 (s, 3H), 3.94 (ddd, J = 2.0, 5.5, 17.0 Hz, 1H), 4.12 (ddd, J = 
2.0, 5.5, 17.0 Hz, 1H), 4.46 (d, J = 6.0 Hz, 2H), 5.95 (td, J = 1.5, 15.5, 1H), 6.08 (br s, 1H), 6.80 (td, J = 5.5, 
15.5 Hz, 1H), 7.27-7.35 (m, 5H). 13C NMR (CDCl3, 100 MHz)  22.5 (q), 39.1 (t), 43.7 (t), 53.6 (q), 60.2 
(s), 125.7 (d), 127.5 (d), 127.9 (d), 128.7 (d), 138.0 (s), 139.3 (d), 155.4 (s), 164.9 (s). IR (cm-1) : 3327, 
2951, 1702, 1670, 1494, 1371, 1250, 1033. HRMS (ESI) m/z calcd for C17H24N2NaO4S [M+Na]+: 375.1349, 
found: 375.1334. 
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Methyl (E)-(tert-butylsulfinyl)4-[(4-methylbenzyl)amino-4-oxobut-2-en-1-yl]carbamate (26b) 
 
Following GP17 with amide 22b (1 equiv., 100 mg, 0.53 mmol) and N-tert-butylsulfinyl carbamate D (2 
equiv., 190 mg, 1.06 mmol) for 30 hours. The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / CycloHexane 6:4) to afford 26b in 27% yield (51 mg, 0.14 mmol). Yellow oil. 
1H NMR (CDCl3, 400 MHz)  1.14 (s, 9H), 2.26 (s, 3H), 3.70 (s, 3H), 3.87 (ddd, J = 2.0, 5.5, 17.0 Hz, 1H), 
4.04 (ddd, J = 1.5, 6.0, 17.0 Hz, 1H), 4.37 (d, J = 6.0 Hz, 2H), 5.73 (br s, 1H), 5.83 (td, J = 1.5, 15.5 Hz, 
1H), 6.73 (ddd, J = 5.5, 6.0, 15.5 Hz, 1H), 7.05-7.12 (m, 4H). 13C NMR (CDCl3, 100 MHz)  22.5 (q), 29.7 
(q), 39.1 (t), 43.6 (t), 53.6 (q), 60.2 (s), 125.8 (d), 128.0 (d), 129.4 (d), 134.9 (s), 137.3 (s), 139.3 (d), 
155.4 (s), 164.7 (s). IR (cm-1) : 3295, 2925, 1717, 1674, 1634, 1443, 1307, 1089, 907, 729. HRMS (ESI) 
m/z calcd for C18H26KN2O4S [M+K]+ : 405.1245, found: 405.1232. 
 
Methyl (E)-(tert-butylsulfinyl)(4-((4-methoxybenzyl)amino)-4-oxobut-2-en-1-yl)carbamate (26c) 
 
Following GP17 with amide 22c (1 equiv., 100 mg, 0.49 mmol) and N-tert-butylsulfinyl carbamate D (2 
equiv., 174 mg, 0.97 mmol) for 30 hours. The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 26c in 16% yield (29 mg, 0.08 mmol). Yellow oil. 
1H NMR (CDCl3, 400 MHz)  1.14 (s, 9H), 3.70 (s, 3H), 3.72 (s, 3H), 3.87 (ddd, J = 2.0, 5.5, 17.0 Hz, 1H), 
4.01-4.08 (m, 1H), 4.35 (d, J = 6.0 Hz, 2H), 5.68 (br s, 1H), 5.83 (td, J= 2.0, 15.0 Hz, 1H), 6.72 (td, J = 6.0, 
15.5 Hz, 1H), 6.79 (d, J = 9.0 Hz, 2H), 7.14 (d, J = 9.0 Hz, 2H). 13C NMR (CDCl3, 100 MHz)  22.5 (q), 39.1 
(t), 43.3 (t), 53.6 (q), 55.3 (q), 60.2 (s), 114.1 (d), 125.8 (d), 129.3 (d), 130.0 (s), 139.3 (d), 155.4 (s), 
159.1 (s), 164.7 (s). IR (cm-1) : 2927, 1717, 1513, 1250, 1089, 909, 731. HRMS (ESI) m/z calcd for 
C18H26KN2O5S [M+K]+: 421.1194, found: 421.1199. 
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Methyl (E)-(tert-butylsulfinyl)(4-((3-methoxybenzyl)amino)-4-oxobut-2-en-1-yl)carbamate (26d) 
 
Following GP17 with amide 22d (1 equiv., 100 mg, 0.49 mmol) and N-tert-butylsulfinyl carbamate D (2 
equiv., 175 mg, 0.97 mmol) for 48 hours. The crude product was purified by flash chromatography on 
silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 26d in 50% yield (93 mg, 0.24 mmol). Pale brown 
oil. 1H NMR (CDCl3, 400 MHz)  1.14 (s, 9H), 3.70 (s, 3H), 3.72 (s, 3H), 3.87 (ddd, J = 2.0, 5.5, 17.0 Hz, 
1H), 4.05 (ddd, J = 1.5, 6.0, 17.0 Hz, 1H), 4.38 (d, J = 6.0 Hz, 2H), 5.86 (td, J = 1.5, 15.5 Hz, 1H), 5.90 (br 
s, 1H), 6.69-6.80 (m, 4H), 7.15-7.20 (m, 1H). 13C NMR (CDCl3, 100 MHz)  22.5 (q), 39.1 (t), 43.7 (t), 53.6 
(q), 55.2 (q), 60.2 (s), 113.0 (d), 113.5 (d), 120.2 (d), 125.7 (d), 129.7 (d), 139.4 (s), 139.5 (d), 155.4 (s), 
159.8 (s), 164.8 (s). IR (cm-1) : 3294, 2958, 1716, 1675, 1634, 1442, 1264, 907, 728. HRMS (ESI) m/z 
calcd for C18H26KN2O5S [M+K]+ : 421.1194, found: 421.1 
 
General procedure (GP18) for the Pd(II)-catalyzed direct acyloxylation. 
 
A flask was charged with LiOH.H2O (2 equiv.) and tBuCO2H (10 equiv.) and the mixture was heated at 
40 °C for 10 minutes. Then BQ (2 equiv.), Pd(OAc)2 (10 mol %) and CH3CN (0.2 M) were added. The 
mixture was stirred for 15 minutes at rt, then the corresponding amide 22 (1 equiv.) was added. The 
mixture was stirred at 40 °C until the completion of the reaction. After cooling to rt, the mixture was 
filtered through a SiO2 pad and washed with Et2O (40 mL). NaOH (2M) was added and the mixture was 
stirred for 15 minutes. The organic phase was hydrolyzed with H2O, extracted with Et2O, dried over 
MgSO4, filtered and concentrated at reduced pressure. The crude product was purified by silica gel 
column chromatography to afford the corresponding pivaloxylated product 27. 
 
(E)-4-(Benzylamino)-4-oxobut-2-en-1-yl pivalate (27a) 
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Following GP18 with 22a (1 equiv., 300 mg, 1.70 mmol) for 24 hours. The crude product was purified 
by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27a in 98% yield (458 
mg, 1.67 mmol). White solid, mp: 66-68 °C. 1H NMR (CDCl3, 400 MHz)  1.23 (s, 9H), 4.50 (d, J = 6.0 Hz, 
2H), 4.69 (dd, J = 5.0, 2.0 Hz, 2H), 6.02 (d, J = 15.5 Hz, 1H), 6.15 (br s, 1H), 6.84-6.90 (m, 1H), 7.26-7.35 
(m, 5H). 13C NMR (CDCl3, 100 MHz)  27.3 (q), 38.9 (s), 43.8 (t), 62.9 (t), 124.3 (d), 127.7 (d), 128.0 (d), 
128.8 (d), 137.9 (s), 138.1 (d), 165.0 (d), 178.0 (d). IR (cm-1) : 3247, 2968, 1727, 1678, 1629, 1278, 
1159. HRMS (ESI) m/z calcd for C16H21NNaO3 [M+Na]+: 298.1419, found: 298.1414. 
 
(E)-4-[(4-Methylbenzyl)amino]-4-oxobut-2-en-1-yl pivalate (27b)  
 
Following GP18 with amide 22b (1 equiv., 100 mg, 0.53 mmol) for 24 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27b in 50% 
yield (75 mg, 0.26 mmol). White solid, mp: 144-145 °C. 1H NMR (CDCl3, 400 MHz)  1.13 (s, 9H), 2.24 
(s, 3H), 4.34-4.36 (m, 2H), 4.57-4.60 (m, 2H), 5.92 (td, J = 2.0, 15.5 Hz, 2H), 6.10 (br s, 1H), 6.72-6.79 
(m, 1H), 7.03-7.09 (m, 4H). 13C NMR (CDCl3, 100 MHz)  21.1 (q), 27.2 (q), 38.8 (s), 43.5 (t), 62.8 (t), 
124.3 (d), 127.9 (d), 129.3 (d), 134.9 (s), 137.3 (s), 137.6 (d), 164.8 (s), 177.9 (s). IR (cm-1) : 3242, 2971, 
1733, 1673, 1622, 1281, 1142. HRMS (ESI) m/z calcd for C17H23NNaO3 [M+Na]+ :312.1570, found: 
312.1570. 
 
(E)-4-[(4-Methoxybenzyl)amino]-4-oxobut-2-en-1-yl pivalate (27c) 
 
Following GP18 with amide 22c (1 equiv., 300 mg, 1.5 mmol) for 23 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27c in 70% 
yield (306 mg, 1.00 mmol). Brown solid, mp: 125-127 °C. 1H NMR (CDCl3, 400 MHz)  1.24 (s, 9H), 3.82 
(s, 3H), 4.47 (dd, J = 1.5, 5.5 Hz, 2H), 4.73 (dd, J = 2.0, 4.5 Hz, 2H), 5.82 (br s, 1H), 5.99 (dt, J = 1.5, 15.0 
Hz, 1H), 6.87-6.93 (m, 3H), 7.23-7.26 (m, 2H).13C NMR (CDCl3, 100 MHz)  27.2 (q), 38.8 (s), 43.3 (t), 
55.3 (q), 62.7 (t), 114.1 (d), 116.1 (d), 124.1 (s), 129.3 (d), 137.9 (d), 159.1 (s), 164.7 (s), 177.9 (s). IR 
(cm-1) : 3371, 2961, 1712, 1674, 1513, 1245, 1161. HRMS (ESI) m/z calcd for C17H23NNaO4 [M+Na]+: 
328.1519, found: 328.1518. 
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(E)-4-[(3-Methoxybenzyl)amino]-4-oxobut-2-en-1-yl pivalate (27d) 
 
Following GP18 with amide 22d (1 equiv., 100 mg, 0.48 mmol) for 23 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27d in 62% 
yield (91 mg, 0.20 mmol). Colorless oil. 1H NMR (CDCl3, 400 MHz)  1.15 (s, 9H), 3.72 (s, 3H), 4.41 (d, J 
= 6.0 Hz, 2H), 4.63 (dd, J = 2.0, 5.0 Hz, 2H), 5.84 (br s, 1H), 5.92 (td, J = 2.0, 15.5 Hz, 1H), 6.73-6.85 (m, 
4H), 7.16-7.20 (m, 1H). 13C NMR (CDCl3, 100 MHz)  27.2 (q), 38.8 (s), 43.7 (t), 55.2 (q), 62.8 (t), 113.0 
(d), 113.6 (d), 120.1 (d), 124.1 (d), 129.8 (d), 137.9 (s), 139.5 (d), 159.9 (s), 164.7 (s), 177.9 (s). IR (cm-
1) : 3271, 2969, 1729, 1675, 1632, 1541, 1263, 1145. HRMS (ESI) m/z calcd for C17H23NNaO4 [M+Na]+: 
328.1519, found: 328.1521. 
 
(E)-4-[(4-Nitrobenzyl)amino]-4-oxobut-2-en-1-yl pivalate (27e) 
 
Following GP18 with amide 22e (1 equiv., 100 mg, 0.45 mmol) for 24 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27e in 75% 
yield (109 mg, 0.34 mmol). White solid, mp: 112-113 °C. 1H NMR (CDCl3, 400 MHz)  1.16 (s, 9H), 4.54 
(dd, J = 3.0, 6.5 Hz, 2H), 4.65 (dd, J = 2.0, 4.0 Hz, 2H), 5.98 (m, 1H), 6.15 (br s, 1H), 6.84 (ddd, J = 15.0, 
6.0, 3.5 Hz, 1H), 7.37 (dd, J = 2.5, 9.0 Hz, 2H), 8.06-8.10 (m, 2H). 13C NMR (CDCl3, 100 MHz)  27.2 (q), 
38.8 (s), 42.9 (t), 62.7 (t), 123.5 (d), 123.8 (d), 128.3 (d), 138.8 (d), 145.7 (s), 147.3 (s), 165.1 (s), 177.8 
(s). IR (cm-1) : 3267, 2974, 1730, 1673, 1633, 1518, 1345, 1145. HRMS (ESI) m/z calcd for C16H20N2NaO5 
[M+Na]+: 343.1264, found: 343.1257. 
 
(E)-4-Oxo-4-[(4-(trifluoromethyl)benzyl)amino]but-2-en-1-yl pivalate (27f) 
 
Following GP18 with amide 22f (1 equiv., 300 mg, 1.23 mmol) for 23 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27f in 91% 
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yield (382 mg, 1.1 mmol). Orange viscous oil. 1H NMR (CDCl3, 400 MHz)  1.14 (s, 9H), 4.46 (d, J = 6.0 
Hz, 2H), 4.63 (dd, J = 2.0, 5.0 Hz, 2H), 5.95 (dt, J = 15.5, 2.0 Hz, 1H), 6.19 (br s, 1H), 6.82 (dt, J = 15.5, 
5.0 Hz, 1H), 7.30-7.32 (m, 2H), 7.48-7.50 (m, 2H). 13C NMR (CDCl3, 100 MHz)  27.1 (q), 38.8 (s), 43.4 
(t), 62.7 (t), 123.7 (d), 124.0 (J = 273.5 Hz, s), 125.6 (J = 3.5 Hz, d), 127.9 (d), 129.8 (J = 31.5 Hz, s), 138.5 
(d), 142.0 (s), 165.1 (s), 177.9 (s). 19F NMR (CDCl3, 282 MHz)  - 62.53. IR (cm-1) : 3276, 3076, 1728, 
1676, 1634, 1324, 1158, 906, 728. HRMS (ESI) m/z calcd for C17H20F3NNaO3 [M+Na]+: 366.1287, found: 
366.1285. 
 
(E)-4-[(Furan-2-ylmethyl)amino]-4-oxobut-2-en-1-yl pivalate (27g) 
 
Following GP18 with amide 22g (1 equiv., 150 mg, 0.9 mmol) for 22 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27g in 35% 
yield (80 mg, 0.30 mmol). Yellow solid, mp: 125 °C. 1H NMR (CDCl3, 400 MHz)  1.16 (s, 9H), 4.44 (d, J 
= 5.5 Hz, 2H), 4.63 (dd, J = 1.5, 5.0 Hz, 2H), 5.90 (br s, 1H), 5.92 (td, J = 1.5, 15.0 Hz, 1H), 6.17-6.18 (m, 
1H), 6.25 (dd, J = 2.0, 3.0 Hz, 1H), 6.81 (ddd, J = 4.5, 5.0, 15.0 Hz, 1H), 7.29 (dd, J = 1.0, 2.0 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz)  27.2 (q), 36.5 (t), 38.8 (s), 62.7 (t), 107.7 (d), 110.5 (d), 123.9 (d), 138.0 (d), 
142.3 (d), 150.9 (s), 164.6 (s), 177.8 (s). IR (cm-1) : 3230, 2966, 1730, 1672, 1626, 1151, 752. HRMS 
(ESI) m/z calcd for C14H19NNaO4 [M+Na]+: 288.1206, found: 288.1201. 
 
(E)-4-Oxo-4-(phenylamino)but-2-en-1-yl pivalate (27h) 
 
Following GP18 with amide 22h (1 equiv., 200 mg, 1.24 mmol) for 20 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27h in 44% 
yield (142 mg, 0.54 mmol). Yellow oil. 1H NMR (CDCl3, 400 MHz)  1.15 (s, 9H), 4.64 (dd, J = 2.0, 5.0 Hz, 
2H), 6.10 (td, J = 2.0, 15.5 Hz, 1H), 6.88 (td, J = 5.0, 15.5 Hz, 1H), 7.03 (t, J = 7.5 Hz, 1H), 7.22 (t, J = 8.0 
Hz, 2H), 7.49 (d, J = 8.0 Hz, 2H), 7.78 (br s, 1H). 13C NMR (CDCl3, 100 MHz)  27.2 (q), 38.9 (s), 62.8 (t), 
120.1 (d), 124.6 (d), 124.9 (d), 129.0 (d), 137.8 (s), 138.7 (d), 163.2 (s), 177.9 (s). IR (cm-1) : 3269, 2927, 
1730, 1678, 1642, 1543, 1442, 1149, 754. HRMS (ESI) m/z calcd for C15H19NNaO3 [M+Na]+ 284.1257, 
found: 284.1267. 
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(E)-4-Oxo-4-(phenethylamino)but-2-en-1-yl pivalate (27i) 
 
Following GP18 with amide 22i (1 equiv., 150 mg, 0.8 mmol) for 22 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27i in 83% 
yield (191 mg, 0.66 mmol). Pale yellow viscous oil. 1H NMR (CDCl3, 400 MHz)  1.15 (s, 9H), 2.79 (t, J = 
7.0 Hz, 2H), 3.51-3.56 (m, 2H), 4.62 (dd, J = 2.0, 5.0 Hz, 2H), 5.46 (s, 1H), 5.83 (dt, J = 15.5, 2.0 Hz, 1H), 
6.76 (dt, J = 15.5, 5.0 Hz, 1H), 7.12-7.26 (m, 5H). 13C NMR (CDCl3, 100 MHz)  27.2 (q), 33.9 (t), 35.6 (s), 
40.7 (t), 62.8 (t), 124.4 (d), 126.6 (d), 128.7 (d), 128.8 (d), 137.5 (s), 138.7 (d), 164.9 (s), 177.8 (s). IR 
(cm-1) : 3283, 2931, 2359, 1731, 1676, 1632, 1282, 1151, 738. HRMS (ESI) m/z calcd for C17H23KNO3 
[M+K]+: 328.1310, found: 328.1312. 
 
(E)-4-(Dibenzylamino)-4-oxobut-2-en-1-yl pivalate (27j) 
 
Following GP18 with amide 22j (1 equiv., 100 mg, 0.4 mmol) for 22 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 4:6) to afford 27j in 60% 
yield (81 mg, 0.22 mmol). Yellow oil. 1H NMR (CDCl3, 400 MHz)  1.15 (s, 9H), 4.54 (s, 2H), 4.71 (s, 2H), 
4.76 (dd, J = 4.5, 2.0 Hz, 2H), 6.49 (dt, J = 15.0, 2.0 Hz, 1H), 7.07 (dt, J = 15.0, 4.5 Hz, 1H), 7.19 (d, J = 7.0 
Hz, 2H), 7.44-7.25 (m, 8H). 13C NMR (CDCl3, 100 MHz)  27.1 (q), 38.8 (s), 48.9 (t), 50.0 (t), 62.9 (t), 
121.0 (d), 126.4 (d), 127.5 (d), 127.7 (d), 128.4 (d), 128.6 (d), 129.0 (d), 136.4 (s), 137.1 (s), 140.1 (d), 
166.5 (s), 177.7 (s). IR (cm-1) : 3030, 2971, 2359, 1730, 1667, 1625, 1426, 1362, 1278, 1150, 960. HRMS 
(ESI) m/z calcd for C23H27NNaO3 [M+Na]+ 388.1883, found: 388.1896. 
 
(E)-4-(Methoxy(methyl)amino)-4-oxobut-2-en-1-yl pivalate (27k) 
 
Following GP18 with amide 22k (1 equiv., 60 mg, 0.46 mmol) for 26 hours. The crude product was 
purified by flash chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 27k in 48% 
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yield (51 mg, 0.22 mmol). Yellow oil. 1H NMR (CDCl3, 400 MHz)  1.22 (s, 9H), 3.23 (s, 3H), 3.68 (s, 3H), 
4.74-4.75 (m, 2H), 6.58 (d, J = 15.5 Hz, 1H), 6.91-6.96 (m, 1H). 13C NMR (CDCl3, 100 MHz)  27.3 (q), 
32.5 (q), 39.0 (s), 61.8 (q), 63.1 (t), 119.6 (d), 140.2 (d), 166.1 (s), 177.8 (s). IR (cm-1) : 2971, 1730, 
1669, 1633, 1364. HRMS (ESI) m/z calcd for C11H19NNaO4 [M+Na]+: 252.1212, found: 252.1206. 
 
Methyl (E)-4-(pivaloyloxy)but-2-enoate (27m) 
 
Following GP18 with methyl 3-butenoate 22m (commercially available) (1 equiv., 100 mg, 0.99 mmol) 
for 22 hours. The crude product was purified by flash chromatography on silica gel (eluent: AcOEt / 
CycloHexane 4:6) to afford 27m in 81% yield (163 mg, 0.81 mmol). Yellow oil. 1H NMR (CDCl3, 400 MHz) 
 1.24 (dd, J = 7.0, 2.0 Hz, 9H), 3.77 (m, 3H), 4.74 (dd, J = 4.5, 2.0 Hz, 2H), 6.03 (dt, J = 16.0, 2.0 Hz, 1H), 
6.88-7.05 (m, 1H). 13C NMR (CDCl3, 100 MHz)  27.0 (q), 38.8 (s), 51.7 (q), 62.4 (t), 121.3 (d), 141.9 (d), 
166.3 (s), 177.7 (s). IR (cm-1) : 2972, 2874, 1728, 1664, 1476, 1367, 1315, 1146. HRMS (ESI) m/z calcd 
for C10H16NaO4 [M+Na]+ 223.0941, found: 223.0935. 
 
General procedure (GP19) for the Pd(0)-catalyzed amination. 
 
A sealed tube was charged with the amide 27a (1 equiv., 50 mg, 0.18 mmol), and CH3CN (900 L, 0.2 
M). Then, Pd(OAc)2 (10 mol %, 4 mg, 0.018 mmol), (+)-BINAP (20 mol %, 22.4 mg, 0.036 mmol), 
phthalimide (3 equiv., 79.5 mg, 0.54 mmol) were added to the mixture. DIPEA was added last via a 
syringe (11.5 equiv., 352 mL, 2.07 mmol) and the mixture was stirred at reflux for the time required to 
complete the reaction (24 h). The solution was filtered through a small plug of silica gel, washed with 
AcOEt and concentrated at reduced pressure. The crude product was purified by silica gel column 
chromatography (eluent: AcOEt / CycloHexane 1:1) to afford 28a in 83% yield (48 mg, 0.15 mmol). 
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General procedure (GP20) for the sequential Pd(II) / Pd(0) catalyzed amination. 
 
A sealed tube was charged with LiOH.H2O (2 equiv.) and tBuCO2H (10 equiv.) and the mixture was 
heated at 40 °C for 10 minutes. Then BQ (2 equiv.), Pd(OAc)2 (10 mol %) and CH3CN (0.2 M) were added. 
The mixture was stirred for 15 minutes at rt, then the corresponding amide (22a,d-g,i) (1 equiv.) was 
added. The mixture was stirred at 40 °C for 8 hours. The completion of the reaction was monitored by 
TLC, and then DIPEA (11.5 equiv.), phtalimide (3 equiv.) and (+)-BINAP (20 mol %) were added and the 
mixture was stirred at 70 °C for 18 hours. After cooling to rt, the mixture was filtered through a SiO2 
pad and washed with AcOEt (20 mL for two times), then concentrated at reduced pressure. The crude 
product was purified by silica gel column chromatography to afford the corresponding aminated 
compounds (28a,d-g,i).  
 
(E)-N-Benzyl-4-(1,3-dioxoisoindolin-2-yl)but-2-enamide (28a) 
 
Following GP20 with amide 22a (1 equiv., 100 mg, 0.57 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28a in 90% yield (142 mg, 
0.44 mmol). White solid, mp: 184-185 °C. 1H NMR (DMSO-d6, 400 MHz)  4.28 (d, J = 6.0 Hz, 2H), 4.33 
(dd, J = 4.5, 2.0 Hz, 2H), 5.96 (dt, J = 15.5, 2.0 Hz, 1H), 6.68 (dt, J = 15.5, 4.5 Hz, 1H), 7.20-7.22 (m, 2H), 
7.27-7.29 (m, 2H), 7.85-7.92 (m, 4H), 8.39 (t, J = 6.0 Hz, 1H). 13C NMR (DMSO-d6, 100 MHz)  38.0 (t), 
42.1 (t), 123.2 (d), 124.4 (d), 126.8 (d), 127.4 (d), 128.3 (d), 131.6 (s), 134.5 (d), 136.3 (s), 139.1 (d), 
164.0 (s), 1674.4 (s). IR (cm-1) : 3282, 1771, 1701, 1629, 977, 720. HRMS (ESI) m/z calcd for 
C19H16N2NaO3 [M+Na]+: 343.1059, found: 343.1053. 
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(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-(4-methylbenzyl)but-2-enamide (28b) 
 
Following GP20 with amide 22b (1 equiv., 100 mg, 0.52 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28b in 22% (38 mg, 0.11 
mmol). Pale yellow solid, mp: 180-182 °C. 1H NMR (CDCl3, 400 MHz)  2.25 (d, J = 4.5 Hz, 3H), 4.32-4.39 
(m, 4H), 5.58 (br s, 1H), 5.82 (dt, J = 15.5, 1.5 Hz, 1H), 6.74-6.80 (m, 1H), 7.03-7.12 (m, 4H), 7.62-7.69 
(m, 2H), 7.75-7.83 (m, 2H). 13C NMR (CDCl3, 100 MHz)  21.0 (q), 38.2 (t), 43.6 (t), 123.5 (d), 125.7 (d), 
127.9 (d), 129.4 (d), 132.0 (d), 134.2 (s), 134.8 (d), 136.8 (s), 137.4 (d), 164.5 (s), 167.6 (s). IR (cm-1) : 
3274, 2923, 1771, 1713, 1666, 1623, 1547, 1458, 1351, 1218, 1118. . HRMS (ESI) m/z calcd for 
C20H18N2NaO3 [M+Na]+: 357.1210, found: 357.1222. 
 
(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-(4-methoxybenzyl)but-2-enamide (28c) 
 
Following GP20 with amide 22c (1 equiv., 100 mg, 0.48 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28c in 53% (90 mg, 0.26 
mmol). White solid, mp: 178-180 °C. 1H NMR (CDCl3, 400 MHz)  3.71 (s, 3H), 4.32-4.36 (m, 4H), 5.61 
(br s, 1H), 5.81 (td, J = 1.5, 15.5 Hz, 1H), 6.73-6.80 (m, 3H), 7.10-7.16 (m, 2H), 7.65-7.71 (m, 2H), 7.76-
7.81 (m, 2H). 13C NMR (CDCl3, 100 MHz)  39.2 (t), 43.4 (t), 55.3 (q), 114.1 (d), 123.5 (d), 125.7 (d), 
129.3 (s), 129.9 (d), 131.9 (d), 134.2 (s), 136.8 (d), 159.1 (s), 164.4 (s), 167.6 (s). IR (cm-1) : 3284, 2926, 
1708, 1620, 1513, 1247. HRMS (ESI) m/z calcd for C20H18N2NaO4 [M+Na]+: 373.1159, found: 373.1163. 
 
(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-(3-methoxybenzyl)but-2-enamide (28d) 
 
Following GP20 with amide 22d (1 equiv., 100 mg, 0.48 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28d in 76% yield (129 mg, 
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0.37 mmol). White solid, mp: 143-144 °C. 1H NMR (CDCl3, 400 MHz)  3.72 (d, J = 6.0 Hz, 3H), 4.31-4.43 
(m, 4H), 5.66 (br s, 1H), 5.83 (dt, J = 15.5, 2.0 Hz, 1H), 6.70-6.84 (m, 4H), 7.10-7.18 (m, 1H), 7.62-7.75 
(m, 2H), 7.75-7.84 (m, 2H). 13C NMR (CDCl3, 100 MHz)  38.2 (t), 43.7 (t), 55.2 (q), 113.1 (d), 113.4 (d), 
120.1 (d), 123.5 (d), 125.5 (d), 129.8 (d), 131.9 (d), 134.2 (d), 136.9 (s), 139.4 (d), 159.9 (s), 164.4 (s), 
167.6 (s). IR (cm-1) : 3275, 2897, 1702, 1631, 1423, 1046, 718. HRMS (ESI) m/z calcd for C20H18N2NaO4 
[M+Na]+ : 373.1159, found: 373.1157. 
 
(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-(furan-2-ylmethyl)but-2-enamide (28g) 
 
Following GP20 with amide 22g (1 equiv., 85 mg, 0.51 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28g in 20% (30 mg, 0.097 
mmol). Pale yellow solid, mp: 144-145 °C. 1H NMR (CDCl3, 400 MHz)  4.34 (dd, J = 2.0, 5.5 Hz, 2H), 4.39 
(d, J = 5.5 Hz, 2H), 5.75 (br s, 1H), 5.82 (td, J = 1.5, 15.5 Hz, 1H), 6.14 (dd, J = 1.0, 3.5 Hz, 1H), 6.22 (dd, 
J = 2.0, 3.0 Hz, 1H), 6.76 (td, J = 5.5, 15.5 Hz, 1H), 7.25 (dd, J = 1.0, 2.0 Hz, 1H), 7.66 (dd, J = 3.0, 5.5 Hz, 
2H), 7.78 (dd, J = 3.0, 5.5 Hz, 2H). 13C NMR (CDCl3, 100 MHz)  36.5 (t), 38.2 (t), 107.7 (d), 110.5 (d), 
123.5 (d), 125.4 (d), 131.9 (d), 134.2 (d), 137.1 (d), 142.2 (d), 150.8 (s), 164.3 (s), 167.6 (s). IR (cm-1) : 
3297, 2917, 1703, 1632, 1556, 1425, 1347, 716. HRMS (ESI) m/z calcd for C17H14N2NaO4 [M+Na]+: 
333.0846, found: 333.0857. 
 
(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-phenylbut-2-enamide (28h) 
 
Following GP20 with amide 22h (1 equiv., 80 mg, 0.49 mmol) and with 1.5 equivalent of phthalimide 
(109 mg, 0.744 mmol). The crude product was purified by flash chromatography on silica gel (eluent: 
AcOEt / CycloHexane 1:1) to afford 28h in 32% yield (44 mg, 0.14 mmol). Pale yellow solid, mp: 173-
174 °C. 1H NMR (CDCl3, 400 MHz)  4.48 (d, J = 5.5 Hz, 2H), 6.05 (d, J = 15.0 Hz, 1H), 6.95 (dt, J = 15.0, 
5.5 Hz, 1H), 7.10 (t, J = 7.5 Hz, 1H), 7.19 (s, 1H), 7.31 (t, J = 8.0 Hz, 2H), 7.51 (d, J = 7.0 Hz, 2H), 7.75 (dd, 
J = 5.5, 3.0 Hz, 2H), 7.84-7.93 (m, 2H). 13C NMR (CDCl3, 100 MHz)  38.2 (t), 119.9 (d), 123.3 (d), 124.6 
(d), 126.1 (d), 129.0 (d), 132.0 (d), 134.3 (s), 137.6 (s), 138.0 (d), 167.6 (s). IR (cm-1) : 3366, 1769, 1706, 
1388, 947, 756. HRMS (ESI) m/z calcd for C18H14N2NaO3 [M+Na]+: 329.0897, found: 329.0901. 
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(E)-4-(1,3-Dioxoisoindolin-2-yl)-N-phenethylbut-2-enamide (28i) 
 
Following GP20 with amide 22i (1 equiv., 100 mg, 0.53 mmol). The crude product was purified by flash 
chromatography on silica gel (eluent: AcOEt / CycloHexane 1:1) to afford 28i in 82% yield (145 mg, 0.43 
mmol). Pale yellow solid, mp: 148-150 °C. 1H NMR (CDCl3, 400 MHz)  2.75 (t, J = 7.0 Hz, 2H), 3.49 (dt, 
J = 6.0, 7.0 Hz, 2H), 4.33 (dd, J = 1.5, 6.0 Hz, 2H), 5.41 (br s, 1H), 5.76 (td, J = 1.5, 15.0 Hz, 1H), 6.71 (td, 
J = 6.0, 15.0 Hz, 1H), 7.09-7.25 (m, 5H), 7.66 (dd, J = 3.0, 5.5 Hz, 2H), 7.78 (dd, J = 3.0, 5.5 Hz, 2H). 13C 
NMR (CDCl3, 100 MHz)  35.5 (t), 38.2 (t), 40.6 (t), 123.5 (d), 125.8 (d), 126.5 (d), 128.6 (d), 128.7 (d), 
131.9 (d), 134.2 (s), 136.5 (s), 138.7 (d), 164.6 (s), 167.7 (s). IR (cm-1) : 3284, 2929, 1711, 1391, 717. 
HRMS (ESI) m/z calcd for C20H18N2NaO3 [M+Na]+: 357.1210, found: 357.1211. 
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General Conclusions 
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The main topic of my Ph.D. concerned the investigation of different transition metal-catalyzed 
reactions involving propargyl or allyl derivatives. Were obtained interesting results both with 
intramolecular alkoxylation sequences of terminal multiple C-C bonds and intermolecular allylic 
amination.  
The first alkoxylation reaction proposed starts from a simple and accessible substrate like a 
propargyl urea or a secondary propargyl amide and by copper(II) catalysis permits to afford a wide 
range of variously substituted haloalkylidene heterocycles. The scope of the procedure was obtained 
working under two different reaction conditions, the former one employes a stoichiometric quantity 
of the proper copper salt, CuCl2 or CuBr2, the latter involves catalytic CuCl2 and a stoichiometric amount 
of the suitable N-halosuccinimide (Scheme 57).  
 
 
 
Scheme 57: Copper(II)-Catalyzed Alkoxyhalogenation of Alkynyl Ureas and Secondary Amides. 
 
The second alkoxylation reaction studied involved a selective 7-endo-cyclization process 
palladium(II)-catalyzed in oxidative conditions of a particular range of substrates, 3-aza-5-alkenols. This 
mechanism was observable only when to the alkoxylation is related an arylation, confirming the 
uniqueness of the procedure (Scheme 58).  
 
 
 
Scheme 58: Possible Pd-Catalyzed exo- and endo-Cyclization of 3-Aza-5-alkenols. 
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Lastly, an intermolecular process was investigated, a palladium(II)-catalyzed allylic amination 
of but-3-enoic derivatives (B3A).  
 
 
 
Scheme 59: Complementary Routes for the Amination of B3A Derivatives.  
 
To conclude, in this chapter we developed two complementary strategies for the palladium-
catalyzed dehydrogenative amination of B3A derivatives, allowing to build-up various -AB2 products. 
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